organoarsenic compound - Ontology Report - Rat Genome Database

Submit Data | Help | Video Tutorials | News | Publications | Download | REST API | Citing RGD | Contact

Advanced Search (OLGA)

CHEBI ONTOLOGY - ANNOTATIONS

{{ watchLinkText }}

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:	organoarsenic compound	go back to main search page
Accession:	CHEBI:33406	browse the term
Synonyms:	related_synonym:	organoarsenic compounds

show annotations for term's descendants Sort by:
Rat (1281 ) Mouse (1425 ) Human (1318 ) Chinchilla (0 ) Bonobo (0 ) Dog (0 ) Squirrel (0 ) Pig (0 ) Green Monkey (0) Naked Mole-rat (0 ) All
Genes (1281)

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

brain-derived neurotrophic factor

decreases expression
multiple interactions

EXP

Arsanilic Acid results in decreased expression of BDNF mRNA; Arsanilic Acid results in decreased expression of BDNF protein
Dexamethasone inhibits the reaction [Arsanilic Acid results in decreased expression of BDNF mRNA]; Dexamethasone inhibits the reaction [Arsanilic Acid results in decreased expression of BDNF protein]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Arsanilic Acid results in decreased expression of BDNF mRNA]]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Arsanilic Acid results in decreased expression of BDNF protein]]

NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:116,619,633...116,670,657

G

caspase 3

increases activity
increases expression
multiple interactions
increases cleavage

EXP

Arsanilic Acid results in increased activity of CASP3 protein
Arsanilic Acid results in increased expression of CASP3 mRNA
Dexamethasone inhibits the reaction [Arsanilic Acid results in increased cleavage of CASP3 protein]; Dexamethasone inhibits the reaction [Arsanilic Acid results in increased expression of CASP3 mRNA]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Arsanilic Acid results in increased cleavage of CASP3 protein]]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Arsanilic Acid results in increased expression of CASP3 mRNA]]

PMID:23848144 PMID:30628712

NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732

G

caspase 9

increases activity

EXP

Arsanilic Acid results in increased activity of CASP9 protein

Ensembl chr 5:159,391,188...159,409,648

G

neurotrophic receptor tyrosine kinase 2

decreases expression
multiple interactions

EXP

Arsanilic Acid results in decreased expression of NTRK2 mRNA; Arsanilic Acid results in decreased expression of NTRK2 protein
Dexamethasone inhibits the reaction [Arsanilic Acid results in decreased expression of NTRK2 mRNA]; Dexamethasone inhibits the reaction [Arsanilic Acid results in decreased expression of NTRK2 protein]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Arsanilic Acid results in decreased expression of NTRK2 mRNA]]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Arsanilic Acid results in decreased expression of NTRK2 protein]]

NCBI chr17:5,560,558...5,875,899
Ensembl chr17:5,564,570...5,874,628

G

solute carrier family 12 member 5

decreases expression
multiple interactions

EXP

Arsanilic Acid results in decreased expression of SLC12A5 mRNA; Arsanilic Acid results in decreased expression of SLC12A5 protein
Dexamethasone inhibits the reaction [Arsanilic Acid results in decreased expression of SLC12A5 mRNA]; Dexamethasone inhibits the reaction [Arsanilic Acid results in decreased expression of SLC12A5 protein]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Arsanilic Acid results in decreased expression of SLC12A5 mRNA]]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Arsanilic Acid results in decreased expression of SLC12A5 protein]]

NCBI chr 3:153,696,517...153,735,801
Ensembl chr 3:174,115,833...174,155,112

dimethylarsinic acid

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

alpha-2-macroglobulin

decreases expression

EXP

Cacodylic Acid results in decreased expression of A2M mRNA

NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:156,569,860...156,619,868

G

alpha-2-macroglobulin-like 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of A2ML1 mRNA

NCBI chr 4:161,815,111...161,857,286
Ensembl chr 4:163,501,585...163,543,506

G

acetoacetyl-CoA synthetase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of AACS mRNA

NCBI chr12:36,774,471...36,817,835
Ensembl chr12:36,774,471...36,822,543

G

alanine and arginine rich domain containing protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of AARD mRNA

NCBI chr 7:83,364,478...83,369,319
Ensembl chr 7:85,253,992...85,259,163

G

ATP-binding cassette, subfamily A (ABC1), member 8a

decreases expression

EXP

Cacodylic Acid results in decreased expression of ABCA8A mRNA

NCBI chr10:95,002,334...95,072,315
Ensembl chr10:95,501,798...95,571,873

G

ATP binding cassette subfamily B member 1A

increases expression
decreases expression

EXP

Cacodylic Acid results in increased expression of ABCB1A mRNA; Cacodylic Acid results in increased expression of ABCB1A protein
Cacodylic Acid results in decreased expression of ABCB1A mRNA

PMID:16436460 PMID:17720352

NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135

G

ATP binding cassette subfamily C member 1

increases expression
affects transport
decreases response to substance
increases transport

EXP
ISO

Cacodylic Acid results in increased expression of ABCC1 mRNA; Cacodylic Acid results in increased expression of ABCC1 protein
ABCC1 protein modified form affects the transport of Cacodylic Acid
ABCC1 protein results in decreased susceptibility to Cacodylic Acid
ABCC1 protein results in increased transport of Cacodylic Acid

PMID:16436460 PMID:29752257

NCBI chr10:1,022,041...1,162,431
Ensembl chr10:1,038,947...1,162,404

G

ATP binding cassette subfamily C member 2

increases expression

EXP

Cacodylic Acid results in increased expression of ABCC2 mRNA; Cacodylic Acid results in increased expression of ABCC2 protein

NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:252,614,017...252,673,471

G

ATP binding cassette subfamily C member 3

increases expression

EXP

Cacodylic Acid results in increased expression of ABCC3 mRNA; Cacodylic Acid results in increased expression of ABCC3 protein

NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,793,583...79,839,494

G

ATP binding cassette subfamily C member 4

increases transport
affects export
increases export

ISO

ABCC4 protein results in increased transport of Cacodylic Acid
ABCC4 gene SNP affects the export of Cacodylic Acid
ABCC4 protein results in increased export of Cacodylic Acid

PMID:24870404 PMID:25752797 PMID:27659809

NCBI chr15:101,948,387...102,182,912
Ensembl chr15:101,949,433...102,181,375

G

ATP binding cassette subfamily C member 9

decreases expression

EXP

Cacodylic Acid results in decreased expression of ABCC9 mRNA

NCBI chr 4:175,531,854...175,655,849
Ensembl chr 4:177,262,848...177,386,348

G

ABI family member 3 binding protein

decreases expression

EXP

Cacodylic Acid results in decreased expression of ABI3BP mRNA

NCBI chr11:57,381,282...57,597,989
Ensembl chr11:57,381,422...57,598,120

G

ArfGAP with coiled-coil, ankyrin repeat and PH domains 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ACAP1 mRNA

NCBI chr10:54,605,323...54,619,472
Ensembl chr10:55,104,040...55,118,185

G

acetylcholinesterase

decreases activity

ISO

Cacodylic Acid results in decreased activity of ACHE protein

NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410

G

acyl-CoA thioesterase 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ACOT1 mRNA

NCBI chr 6:103,636,173...103,644,167
Ensembl chr 6:109,367,268...109,380,749

G

acyl-CoA thioesterase 12

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ACOT12 mRNA

NCBI chr 2:22,986,867...23,027,538
Ensembl chr 2:24,721,910...24,765,298

G

acyl-CoA oxidase 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ACOX2 mRNA

NCBI chr15:16,660,584...16,692,160
Ensembl chr15:19,090,926...19,122,392

G

acrosin binding protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ACRBP mRNA

NCBI chr 4:157,851,149...157,864,211
Ensembl chr 4:159,537,391...159,550,454

G

actinin, alpha 1

increases expression

EXP

Cacodylic Acid results in increased expression of ACTN1 mRNA

NCBI chr 6:98,998,553...99,093,334
Ensembl chr 6:104,731,485...104,826,172

G

ADAM metallopeptidase with thrombospondin type 1 motif, 19

decreases expression

EXP

Cacodylic Acid results in decreased expression of ADAMTS19 mRNA

NCBI chr18:52,346,448...52,531,245
Ensembl chr18:54,545,357...54,729,181

G

ADAM metallopeptidase with thrombospondin type 1 motif, 2

decreases expression

EXP

Cacodylic Acid results in decreased expression of ADAMTS2 mRNA

NCBI chr10:34,920,992...35,126,465
Ensembl chr10:35,422,030...35,627,483

G

ADAM metallopeptidase with thrombospondin type 1 motif, 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ADAMTS4 mRNA

NCBI chr13:83,670,556...83,680,045
Ensembl chr13:86,202,642...86,212,514

G

ADAM metallopeptidase with thrombospondin type 1 motif, 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ADAMTS6 mRNA

NCBI chr 2:35,421,483...35,633,305
Ensembl chr 2:37,155,288...37,367,070

G

adhesion G protein-coupled receptor G1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ADGRG1 mRNA

NCBI chr19:10,009,983...10,047,138
Ensembl chr19:10,010,031...10,047,124

G

alcohol dehydrogenase 1C (class I), gamma polypeptide

decreases expression

EXP

Cacodylic Acid results in decreased expression of ADH1 mRNA

NCBI chr 2:226,797,303...226,808,892
Ensembl chr 2:229,470,703...229,482,291

G

adiponectin, C1Q and collagen domain containing

decreases expression

EXP

Cacodylic Acid results in decreased expression of ADIPOQ mRNA

NCBI chr11:77,721,912...77,735,644
Ensembl chr11:91,226,180...91,240,169

G

adrenomedullin

increases expression
multiple interactions

ISO

Cacodylic Acid results in increased expression of ADM mRNA
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ADM mRNA

PMID:32052077 PMID:34876320 PMID:38630284

NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:174,178,773...174,182,371

G

adrenoceptor alpha 2B

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ADRA2B mRNA

NCBI chr 3:114,585,174...114,589,220
Ensembl chr 3:135,038,474...135,042,525

G

adrenoceptor beta 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ADRB1 mRNA

NCBI chr 1:255,771,962...255,774,973
Ensembl chr 1:265,766,079...265,849,237

G

adrenoceptor beta 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ADRB2 mRNA

NCBI chr18:57,912,760...57,914,802
Ensembl chr18:57,911,348...57,914,803

G

ALF transcription elongation factor 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of AFF3 mRNA

NCBI chr 9:40,399,099...40,856,716
Ensembl chr 9:47,894,903...48,353,000

G

alpha-fetoprotein

increases expression

ISO

Cacodylic Acid results in increased expression of AFP mRNA

NCBI chr14:17,857,584...17,875,645
Ensembl chr14:17,857,584...17,875,649

G

anterior gradient 3, protein disulphide isomerase family member

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of AGR3 mRNA

NCBI chr 6:52,643,391...52,666,638
Ensembl chr 6:58,370,701...58,399,859

G

angiotensin II receptor-associated protein

decreases expression

ISO

Cacodylic Acid results in decreased expression of AGTRAP mRNA

NCBI chr 5:158,507,427...158,519,036
Ensembl chr 5:163,791,887...163,802,174

G

AT hook, DNA binding motif, containing 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of AHDC1 mRNA

NCBI chr 5:145,228,228...145,294,170
Ensembl chr 5:150,512,037...150,583,144

G

aryl hydrocarbon receptor

multiple interactions

ISO

AHR mutant form inhibits the reaction [Cacodylic Acid results in increased expression of CYP1A1 protein]; Cacodylic Acid results in decreased expression of and affects the localization of AHR protein
Cacodylic Acid affects the reaction [[Tetrachlorodibenzodioxin results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA]; Cacodylic Acid affects the reaction [[Tetrachlorodibenzodioxin results in increased activity of AHR protein] which results in increased expression of CYP1A1 protein]

PMID:24161444 PMID:28134025

NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901

G

aryl-hydrocarbon receptor repressor

decreases expression

EXP

Cacodylic Acid results in decreased expression of AHRR mRNA

NCBI chr 1:28,993,634...29,088,673
Ensembl chr 1:30,810,866...30,952,866

G

alpha-2-HS-glycoprotein

decreases expression

ISO

Cacodylic Acid results in decreased expression of AHSG mRNA

NCBI chr11:91,625,975...91,632,583
Ensembl chr11:91,625,975...91,634,039

G

autoimmune regulator

multiple interactions

ISO

[Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of AIRE mRNA

NCBI chr20:10,635,775...10,650,709
Ensembl chr20:10,635,775...10,650,709

G

adenylate kinase 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of AK4 mRNA

NCBI chr 5:116,039,222...116,099,064
Ensembl chr 5:121,154,572...121,214,401

G

aldo-keto reductase family 1 member B15

increases expression

EXP

Cacodylic Acid results in increased expression of AKR1B8 mRNA

NCBI chr 4:62,997,241...63,009,815
Ensembl chr 4:63,960,880...63,978,349

G

aldo-keto reductase family 1, member C3

increases expression

ISO

Cacodylic Acid results in increased expression of AKR1C3 mRNA

NCBI chr17:71,020,884...71,037,779
Ensembl chr17:70,970,900...71,048,438

G

aldo-keto reductase family 7, member A2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of AKR7A5 mRNA

NCBI chr 5:151,552,375...151,560,914
Ensembl chr 5:156,835,551...156,844,109

G

AKT serine/threonine kinase 1

multiple interactions

ISO
EXP

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of AKT1 mRNA
Cacodylic Acid results in increased expression of and results in increased phosphorylation of AKT1 protein
Cacodylic Acid results in decreased expression of and results in decreased phosphorylation of AKT1 protein

PMID:23192986 PMID:32890875 PMID:36000705

NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610

G

albumin

decreases expression
multiple interactions

ISO

Cacodylic Acid results in decreased expression of ALB mRNA
[Arsenic results in increased abundance of Cacodylic Acid] which affects the secretion of ALB protein

PMID:32052077 PMID:36754906

NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865

G

aldehyde dehydrogenase 1 family, member A1

increases expression

EXP

Cacodylic Acid results in increased expression of ALDH1A1 mRNA; Cacodylic Acid results in increased expression of ALDH1A1 protein

PMID:33211169 PMID:37567419

NCBI chr 1:227,426,939...227,579,497
Ensembl chr 1:227,427,070...227,579,500

G

aldolase, fructose-bisphosphate C

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ALDOC mRNA

NCBI chr10:63,217,477...63,221,066
Ensembl chr10:63,715,489...63,719,133

G

alpha-kinase 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ALPK1 mRNA

NCBI chr 2:216,126,939...216,247,180
Ensembl chr 2:218,780,189...218,921,646

G

alkaline phosphatase, placental

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of AKP3 mRNA

NCBI chr 9:87,765,846...87,768,606
Ensembl chr 9:95,213,374...95,219,451

G

angiopoietin like 7

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ANGPTL7 mRNA

NCBI chr 5:158,932,096...158,937,281
Ensembl chr 5:164,215,223...164,220,584

G

ankyrin repeat domain 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ANKRD1 mRNA

NCBI chr 1:233,815,851...233,834,891
Ensembl chr 1:243,228,448...243,263,751

G

ANKRD40 C-terminal like

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ANKRD40CL mRNA

NCBI chr10:79,227,791...79,236,365
Ensembl chr10:79,728,105...79,732,218

G

ANTXR cell adhesion molecule 1

decreases expression

EXP

Cacodylic Acid results in decreased expression of ANTXR1 mRNA

NCBI chr 4:119,590,770...119,778,232
Ensembl chr 4:121,148,103...121,336,892

G

annexin A8

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ANXA8 mRNA

NCBI chr16:9,397,144...9,412,072
Ensembl chr16:9,403,353...9,418,310

G

amine oxidase, copper containing 3

multiple interactions
decreases expression
increases expression

ISO
EXP

OGG1 protein inhibits the reaction [Cacodylic Acid results in increased expression of AOC3 mRNA]
Cacodylic Acid results in decreased expression of AOC3 mRNA

PMID:17441966 PMID:37567419

NCBI chr10:86,272,757...86,280,702

G

apolipoprotein E

affects response to substance
multiple interactions

ISO

APOE protein affects the susceptibility to Cacodylic Acid
AS3MT protein affects the reaction [APOE protein affects the susceptibility to Cacodylic Acid]

NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:88,481,385...88,485,855

G

apolipoprotein L7A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of APOL7A mRNA

Ensembl chr 7:111,011,645...111,017,084

G

apolipoprotein L9a

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of APOL9A mRNA

NCBI chr 7:109,140,871...109,149,799
Ensembl chr 7:111,021,453...111,028,213

G

amyloid beta precursor protein

multiple interactions
increases expression

ISO

Cacodylic Acid results in increased cleavage of and affects the secretion of APP protein mutant form; Cacodylic Acid results in increased expression of and affects the localization of APP protein mutant form
Cacodylic Acid results in increased expression of APP protein

NCBI chr11:37,506,207...37,724,351
Ensembl chr11:37,506,408...37,722,971

G

aquaporin 3 (Gill blood group)

decreases expression

ISO

Cacodylic Acid results in decreased expression of AQP3 mRNA

NCBI chr 5:61,035,165...61,040,683
Ensembl chr 5:61,035,166...61,040,685

G

aquaporin 7

increases expression

EXP

Cacodylic Acid results in increased expression of AQP7 mRNA

NCBI chr 5:60,968,495...60,982,618
Ensembl chr 5:60,967,558...60,982,618

G

aquaporin 9

increases expression

ISO

Cacodylic Acid results in increased expression of AQP9 mRNA

NCBI chr 8:80,678,027...80,718,273
Ensembl chr 8:80,678,030...80,717,240

G

androgen receptor

decreases expression

EXP

Cacodylic Acid results in decreased expression of AR mRNA

NCBI chr X:67,135,317...67,304,476
Ensembl chr X:67,135,317...67,304,467

G

amphiregulin

multiple interactions
increases expression

ISO
EXP

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of AREG mRNA
Cacodylic Acid results in increased expression of AREG mRNA

PMID:34876320 PMID:37567419

NCBI chr14:17,256,384...17,265,641
Ensembl chr14:17,256,384...17,265,641

G

ARF GTPase 6

increases expression

EXP

Cacodylic Acid results in increased expression of ARF6 mRNA

NCBI chr 6:93,589,777...93,590,925
Ensembl chr 6:93,569,234...93,610,536

G

Rho GTPase activating protein 15

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ARHGAP15 mRNA

NCBI chr 3:27,989,368...28,592,722
Ensembl chr 3:48,382,904...49,011,378

G

Rho GTPase activating protein 21

increases expression

ISO

Cacodylic Acid results in increased expression of ARHGAP21 mRNA

NCBI chr17:83,348,673...83,472,202
Ensembl chr17:88,256,961...88,380,797

G

Rho GTPase activating protein 25

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ARHGAP25 mRNA

NCBI chr 4:119,896,844...119,974,982
Ensembl chr 4:121,454,151...121,552,913

G

Rho GTPase activating protein 28

decreases expression

EXP

Cacodylic Acid results in decreased expression of ARHGAP28 mRNA

NCBI chr 9:115,277,849...115,444,789
Ensembl chr 9:115,279,734...115,445,008

G

Rho GTPase activating protein 30

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ARHGAP30 mRNA

NCBI chr13:83,822,290...83,843,634
Ensembl chr13:86,354,547...86,376,888

G

Rho GTPase activating protein 45

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ARHGAP45 mRNA

NCBI chr 7:10,325,515...10,340,955
Ensembl chr 7:10,325,539...10,341,890

G

Rho GTPase activating protein 8

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ARHGAP8 mRNA

NCBI chr 7:115,842,223...115,902,094
Ensembl chr 7:117,730,578...117,782,030

G

Rho GDP dissociation inhibitor beta

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ARHGDIB mRNA

NCBI chr 4:169,822,951...169,841,884
Ensembl chr 4:171,554,140...171,573,068

G

Rho guanine nucleotide exchange factor 38

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ARHGEF38 mRNA

NCBI chr 2:221,610,212...221,739,841
Ensembl chr 2:224,284,238...224,413,974

G

ARF like GTPase 5C

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ARL5C mRNA

NCBI chr10:82,985,213...82,993,425
Ensembl chr10:83,481,540...83,488,406

G

ARF like GTPase 9

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ARL9 mRNA

NCBI chr14:31,157,573...31,166,803
Ensembl chr14:31,511,330...31,520,988

G

arrestin domain containing 4

increases expression

EXP

Cacodylic Acid results in increased expression of ARRDC4 mRNA

NCBI chr 1:122,369,355...122,383,351
Ensembl chr 1:131,779,437...131,793,565

G

arsenite methyltransferase

multiple interactions
increases expression

ISO

[AS3MT gene polymorphism affects the metabolism of Arsenic] which affects the abundance of Cacodylic Acid; [AS3MT gene polymorphism affects the susceptibility to Arsenic] which results in increased abundance of Cacodylic Acid; [AS3MT protein polymorphism results in increased metabolism of arsenite] which results in increased chemical synthesis of Cacodylic Acid; [AS3MT protein polymorphism results in increased metabolism of monomethylarsonic acid] which results in increased chemical synthesis of Cacodylic Acid; [AS3MT protein results in increased metabolism of arsenite] which results in increased chemical synthesis of Cacodylic Acid; [AS3MT protein results in increased metabolism of monomethylarsonic acid] which results in increased chemical synthesis of Cacodylic Acid
Cacodylic Acid results in increased expression of AS3MT protein
AS3MT protein affects the reaction [APOE protein affects the susceptibility to Cacodylic Acid]

PMID:22868225 PMID:24845704 PMID:28728140 PMID:32650499 PMID:36399430

NCBI chr 1:245,595,939...245,628,921
Ensembl chr 1:255,537,109...255,569,249

G

ankyrin repeat and SOCS box-containing 14

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ASB14 mRNA

NCBI chr16:2,095,567...2,123,259
Ensembl chr16:2,102,363...2,130,590

G

ankyrin repeat and SOCS box-containing 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ASB4 mRNA

NCBI chr 4:33,506,992...33,544,630
Ensembl chr 4:34,473,408...34,512,888

G

assembly factor for spindle microtubules

increases expression

EXP

Cacodylic Acid results in increased expression of ASPM mRNA

NCBI chr13:53,625,584...53,674,489
Ensembl chr13:53,625,584...53,674,489

G

aspartic peptidase, retroviral-like 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ASPRV1 mRNA

NCBI chr 4:119,077,415...119,078,887
Ensembl chr 4:120,634,793...120,636,260

G

activating transcription factor 3

multiple interactions
increases expression

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ATF3 mRNA
Cacodylic Acid results in increased expression of ATF3 mRNA; Cacodylic Acid results in increased expression of ATF3 protein

PMID:34876320 PMID:38630284

NCBI chr13:102,751,278...102,800,520
Ensembl chr13:105,282,440...105,295,750

G

activating transcription factor 4

increases expression

EXP
ISO

Cacodylic Acid results in increased expression of ATF4 mRNA

PMID:16122865 PMID:23221991

NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:113,684,681...113,686,739

G

activating transcription factor 7 interacting protein 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ATF7IP2 mRNA

NCBI chr10:5,403,099...5,445,989
Ensembl chr10:5,909,658...5,952,995

G

ATPase phospholipid transporting 10D (putative)

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ATP10D mRNA

NCBI chr14:35,911,728...36,012,549
Ensembl chr14:36,265,696...36,366,460

G

ATPase H+ transporting V0 subunit a4

increases expression

ISO

Cacodylic Acid results in increased expression of ATP6V0A4 mRNA

NCBI chr 4:66,760,163...66,842,126
Ensembl chr 4:67,727,145...67,809,092

G

ATPase copper transporting beta

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ATP7B mRNA

NCBI chr16:76,654,725...76,726,092
Ensembl chr16:76,653,660...76,728,801

G

arginine vasopressin receptor 1A

decreases expression

EXP

Cacodylic Acid results in decreased expression of AVPR1A mRNA

NCBI chr 7:59,999,743...60,003,667
Ensembl chr 7:59,999,738...60,003,837

G

axin 2

decreases expression

EXP

Cacodylic Acid results in decreased expression of AXIN2 mRNA

NCBI chr10:94,393,379...94,426,579
Ensembl chr10:94,395,909...94,426,575

G

Beta-1,3-galactosyltransferase 5

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of B3GALT5 mRNA

NCBI chr11:35,584,273...35,630,922
Ensembl chr11:49,006,560...49,101,283

G

UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of B3GNT5 mRNA

NCBI chr11:81,141,102...81,153,206
Ensembl chr11:94,645,480...94,660,514

G

BCL2-associated agonist of cell death

increases expression

EXP
ISO

Cacodylic Acid results in increased expression of BAD mRNA
Cacodylic Acid results in increased expression of BAD mRNA; Cacodylic Acid results in increased expression of BAD protein

PMID:16122865 PMID:22246474

NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:213,562,187...213,572,034

G

B-cell scaffold protein with ankyrin repeats 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of BANK1 mRNA

NCBI chr 2:227,203,998...227,474,008
Ensembl chr 2:227,203,998...227,474,037

G

Btg3 associated nuclear protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of BANP mRNA

NCBI chr19:66,916,417...66,994,286
Ensembl chr19:66,916,267...66,991,317

G

BCL2 associated X, apoptosis regulator

increases expression
affects localization

EXP
ISO

Cacodylic Acid results in increased expression of BAX mRNA
Cacodylic Acid affects the localization of BAX protein

PMID:16122865 PMID:36000705

NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429

G

branched chain ketoacid dehydrogenase kinase

decreases expression

EXP

Cacodylic Acid results in decreased expression of BCKDK mRNA

NCBI chr 1:182,515,335...182,520,007
Ensembl chr 1:191,946,471...191,953,453

G

BCL2, apoptosis regulator

increases expression

ISO

Cacodylic Acid results in increased expression of BCL2 mRNA; Cacodylic Acid results in increased expression of BCL2 protein

NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900

G

Bcl2-like 1

increases expression

ISO

Cacodylic Acid results in increased expression of BCL2L1 mRNA

NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907
Ensembl chr 1:161,745,540...161,764,907

G

BCL6 co-repressor-like 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of BCORL1 mRNA

NCBI chr X:132,394,703...132,462,414
Ensembl chr X:132,397,069...132,461,976

G

brain expressed X-linked 3

increases expression

EXP

Cacodylic Acid results in increased expression of BEX3 mRNA

NCBI chr X:99,273,270...99,274,799
Ensembl chr X:104,064,515...104,075,906

G

bifunctional apoptosis regulator

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of BFAR mRNA

NCBI chr10:1,552,019...1,585,040
Ensembl chr10:2,059,058...2,094,183

G

basic helix-loop-helix family, member e41

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of BHLHE41 mRNA

NCBI chr 4:178,834,264...178,838,618
Ensembl chr 4:180,565,003...180,569,355

G

BH3 interacting domain death agonist

decreases expression

ISO

Cacodylic Acid results in decreased expression of BID protein

NCBI chr 4:155,785,366...155,808,775
Ensembl chr 4:155,785,377...155,808,275

G

baculoviral IAP repeat-containing 5

increases expression
multiple interactions

EXP
ISO

Cacodylic Acid results in increased expression of BIRC5 mRNA; Cacodylic Acid results in increased expression of BIRC5 protein
Cacodylic Acid inhibits the reaction [sodium arsenite results in increased expression of BIRC5 protein]; monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [Cacodylic Acid results in increased expression of BIRC5 mRNA]

NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,572,080...103,582,155

G

BLK proto-oncogene, Src family tyrosine kinase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of BLK mRNA

NCBI chr15:41,802,701...41,841,004
Ensembl chr15:41,802,994...41,840,982

G

basic helix-loop-helix ARNT like 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of BMAL1 mRNA

NCBI chr 1:167,331,756...167,430,235
Ensembl chr 1:176,829,305...176,864,739

G

bone morphogenetic protein 1

decreases expression

ISO

Cacodylic Acid results in decreased expression of BMP1 mRNA

NCBI chr15:45,551,603...45,595,862
Ensembl chr15:51,961,310...52,005,485

G

bone morphogenetic protein 5

decreases expression

EXP

Cacodylic Acid results in decreased expression of BMP5 mRNA

NCBI chr 8:76,517,164...76,639,925
Ensembl chr 8:85,396,925...85,520,189

G

bone morphogenetic protein receptor type 1A

increases expression

EXP

Cacodylic Acid results in increased expression of BMPR1A mRNA

NCBI chr16:9,740,751...9,786,861
Ensembl chr16:9,742,875...9,786,861

G

BOC cell adhesion associated, oncogene regulated

decreases expression

EXP

Cacodylic Acid results in decreased expression of BOC mRNA

NCBI chr11:56,122,697...56,198,060
Ensembl chr11:69,628,660...69,704,004

G

BCL2 family apoptosis regulator BOK

increases expression

EXP

Cacodylic Acid results in increased expression of BOK mRNA

NCBI chr 9:101,670,729...101,681,834
Ensembl chr 9:101,670,625...101,681,833

G

Bri3 binding protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of BRI3BP mRNA

NCBI chr12:31,176,742...31,188,563
Ensembl chr12:36,838,098...36,849,919

G

Bruton tyrosine kinase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of BTK mRNA

NCBI chr X:102,016,070...102,055,448
Ensembl chr X:102,016,074...102,055,143

G

B and T lymphocyte associated

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of BTLA mRNA

NCBI chr11:55,563,683...55,588,187
Ensembl chr11:69,052,644...69,093,224

G

C1q and TNF related 3

multiple interactions
decreases expression

ISO
EXP

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of C1QTNF3 mRNA
Cacodylic Acid results in decreased expression of C1QTNF3 mRNA

PMID:34876320 PMID:37567419

NCBI chr 2:59,917,099...59,939,519
Ensembl chr 2:61,644,276...61,666,559

G

complement C1r

decreases expression

EXP

Cacodylic Acid results in decreased expression of C1R mRNA

NCBI chr 4:159,099,013...159,109,770
Ensembl chr 4:159,098,918...159,109,714

G

complement C1s

decreases expression

EXP

Cacodylic Acid results in decreased expression of C1S mRNA

NCBI chr 4:159,116,549...159,128,736
Ensembl chr 4:159,116,549...159,128,736

G

complement C7

multiple interactions

ISO

[Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of C7 mRNA

NCBI chr 2:54,088,116...54,165,102
Ensembl chr 2:55,816,807...55,892,672

G

similar to human chromosome 19 open reading frame 38

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of AB124611 mRNA

NCBI chr 8:20,061,494...20,095,705
Ensembl chr 8:28,354,725...28,371,804

G

complement C9

multiple interactions

ISO

[Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of C9 mRNA

NCBI chr 2:57,300,510...57,348,759
Ensembl chr 2:57,300,427...57,348,752

G

carbonic anhydrase 12

increases expression

ISO

Cacodylic Acid results in increased expression of CA12 mRNA

NCBI chr 8:76,169,723...76,225,465
Ensembl chr 8:76,169,815...76,225,465

G

carbonic anhydrase 13

increases expression

ISO

Cacodylic Acid results in increased expression of CAR13 mRNA

NCBI chr 2:86,928,401...86,959,525
Ensembl chr 2:88,649,625...88,680,763

G

carbonic anhydrase 3

decreases expression

ISO
EXP

Cacodylic Acid results in decreased expression of CAR3 mRNA

PMID:17441966 PMID:37567419

NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:88,491,670...88,500,524

G

calcium voltage-gated channel subunit alpha1 I

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CACNA1I mRNA

NCBI chr 7:111,835,996...111,947,418
Ensembl chr 7:113,716,266...113,827,670

G

calcitonin receptor like receptor

decreases expression

EXP

Cacodylic Acid results in decreased expression of CALCRL mRNA

NCBI chr 3:69,428,348...69,525,910
Ensembl chr 3:89,835,077...89,887,350

G

calmodulin 2

increases expression

EXP

Cacodylic Acid results in increased expression of CALM2 mRNA

NCBI chr 6:7,091,624...7,104,284
Ensembl chr15:64,519,554...64,520,657
Ensembl chr 6:64,519,554...64,520,657

G

calumenin

increases expression

EXP

Cacodylic Acid results in increased expression of CALU mRNA

NCBI chr 4:57,949,086...57,976,589
Ensembl chr 4:58,914,421...58,941,956

G

calcium/calmodulin-dependent protein kinase IG

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CAMK1G mRNA

NCBI chr13:104,877,909...104,901,658
Ensembl chr13:107,406,584...107,430,230

G

cyclase associated actin cytoskeleton regulatory protein 1

increases expression

EXP

Cacodylic Acid results in increased expression of CAP1 mRNA

NCBI chr 5:135,142,108...135,168,885
Ensembl chr 5:140,427,269...140,453,470

G

calpain 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CAPN3 mRNA

NCBI chr 3:107,407,518...107,457,858
Ensembl chr 3:127,861,589...127,911,638

G

calpain 9

increases expression

EXP

Cacodylic Acid results in increased expression of CAPN9 mRNA

NCBI chr19:52,549,448...52,586,413
Ensembl chr19:69,446,847...69,483,810

G

caspase recruitment domain family, member 11

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CARD11 mRNA

NCBI chr12:18,735,088...18,872,045
Ensembl chr12:18,735,088...18,872,045

G

capping protein regulator and myosin 1 linker 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CARMIL2 mRNA

NCBI chr19:50,481,911...50,496,672
Ensembl chr19:50,484,324...50,496,669

G

caspase 12

increases expression

ISO

Cacodylic Acid results in increased expression of CASP12 mRNA; Cacodylic Acid results in increased expression of CASP12 protein

NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:10,926,994...10,954,442

G

caspase 2

increases expression

ISO

Cacodylic Acid analog results in increased expression of CASP2 protein

NCBI chr 4:71,149,632...71,167,388
Ensembl chr 4:72,116,246...72,134,022

G

caspase 3

multiple interactions
increases cleavage
increases activity
increases expression
increases response to substance

EXP
ISO

benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [CASP3 protein results in increased susceptibility to Cacodylic Acid]; Buthionine Sulfoximine inhibits the reaction [Cacodylic Acid results in increased activity of CASP3 protein]
Cacodylic Acid results in increased cleavage of CASP3 protein
[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of CASP3 mRNA
Cacodylic Acid analog results in increased activity of CASP3 protein; Cacodylic Acid results in increased activity of CASP3 protein
Cacodylic Acid results in increased expression of CASP3 mRNA

PMID:15276415 PMID:16122865 PMID:19465042 PMID:23192986 PMID:23994116 More...

NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732

G

caspase 6

affects binding

ISO

CASP6 protein binds to Cacodylic Acid analog

NCBI chr 2:221,140,287...221,152,727
Ensembl chr 2:221,140,256...221,152,726

G

caspase 8

multiple interactions
increases response to substance

EXP

benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [CASP8 protein results in increased susceptibility to Cacodylic Acid]

NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:67,758,033...67,806,699

G

caspase 9

multiple interactions
increases response to substance

EXP

benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [CASP9 protein results in increased susceptibility to Cacodylic Acid]

Ensembl chr 5:159,391,188...159,409,648

G

catalase

increases expression
increases activity
decreases activity
multiple interactions

EXP

Cacodylic Acid results in increased expression of CAT mRNA
Cacodylic Acid results in increased activity of CAT protein
Cacodylic Acid results in decreased activity of CAT protein
[CAT protein results in decreased oxidation of dimethylarsinous acid] which results in decreased chemical synthesis of Cacodylic Acid; monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [Cacodylic Acid results in increased activity of CAT protein]

PMID:16122865 PMID:18619986 PMID:24095718 PMID:32474354

NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526

G

cation channel, sperm associated 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CATSPER4 mRNA

NCBI chr 5:146,427,682...146,447,346
Ensembl chr 5:151,711,194...151,730,750

G

caveolin 2

decreases expression

ISO

Cacodylic Acid results in decreased expression of CAV2 mRNA

NCBI chr 4:46,582,681...46,590,058
Ensembl chr 4:46,582,096...46,591,425

G

coiled-coil domain containing 122

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CCDC122 mRNA

NCBI chr15:52,407,717...52,470,163
Ensembl chr15:58,816,873...58,879,592

G

coiled-coil domain containing 162

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CCDC162 mRNA

NCBI chr20:45,044,891...45,237,905
Ensembl chr20:46,627,277...46,818,249

G

coiled-coil domain containing 71-like

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CCDC71L mRNA

NCBI chr 6:48,960,020...48,964,112
Ensembl chr 6:54,617,540...55,014,344

G

coiled-coil domain containing 78

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CCDC78 mRNA

NCBI chr10:14,808,355...14,812,284
Ensembl chr10:15,311,868...15,319,425

G

coiled-coil domain containing 80

decreases expression

EXP

Cacodylic Acid results in decreased expression of CCDC80 mRNA

NCBI chr11:55,685,165...55,718,827
Ensembl chr11:69,191,189...69,224,844

G

coiled-coil domain containing 87

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CCDC87 mRNA

NCBI chr 1:202,135,021...202,137,717
Ensembl chr 1:211,475,789...211,568,008

G

coiled-coil domain containing 88C

decreases expression

ISO

Cacodylic Acid results in decreased expression of CCDC88C mRNA

NCBI chr 6:125,899,337...126,019,162
Ensembl chr 6:125,899,526...126,018,865

G

coiled-coil domain containing 92B

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CCDC92B mRNA

NCBI chr10:59,479,798...59,501,486
Ensembl chr10:59,978,203...59,999,887

G

C-C motif chemokine ligand 11

decreases expression

ISO
EXP

Cacodylic Acid results in decreased expression of CCL11 mRNA

PMID:32052077 PMID:37567419

NCBI chr10:67,525,975...67,530,576
Ensembl chr10:67,525,862...67,530,575

G

C-C motif chemokine ligand 21

decreases expression

EXP

Cacodylic Acid results in decreased expression of CCL21 mRNA

NCBI chr 5:61,776,411...61,777,515
Ensembl chr 5:61,776,413...61,777,540

G

C-C motif chemokine ligand 22

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CCL22 mRNA

NCBI chr19:10,257,602...10,264,373
Ensembl chr19:10,263,589...10,270,359

G

C-C motif chemokine ligand 26

multiple interactions

ISO

[Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of CCL26 mRNA

NCBI chr12:26,745,972...26,750,924

G

cellular communication network factor 1

multiple interactions
decreases expression

ISO
EXP

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CCN1 mRNA
Cacodylic Acid results in decreased expression of CYR61 mRNA

PMID:34876320 PMID:37567419

NCBI chr 2:237,222,730...237,225,689
Ensembl chr 2:237,222,432...237,225,883

G

cyclin A2

increases expression

EXP

Cacodylic Acid results in increased expression of CCNA2 mRNA

NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:121,355,363...121,361,701

G

cyclin B2

increases expression

EXP

Cacodylic Acid results in increased expression of CCNB2 mRNA

NCBI chr 8:79,968,459...79,981,717
Ensembl chr 8:79,968,465...79,981,682

G

cyclin C

increases expression
multiple interactions

ISO

Cacodylic Acid results in increased expression of CCNC mRNA
OGG1 protein inhibits the reaction [Cacodylic Acid results in increased expression of CCNC mRNA]

NCBI chr 5:35,266,828...35,284,943
Ensembl chr 5:40,063,623...40,093,370

G

cyclin D1

increases expression

EXP

Cacodylic Acid results in increased expression of CCND1 mRNA; Cacodylic Acid results in increased expression of CCND1 protein

PMID:12151359 PMID:17481689 PMID:24832369

NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810

G

cyclin D2

affects expression

EXP

Cacodylic Acid affects the expression of CCND2 mRNA

NCBI chr 4:161,653,048...161,675,422
Ensembl chr 4:161,653,048...161,680,301
Ensembl chr 4:161,653,048...161,680,301

G

C-C motif chemokine receptor 2

decreases expression

EXP

Cacodylic Acid results in decreased expression of CCR2 mRNA

NCBI chr 8:132,611,883...132,619,106
Ensembl chr 8:132,611,410...132,620,059

G

C-C motif chemokine receptor 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CCR6 mRNA

NCBI chr 1:52,474,477...52,508,301
Ensembl chr 1:55,021,833...55,046,059

G

C-C motif chemokine receptor 7

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CCR7 mRNA

NCBI chr10:84,594,399...84,604,514
Ensembl chr10:84,593,594...84,604,501

G

CD180 molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD180 mRNA

NCBI chr 2:33,855,940...33,870,046
Ensembl chr 2:35,589,451...35,603,982

G

Cd2 molecule

increases expression
multiple interactions

EXP
ISO

Cacodylic Acid results in increased expression of CD2 mRNA
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD2 mRNA

PMID:16122865 PMID:34876320

NCBI chr 2:191,399,510...191,412,659
Ensembl chr 2:191,399,510...191,413,665

G

CD22 molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD22 mRNA

NCBI chr 1:95,243,785...95,270,430
Ensembl chr 1:95,244,868...95,259,730

G

Cd28 molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD28 mRNA

NCBI chr 9:69,660,316...69,689,192
Ensembl chr 9:69,545,326...69,689,192

G

CD36 molecule

decreases expression

ISO

Cacodylic Acid results in decreased expression of CD36 mRNA

NCBI chr 4:18,209,088...18,302,142

G

CD37 molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD37 mRNA

NCBI chr 1:95,719,171...95,724,662
Ensembl chr 1:104,849,166...104,861,276

G

Cd4 molecule

decreases expression

EXP

Cacodylic Acid results in decreased expression of CD4 mRNA

NCBI chr 4:159,355,147...159,381,636
Ensembl chr 4:159,356,337...159,381,461

G

CD40 molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD40 mRNA

NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:174,209,719...174,224,847

G

CD46 molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD46 mRNA

NCBI chr13:109,104,122...109,134,903

G

Cd5 molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD5 mRNA

NCBI chr 1:216,790,245...216,811,209
Ensembl chr 1:216,790,245...216,811,209

G

CD52 molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD52 mRNA

NCBI chr 5:146,319,789...146,321,348
Ensembl chr 5:151,603,524...151,605,086

G

Cd53 molecule

multiple interactions
decreases expression

ISO
EXP

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD53 mRNA
Cacodylic Acid results in decreased expression of CD53 mRNA

PMID:34876320 PMID:37567419

NCBI chr 2:194,352,139...194,399,668
Ensembl chr 2:197,040,369...197,218,593

G

Cd6 molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD6 mRNA

NCBI chr 1:216,867,767...216,906,642
Ensembl chr 1:216,867,771...216,879,432

G

Cd68 molecule

increases expression

ISO

Cacodylic Acid results in increased expression of CD68 mRNA

NCBI chr10:54,381,814...54,383,693
Ensembl chr10:54,880,563...54,882,540

G

Cd69 molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD69 mRNA

NCBI chr 4:162,725,446...162,733,364
Ensembl chr 4:164,411,485...164,419,509

G

CD74 molecule

decreases expression

EXP

Cacodylic Acid results in decreased expression of CD74 mRNA

NCBI chr18:56,527,071...56,536,406
Ensembl chr18:56,527,132...56,536,410

G

CD79a molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD79A mRNA

NCBI chr 1:89,621,460...89,625,813
Ensembl chr 1:89,621,460...89,625,812

G

CD79b molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD79B mRNA

NCBI chr10:91,739,134...91,742,312
Ensembl chr10:91,739,137...91,742,405

G

CD83 molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD83 mRNA

NCBI chr17:20,887,309...20,907,009
Ensembl chr17:21,093,281...21,113,047

G

CD84 molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD84 mRNA

NCBI chr13:86,859,979...86,899,984
Ensembl chr13:86,859,990...86,894,318

G

CD86 molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD86 mRNA

NCBI chr11:77,647,565...77,706,178
Ensembl chr11:77,647,600...77,725,361

G

cell division cycle 123

increases expression

EXP

Cacodylic Acid results in increased expression of CDC123 mRNA

NCBI chr17:72,459,270...72,503,316
Ensembl chr17:77,368,397...77,412,659

G

cell division cycle 37, HSP90 cochaperone

increases expression

EXP

Cacodylic Acid results in increased expression of CDC37 mRNA

NCBI chr 8:27,954,292...27,966,935
Ensembl chr 8:27,948,016...27,983,931

G

CDC42 effector protein 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CDC42EP2 mRNA

NCBI chr 1:212,631,317...212,640,231
Ensembl chr 1:212,629,881...212,640,234

G

cell division cycle 5-like

increases expression

EXP

Cacodylic Acid results in increased expression of CDC5L mRNA

NCBI chr 9:15,564,949...15,603,453
Ensembl chr 9:23,062,205...23,100,899

G

cadherin 1

increases expression

EXP

Cacodylic Acid results in increased expression of CDH1 mRNA

PMID:16122865 PMID:17481689

NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565

G

cadherin 13

affects expression

EXP

Cacodylic Acid affects the expression of CDH13 mRNA

NCBI chr19:46,349,562...47,387,462
Ensembl chr19:63,258,122...64,296,119

G

cadherin 4

increases expression
multiple interactions

ISO

Cacodylic Acid results in increased expression of CDH4 mRNA
OGG1 protein inhibits the reaction [Cacodylic Acid results in increased expression of CDH4 mRNA]

NCBI chr 3:166,525,092...167,003,380
Ensembl chr 3:186,902,751...187,381,020

G

cadherin 8

decreases expression

EXP

Cacodylic Acid results in decreased expression of CDH8 mRNA

NCBI chr19:5,494,038...5,901,810
Ensembl chr19:5,500,221...5,902,627

G

cyclin-dependent kinase 9

increases expression

EXP

Cacodylic Acid results in increased expression of CDK9 mRNA

NCBI chr 3:15,996,467...16,001,315
Ensembl chr 3:36,394,169...36,399,528

G

cyclin dependent kinase like 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CDKL1 mRNA

NCBI chr 6:93,960,157...94,005,207
Ensembl chr 6:93,959,911...94,006,115

G

cyclin-dependent kinase inhibitor 1A

decreases expression
multiple interactions

EXP
ISO

Cacodylic Acid results in decreased expression of CDKN1A mRNA; Cacodylic Acid results in decreased expression of CDKN1A protein
[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of CDKN1A mRNA

PMID:12151359 PMID:17481689 PMID:23192986

NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969

G

cyclin-dependent kinase inhibitor 1C

decreases expression

EXP

Cacodylic Acid results in decreased expression of CDKN1C mRNA

NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:208,084,787...208,087,498

G

cyclin-dependent kinase inhibitor 2A

decreases expression
decreases methylation

EXP
ISO

Cacodylic Acid results in decreased expression of CDKN2A mRNA
Cacodylic Acid results in decreased methylation of CDKN2A promoter alternative form

PMID:16122865 PMID:23073540

NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:109,100,772...109,119,248

G

cyclin-dependent kinase inhibitor 2B

decreases expression

EXP

Cacodylic Acid results in decreased expression of CDKN2B mRNA

NCBI chr 5:104,009,839...104,019,082
Ensembl chr 5:109,114,322...109,134,855

G

CEA cell adhesion molecule 6

multiple interactions

ISO

[Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of CEACAM6 mRNA

NCBI chr 1:80,416,531...80,434,668
Ensembl chr 1:89,544,400...89,562,552

G

CCAAT/enhancer binding protein gamma

decreases expression

EXP

Cacodylic Acid results in decreased expression of CEBPG mRNA

NCBI chr 1:96,820,981...96,829,736
Ensembl chr 1:96,810,214...96,830,283

G

CECR2, histone acetyl-lysine reader

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CECR2 mRNA

NCBI chr 4:153,890,310...153,998,078
Ensembl chr 4:155,562,727...155,666,741

G

cadherin, EGF LAG seven-pass G-type receptor 3

decreases expression

EXP

Cacodylic Acid results in decreased expression of CELSR3 mRNA

NCBI chr 8:109,530,597...109,558,360
Ensembl chr 8:118,409,136...118,436,847

G

cell migration inducing hyaluronidase 1

increases expression

ISO

Cacodylic Acid results in increased expression of CEMIP mRNA

NCBI chr 1:137,906,921...138,062,430
Ensembl chr 1:147,316,052...147,471,768

G

centromere protein E

increases expression

EXP

Cacodylic Acid results in increased expression of CENPE mRNA

NCBI chr 2:226,310,970...226,369,636
Ensembl chr 2:226,300,798...226,369,636

G

centromere protein F

increases expression

EXP

Cacodylic Acid results in increased expression of CENPF mRNA

NCBI chr13:101,184,127...101,229,714
Ensembl chr13:103,715,344...103,760,886

G

carboxylesterase 2F

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CES2F mRNA

NCBI chr19:7,527...14,898
Ensembl chr19:13,987...21,358

G

cilia and flagella associated protein 47

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CFAP47 mRNA

NCBI chr X:43,264,687...43,616,607
Ensembl chr X:47,149,334...47,504,257

G

complement factor D

increases expression
multiple interactions

ISO

Cacodylic Acid results in increased expression of CFD mRNA
OGG1 protein inhibits the reaction [Cacodylic Acid results in increased expression of CFD mRNA]

NCBI chr 7:10,463,773...10,465,496
Ensembl chr 7:10,463,775...10,465,572

G

ChaC glutathione-specific gamma-glutamylcyclotransferase 1

increases expression

ISO

Cacodylic Acid results in increased expression of CHAC1 mRNA

NCBI chr 3:126,796,131...126,799,352
Ensembl chr 3:126,796,024...126,799,361

G

chondroadherin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CHAD mRNA

NCBI chr10:79,512,170...79,515,941
Ensembl chr10:80,008,767...80,012,816

G

choline O-acetyltransferase

increases activity

ISO

Cacodylic Acid results in increased activity of CHAT protein

NCBI chr16:7,657,362...7,717,093
Ensembl chr16:7,663,665...7,723,416

G

checkpoint kinase 2

increases expression

EXP

Cacodylic Acid results in increased expression of CHEK2 mRNA

NCBI chr12:51,448,838...51,481,159
Ensembl chr12:51,449,140...51,480,667

G

chitinase 3 like 1

increases expression

ISO

Cacodylic Acid results in increased expression of CHI3L1 mRNA

NCBI chr13:48,193,839...48,201,822
Ensembl chr13:48,193,800...48,201,825

G

chondrolectin

decreases expression

EXP

Cacodylic Acid results in decreased expression of CHODL mRNA

NCBI chr11:17,654,137...17,676,450
Ensembl chr11:31,141,021...31,163,334

G

cysteine and histidine rich domain containing 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CHORDC1 mRNA

NCBI chr 8:15,374,356...15,398,436
Ensembl chr 8:23,650,865...23,677,696

G

cholinergic receptor nicotinic alpha 9 subunit

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CHRNA9 mRNA

NCBI chr14:42,235,218...42,241,939
Ensembl chr14:42,588,948...42,595,669

G

carbohydrate sulfotransferase 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CHST3 mRNA

NCBI chr20:28,114,386...28,152,046
Ensembl chr20:28,657,308...28,694,526

G

component of inhibitor of nuclear factor kappa B kinase complex

increases expression

EXP

Cacodylic Acid results in increased expression of CHUK mRNA; Cacodylic Acid results in increased expression of CHUK protein

NCBI chr 1:242,959,539...242,995,066
Ensembl chr 1:252,908,749...252,944,273

G

circadian associated repressor of transcription

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CIART mRNA

NCBI chr 2:186,108,744...186,113,778
Ensembl chr 2:186,108,752...186,112,246

G

class II, major histocompatibility complex, transactivator

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CIITA mRNA

NCBI chr10:5,139,947...5,187,493
Ensembl chr10:5,647,085...5,694,342

G

cartilage intermediate layer protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CILP mRNA

NCBI chr 8:65,777,281...65,792,251
Ensembl chr 8:74,671,534...74,687,409

G

cold inducible RNA binding protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CIRBP mRNA

NCBI chr 7:10,184,515...10,189,623

G

Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2

increases expression

ISO

Cacodylic Acid results in increased expression of CITED2 mRNA

NCBI chr 1:14,132,303...14,134,746
Ensembl chr 1:14,103,457...14,134,782

G

CDC28 protein kinase regulatory subunit 2

increases expression

EXP

Cacodylic Acid results in increased expression of CKS2 mRNA

NCBI chr17:13,570,611...13,575,770
Ensembl chr17:13,722,361...13,727,519

G

chloride channel accessory 4

decreases expression

ISO

Cacodylic Acid results in decreased expression of CLCA4 mRNA

NCBI chr 2:233,883,625...233,904,993
Ensembl chr 2:236,544,201...236,563,435

G

cardiotrophin-like cytokine factor 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CLCF1 mRNA

NCBI chr 1:201,507,763...201,517,607
Ensembl chr 1:210,937,255...210,947,064

G

C-type lectin domain containing 7A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CLEC7A mRNA

NCBI chr 4:162,902,731...162,913,931
Ensembl chr 4:164,588,754...164,599,919

G

clusterin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CLU mRNA

NCBI chr15:44,336,619...44,375,861
Ensembl chr15:44,359,914...44,375,860

G

cannabinoid receptor 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CNR2 mRNA

NCBI chr 5:153,408,968...153,435,092
Ensembl chr 5:153,409,147...153,435,961

G

ciliary neurotrophic factor receptor

decreases expression

EXP

Cacodylic Acid results in decreased expression of CNTFR mRNA

NCBI chr 5:56,823,448...56,861,049
Ensembl chr 5:61,619,326...61,645,795

G

cochlin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of COCH mRNA

NCBI chr 6:74,766,485...74,780,504
Ensembl chr 6:74,766,419...74,780,502

G

collagen type XI alpha 2 chain

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of COL11A2 mRNA

NCBI chr20:4,788,829...4,818,492
Ensembl chr20:4,788,829...4,817,648

G

collagen type XIV alpha 1 chain

decreases expression

EXP

Cacodylic Acid results in decreased expression of COL14A1 mRNA

NCBI chr 7:86,722,093...86,937,215
Ensembl chr 7:88,611,828...88,826,938

G

collagen type XV alpha 1 chain

decreases expression

EXP

Cacodylic Acid results in decreased expression of COL15A1 mRNA

NCBI chr 5:61,501,963...61,607,591
Ensembl chr 5:66,297,461...66,403,170

G

collagen type I alpha 1 chain

decreases expression

EXP

Cacodylic Acid results in decreased expression of COL1A1 mRNA

NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460

G

collagen type I alpha 2 chain

decreases expression

EXP

Cacodylic Acid results in decreased expression of COL1A2 mRNA

NCBI chr 4:33,518,557...33,553,484
Ensembl chr 4:33,518,420...33,553,995

G

collagen type III alpha 1 chain

decreases expression

EXP

Cacodylic Acid results in decreased expression of COL3A1 mRNA

NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:54,866,632...54,903,232

G

collagen type VI alpha 1 chain

decreases expression

EXP

Cacodylic Acid results in decreased expression of COL6A1 mRNA

NCBI chr20:11,906,105...11,924,599
Ensembl chr20:11,905,457...11,924,107

G

collagen type VII alpha 1 chain

decreases expression
multiple interactions

ISO

Cacodylic Acid results in decreased expression of COL7A1 mRNA
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of COL7A1 mRNA

PMID:17441966 PMID:34876320

NCBI chr 8:109,604,877...109,637,249
Ensembl chr 8:118,483,364...118,517,439

G

collectin sub-family member 12

decreases expression

EXP

Cacodylic Acid results in decreased expression of COLEC12 mRNA

NCBI chr18:732,950...920,620
Ensembl chr18:1,005,741...1,195,297

G

collagen like tail subunit of asymmetric acetylcholinesterase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of COLQ mRNA

NCBI chr16:6,731,850...6,824,973
Ensembl chr16:6,738,251...6,793,501

G

cartilage oligomeric matrix protein

increases expression

EXP

Cacodylic Acid results in increased expression of COMP mRNA

NCBI chr16:19,081,172...19,089,548
Ensembl chr16:19,081,172...19,089,605

G

coronin 1A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CORO1A mRNA

NCBI chr 1:190,726,129...190,731,133
Ensembl chr 1:190,726,130...190,731,102

G

coactosin-like F-actin binding protein 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of COTL1 mRNA

NCBI chr19:64,780,309...64,814,629
Ensembl chr19:64,780,322...64,814,840

G

carboxypeptidase D

decreases expression

EXP

Cacodylic Acid results in decreased expression of CPD mRNA

NCBI chr10:62,121,681...62,185,638
Ensembl chr10:62,121,679...62,185,638

G

carboxypeptidase M

decreases expression

EXP

Cacodylic Acid results in decreased expression of CPM mRNA

NCBI chr 7:53,225,647...53,286,220
Ensembl chr 7:55,111,599...55,172,114

G

cleavage and polyadenylation specific factor 4-like

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CPSF4L mRNA

NCBI chr10:98,741,816...98,756,069
Ensembl chr10:99,242,794...99,257,172

G

carboxypeptidase X (M14 family), member 1

multiple interactions
decreases expression

ISO
EXP

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CPXM1 mRNA
Cacodylic Acid results in decreased expression of CPXM1 mRNA

PMID:34876320 PMID:37567419

NCBI chr 3:117,588,532...117,595,330
Ensembl chr 3:138,041,645...138,048,857

G

complement C3d receptor 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CR2 mRNA

NCBI chr13:106,678,579...106,716,595
Ensembl chr13:109,213,867...109,244,552

G

cAMP responsive element binding protein 3-like 1

decreases expression

EXP

Cacodylic Acid results in decreased expression of CREB3L1 mRNA

NCBI chr 3:77,952,589...77,993,513
Ensembl chr 3:98,408,058...98,449,104

G

CDP-L-ribitol pyrophosphorylase A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CRPPA mRNA

NCBI chr 6:53,120,264...53,397,030
Ensembl chr 6:58,848,621...59,181,406

G

cytotoxic and regulatory T cell molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CRTAM mRNA

NCBI chr 8:50,237,210...50,274,472
Ensembl chr 8:50,237,210...50,274,472

G

cryptochrome circadian regulator 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CRY1 mRNA

NCBI chr 7:18,529,823...18,594,092
Ensembl chr 7:20,417,107...20,481,822

G

cysteine and serine rich nuclear protein 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CSRNP2 mRNA

NCBI chr 7:131,594,232...131,610,075
Ensembl chr 7:133,473,027...133,488,868

G

catenin alpha 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CTNNA3 mRNA

NCBI chr20:23,614,469...25,200,026
Ensembl chr20:23,613,016...25,198,805

G

catenin delta 2

increases expression

ISO

Cacodylic Acid results in increased expression of CTNND2 mRNA

NCBI chr 2:82,879,469...83,727,409
Ensembl chr 2:82,879,469...83,727,409

G

cathepsin G

multiple interactions

ISO

[Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of CTSG mRNA

NCBI chr15:33,901,230...33,907,596
Ensembl chr15:33,901,754...33,907,596

G

cathepsin H

decreases expression

EXP

Cacodylic Acid results in decreased expression of CTSH mRNA

NCBI chr 8:99,488,756...99,507,639
Ensembl chr 8:99,488,874...99,509,181

G

C-X-C motif chemokine ligand 10

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CXCL10 mRNA

NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261

G

C-X-C motif chemokine ligand 17

decreases expression

ISO

Cacodylic Acid results in decreased expression of CXCL17 mRNA

NCBI chr 1:80,984,751...80,996,842
Ensembl chr 1:90,112,771...90,124,535

G

C-X-C motif chemokine ligand 9

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CXCL9 mRNA

NCBI chr14:16,007,166...16,012,077
Ensembl chr14:16,007,204...16,014,299

G

cytochrome b-245 beta chain

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CYBB mRNA

NCBI chr X:16,030,596...16,065,065
Ensembl chr X:16,030,596...16,065,065

G

cytochrome b reductase 1

decreases expression

EXP

Cacodylic Acid results in decreased expression of CYBRD1 mRNA

NCBI chr 3:55,934,874...55,962,132
Ensembl chr 3:76,342,404...76,370,061

G

cytoplasmic FMR1 interacting protein 2

decreases expression

EXP

Cacodylic Acid results in decreased expression of CYFIP2 mRNA

NCBI chr10:31,122,653...31,242,440
Ensembl chr10:31,122,653...31,242,440

G

cytochrome P450, family 1, subfamily a, polypeptide 1

multiple interactions
decreases expression
increases expression

ISO
EXP

AHR mutant form inhibits the reaction [Cacodylic Acid results in increased expression of CYP1A1 protein]; Cacodylic Acid promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A1 protein]; Cacodylic Acid promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; Cacodylic Acid results in increased expression of and results in increased activity of CYP1A1 protein
Cacodylic Acid results in decreased expression of CYP1A1 mRNA
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CYP1A1 mRNA; Cacodylic Acid affects the reaction [[Tetrachlorodibenzodioxin results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA]; Cacodylic Acid affects the reaction [[Tetrachlorodibenzodioxin results in increased activity of AHR protein] which results in increased expression of CYP1A1 protein]
Cacodylic Acid results in increased expression of CYP1A1 mRNA

PMID:24161444 PMID:28134025 PMID:34876320 PMID:37567419

NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012

G

cytochrome P450, family 1, subfamily a, polypeptide 2

increases expression

EXP

Cacodylic Acid results in increased expression of CYP1A2 mRNA

NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149

G

cytochrome P450, family 1, subfamily b, polypeptide 1

decreases expression

EXP

Cacodylic Acid results in decreased expression of CYP1B1 mRNA

NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142

G

cytochrome P450, family 2, subfamily b, polypeptide 1

multiple interactions
increases expression

EXP

[Cacodylic Acid co-treated with Diethylnitrosamine] results in increased expression of CYP2B1 mRNA; [Cacodylic Acid co-treated with Diethylnitrosamine] results in increased expression of CYP2B1 protein
Cacodylic Acid results in increased expression of CYP2B1 mRNA

PMID:12115560 PMID:17481689

NCBI chr 1:81,518,387...81,544,999

G

cytochrome P450, family 2, subfamily b, polypeptide 2

multiple interactions

EXP

[Cacodylic Acid co-treated with Diethylnitrosamine] results in increased expression of CYP2B2 mRNA

NCBI chr 1:90,722,243...90,736,272

G

cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1

increases expression

EXP

Cacodylic Acid results in increased expression of CYP3A23-3A1 mRNA

NCBI chr12:9,256,159...9,285,020
Ensembl chr12:14,368,266...14,398,813

G

cytochrome P450, family 4, subfamily f, polypeptide 18

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CYP4F18 mRNA

NCBI chr16:17,763,543...17,804,944
Ensembl chr16:17,740,001...17,838,958

G

cytochrome P450 family 7 subfamily B member 1

increases expression
multiple interactions

ISO

Cacodylic Acid results in increased expression of CYP7B1 mRNA
OGG1 protein inhibits the reaction [Cacodylic Acid results in increased expression of CYP7B1 mRNA]

NCBI chr 2:102,419,011...102,586,047
Ensembl chr 2:102,419,011...102,451,804

G

DAB adaptor protein 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DAB1 mRNA

NCBI chr 5:123,621,510...124,742,585
Ensembl chr 5:124,369,415...124,742,584

G

D-box binding PAR bZIP transcription factor

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DBP mRNA

NCBI chr 1:96,175,796...96,180,745
Ensembl chr 1:105,312,108...105,317,205

G

doublecortin-like kinase 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DCLK3 mRNA

NCBI chr 8:111,401,544...111,453,999
Ensembl chr 8:120,279,757...120,332,432

G

damage specific DNA binding protein 2

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of DDB2 mRNA

NCBI chr 3:77,185,114...77,207,650
Ensembl chr 3:97,640,579...97,664,066

G

DNA-damage inducible transcript 3

increases expression

ISO

Cacodylic Acid results in increased expression of DDIT3 mRNA

NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509

G

DEAD box helicase 3, Y-linked

increases expression

ISO

Cacodylic Acid results in increased expression of DDX3Y mRNA

NCBI chr Y:1,115,095...1,135,754
Ensembl chr Y:1,191,242...1,210,650

G

DEF6 guanine nucleotide exchange factor

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DEF6 mRNA

NCBI chr20:6,268,579...6,290,030
Ensembl chr20:6,269,357...6,291,771

G

defensin alpha 5

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DEFA21 mRNA

NCBI chr16:77,044,994...77,047,318
Ensembl chr16:77,044,994...77,047,318

G

DEP domain containing 1

increases expression

EXP

Cacodylic Acid results in increased expression of DEPDC1 mRNA

NCBI chr 2:248,684,508...248,717,951
Ensembl chr 2:251,343,281...251,376,709

G

diacylglycerol kinase, beta

decreases expression

ISO

Cacodylic Acid results in decreased expression of DGKB mRNA

NCBI chr 6:54,640,948...55,397,210
Ensembl chr 6:60,368,519...61,124,420

G

7-dehydrocholesterol reductase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DHCR7 mRNA

NCBI chr 1:208,444,434...208,460,408
Ensembl chr 1:208,444,434...208,461,382

G

dehydrogenase/reductase 11

decreases expression

ISO

Cacodylic Acid results in decreased expression of DHRS11 mRNA

NCBI chr10:69,698,214...69,708,294
Ensembl chr10:70,195,637...70,205,893

G

dehydrogenase/reductase 9

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DHRS9 mRNA

NCBI chr 3:54,147,834...54,170,052
Ensembl chr 3:74,555,606...74,581,376

G

DIRAS family GTPase 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DIRAS2 mRNA

NCBI chr17:12,730,040...12,761,511
Ensembl chr17:12,880,385...12,914,291

G

dickkopf WNT signaling pathway inhibitor 2

decreases expression

EXP

Cacodylic Acid results in decreased expression of DKK2 mRNA

NCBI chr 2:220,568,338...220,660,225
Ensembl chr 2:223,242,377...223,334,724

G

dynein, axonemal, heavy chain 10

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DNAH10 mRNA

NCBI chr12:31,823,451...31,946,857
Ensembl chr12:37,472,813...37,640,860

G

dynein, axonemal, heavy chain 9

decreases expression

EXP

Cacodylic Acid results in decreased expression of DNAH9 mRNA

NCBI chr10:50,496,174...50,864,909
Ensembl chr10:50,996,796...51,363,963

G

dynein axonemal intermediate chain 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DNAI4 mRNA

NCBI chr 5:117,787,398...117,876,216
Ensembl chr 5:123,016,480...123,105,283

G

DnaJ heat shock protein family (Hsp40) member B13

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DNAJB13 mRNA

NCBI chr 1:164,260,716...164,275,172
Ensembl chr 1:164,260,724...164,275,093

G

DnaJ heat shock protein family (Hsp40) member B3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DNAJB3 mRNA

NCBI chr 9:88,795,542...88,796,555
Ensembl chr 9:96,243,071...96,244,408

G

deoxyribonuclease 1 like 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DNASE1L2 mRNA

NCBI chr10:13,471,850...13,473,447
Ensembl chr10:13,976,012...13,978,366

G

deoxyribonuclease 1L3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DNASE1L3 mRNA

NCBI chr15:19,351,683...19,378,536
Ensembl chr15:19,352,493...19,378,531

G

dedicator of cytokinesis 10

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DOCK10 mRNA

NCBI chr 9:81,843,599...82,101,540
Ensembl chr 9:89,291,800...89,549,973

G

dedicator of cytokinesis 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DOCK2 mRNA

NCBI chr10:19,331,412...19,748,987
Ensembl chr10:19,331,412...19,748,969

G

docking protein 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DOK3 mRNA

NCBI chr17:9,109,633...9,115,188
Ensembl chr17:9,114,762...9,120,335

G

dopamine receptor D3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DRD3 mRNA

NCBI chr11:70,385,586...70,437,793
Ensembl chr11:70,385,586...70,446,760

G

dual oxidase 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DUOX2 mRNA

NCBI chr 3:129,680,543...129,698,886
Ensembl chr 3:129,680,546...129,699,203

G

dual oxidase maturation factor 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DUOXA1 mRNA

NCBI chr 3:129,703,416...129,714,110
Ensembl chr 3:129,703,416...129,706,829

G

dual oxidase maturation factor 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DUOXA2 mRNA

NCBI chr 3:129,698,938...129,702,656
Ensembl chr 3:129,698,092...129,702,656

G

dual specificity phosphatase 1

multiple interactions
increases expression

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DUSP1 mRNA
Cacodylic Acid results in increased expression of DUSP1 mRNA

PMID:34876320 PMID:38630284

NCBI chr10:17,184,853...17,187,646
Ensembl chr10:17,184,823...17,187,644

G

dual specificity phosphatase 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DUSP2 mRNA

NCBI chr 3:114,556,325...114,558,510
Ensembl chr 3:135,009,590...135,011,809

G

dual specificity phosphatase 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DUSP6 mRNA

NCBI chr 7:35,979,502...35,983,834
Ensembl chr 7:35,977,921...35,983,833

G

ELL associated factor 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of EAF2 mRNA

NCBI chr11:77,465,585...77,509,993
Ensembl chr11:77,406,020...77,509,993

G

epithelial cell transforming 2

increases expression

EXP

Cacodylic Acid results in increased expression of ECT2 mRNA

NCBI chr 2:111,904,522...111,966,786
Ensembl chr 2:111,904,522...111,966,626

G

endothelin 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of EDN1 mRNA

NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687

G

eukaryotic translation elongation factor 1 alpha 1

decreases expression

EXP

Cacodylic Acid results in decreased expression of EEF1A1 mRNA

NCBI chr 8:88,221,839...88,225,688
Ensembl chr 8:88,221,843...88,225,072

G

ephrin A3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of EFNA3 mRNA

NCBI chr 2:177,026,928...177,035,838
Ensembl chr 2:177,026,933...177,044,843

G

epidermal growth factor receptor

increases expression

EXP

Cacodylic Acid results in increased expression of EGFR mRNA

NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358

G

early growth response 1

increases expression
multiple interactions

ISO

Cacodylic Acid results in increased expression of EGR1 mRNA
[Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of EGR1 mRNA; [sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of EGR1 mRNA

PMID:15345372 PMID:23192986 PMID:28793237

NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843

G

early growth response 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of EGR3 mRNA

NCBI chr15:45,150,335...45,156,052
Ensembl chr15:51,560,344...51,565,712

G

EH-domain containing 3

increases expression

ISO

Cacodylic Acid results in increased expression of EHD3 mRNA

NCBI chr 6:27,392,709...27,417,445
Ensembl chr 6:27,392,709...27,417,445

G

euchromatic histone lysine methyltransferase 2

increases expression

ISO

Cacodylic Acid results in increased expression of EHMT2 mRNA

NCBI chr20:3,924,263...3,941,238
Ensembl chr20:3,924,263...3,941,384

G

eukaryotic translation initiation factor 2, subunit 3, structural gene Y-linked

increases expression

ISO

Cacodylic Acid results in increased expression of EIF2S3Y mRNA

NCBI chr Y:869,654...889,341
Ensembl chr Y:944,618...964,778

G

extracellular leucine-rich repeat and fibronectin type III domain containing 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ELFN2 mRNA

NCBI chr 7:110,220,293...110,272,770
Ensembl chr 7:112,074,331...112,153,451

G

embigin

increases expression

EXP

Cacodylic Acid results in increased expression of EMB mRNA

NCBI chr 2:49,070,509...49,125,042
Ensembl chr 2:50,801,973...50,862,920

G

endonuclease, poly(U)-specific

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ENDOU mRNA

NCBI chr 7:128,844,872...128,866,572
Ensembl chr 7:130,723,972...130,745,672

G

enolase 2

decreases expression

EXP

Cacodylic Acid results in decreased expression of ENO2 mRNA

NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:159,258,371...159,267,220

G

ectonucleotide pyrophosphatase/phosphodiesterase 2

decreases expression

EXP

Cacodylic Acid results in decreased expression of ENPP2 mRNA

NCBI chr 7:88,092,140...88,214,758
Ensembl chr 7:88,092,140...88,214,957

G

eomesodermin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of EOMES mRNA

NCBI chr 8:127,059,215...127,067,070
Ensembl chr 8:127,059,215...127,067,070

G

EPM2A glucan phosphatase, laforin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of EPM2A mRNA

NCBI chr 1:5,727,111...5,845,338
Ensembl chr 1:7,547,342...7,669,604

G

erb-b2 receptor tyrosine kinase 2

multiple interactions

EXP

Cacodylic Acid results in increased expression of and results in increased phosphorylation of ERBB2 protein

NCBI chr10:83,907,491...83,931,365
Ensembl chr10:83,907,460...83,931,481

G

epiregulin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of EREG mRNA

NCBI chr14:17,311,485...17,325,260
Ensembl chr14:17,311,485...17,325,260

G

endogenous retrovirus group FRD member 1, envelope

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SYNA mRNA

NCBI chr12:22,151,211...22,158,264
Ensembl chr12:27,787,680...27,794,732

G

estrogen receptor 1

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of ESR1 mRNA

NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354

G

ethanolamine kinase 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ETNK2 mRNA

NCBI chr13:44,811,012...44,829,052
Ensembl chr13:47,363,060...47,381,100

G

ETS proto-oncogene 1, transcription factor

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ETS1 mRNA

NCBI chr 8:39,303,936...39,426,022
Ensembl chr 8:39,303,925...39,426,021

G

exophilin 5

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of EXPH5 mRNA

NCBI chr 8:53,698,825...53,775,371
Ensembl chr 8:62,595,116...62,671,575

G

fatty acid binding protein 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FABP1 mRNA

NCBI chr 4:104,744,302...104,753,119
Ensembl chr 4:104,744,309...104,753,113

G

fatty acid binding protein 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FABP3 mRNA

NCBI chr 5:142,651,962...142,658,707
Ensembl chr 5:147,936,119...147,942,881

G

fatty acid desaturase 3

increases expression

ISO

Cacodylic Acid results in increased expression of FADS3 mRNA

NCBI chr 1:216,110,547...216,127,431
Ensembl chr 1:216,110,201...216,141,758

G

family with sequence similarity 151, member A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of FAM151A mRNA

NCBI chr 5:121,514,804...121,527,555
Ensembl chr 5:126,743,555...126,756,373

G

FAM161 centrosomal protein B

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of FAM161B mRNA

NCBI chr 6:103,990,603...104,007,754
Ensembl chr 6:109,722,569...109,750,036

G

family with sequence similarity 169, member B

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FAM169B mRNA

NCBI chr 1:121,878,670...121,968,272
Ensembl chr 1:131,288,799...131,370,145

G

family with sequence similarity 89, member A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FAM89A mRNA

NCBI chr19:52,710,002...52,722,630
Ensembl chr19:69,607,391...69,620,019

G

Fas cell surface death receptor

decreases expression

ISO

Cacodylic Acid results in decreased expression of FAS mRNA
Cacodylic Acid results in decreased expression of FAS protein

PMID:29864498 PMID:36000705

NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104

G

Fas ligand

increases expression
decreases expression

EXP
ISO

Cacodylic Acid results in increased expression of FASLG mRNA
Cacodylic Acid results in decreased expression of FASL mRNA

PMID:15345372 PMID:17481689

NCBI chr13:76,680,885...76,706,042
Ensembl chr13:76,688,243...76,695,503

G

fibulin 1

decreases expression

EXP

Cacodylic Acid results in decreased expression of FBLN1 mRNA

NCBI chr 7:118,190,347...118,269,965
Ensembl chr 7:118,190,478...118,269,965

G

fibulin 5

decreases expression

EXP

Cacodylic Acid results in decreased expression of FBLN5 mRNA

NCBI chr 6:120,899,219...120,977,829
Ensembl chr 6:126,664,100...126,746,296

G

fibrillin 1

decreases expression

EXP

Cacodylic Acid results in decreased expression of FBN1 mRNA

NCBI chr 3:112,554,257...112,750,835
Ensembl chr 3:133,008,361...133,204,283

G

fructose-bisphosphatase 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FBP1 mRNA

NCBI chr17:2,207,271...2,230,076
Ensembl chr17:2,213,492...2,235,746

G

F-box and leucine-rich repeat protein 22

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of FBXL22 mRNA

NCBI chr 8:67,069,998...67,076,685
Ensembl chr 8:75,965,027...75,971,714

G

F-box protein 24

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of FBXO24 mRNA

NCBI chr12:19,072,668...19,083,067
Ensembl chr12:24,709,468...24,719,848

G

Fc epsilon receptor II

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FCER2A mRNA

NCBI chr12:1,742,809...1,754,476
Ensembl chr12:6,540,703...6,549,374

G

Fc gamma receptor 2B

decreases expression

EXP

Cacodylic Acid results in decreased expression of FCGR2B mRNA

NCBI chr13:85,725,897...85,740,517
Ensembl chr13:85,725,897...85,740,517

G

Fc receptor-like A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FCRLA mRNA

NCBI chr13:83,160,453...83,170,170
Ensembl chr13:85,693,122...85,703,176

G

farnesyl diphosphate farnesyl transferase 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FDFT1 mRNA

NCBI chr15:37,412,143...37,440,198
Ensembl chr15:41,588,117...41,616,168

G

farnesyl diphosphate synthase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FDPS mRNA

NCBI chr 2:176,795,192...176,804,816
Ensembl chr 2:176,795,192...176,807,136

G

fer-1-like family member 5

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of FER1L5 mRNA

NCBI chr 9:38,605,835...38,661,869
Ensembl chr 9:46,103,760...46,156,479

G

FEV transcription factor, ETS family member

decreases expression

EXP

Cacodylic Acid results in decreased expression of FEV mRNA

NCBI chr 9:76,439,164...76,443,603
Ensembl chr 9:83,887,844...83,891,737

G

free fatty acid receptor 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FFAR1 mRNA

NCBI chr 1:95,238,785...95,239,689
Ensembl chr 1:95,238,785...95,239,691

G

fibroblast growth factor 11

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of FGF11 mRNA

NCBI chr10:54,516,508...54,522,067
Ensembl chr10:55,016,411...55,020,454

G

fibroblast growth factor 2

increases expression

ISO

Cacodylic Acid results in increased expression of FGF2 mRNA

NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:122,164,454...122,224,493

G

fibroblast growth factor 23

decreases expression

ISO

Cacodylic Acid results in decreased expression of FGF23 mRNA

NCBI chr 4:159,914,267...159,923,821
Ensembl chr 4:161,600,383...161,609,991

G

fibroblast growth factor 9

increases expression

EXP

Cacodylic Acid results in increased expression of FGF9 mRNA

NCBI chr15:32,208,993...32,254,952
Ensembl chr15:36,325,599...36,367,926

G

fibroblast growth factor binding protein 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FGFBP3 mRNA

NCBI chr 1:234,644,023...234,646,028
Ensembl chr 1:244,056,307...244,065,654

G

fibrinogen-like 2

decreases expression

EXP

Cacodylic Acid results in decreased expression of FGL2 mRNA

NCBI chr 4:13,710,566...13,716,207
Ensembl chr 4:14,602,771...14,608,405

G

FGR proto-oncogene, Src family tyrosine kinase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FGR mRNA

NCBI chr 5:145,189,814...145,219,571
Ensembl chr 5:150,473,792...150,503,169

G

fibrinogen C domain containing 1

decreases expression

ISO

Cacodylic Acid results in decreased expression of FIBCD1 mRNA

NCBI chr 3:15,092,682...15,126,371
Ensembl chr 3:35,490,459...35,524,142

G

FKBP prolyl isomerase 5

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of FKBP5 mRNA

NCBI chr20:6,458,931...6,577,227
Ensembl chr20:6,458,940...6,543,118

G

flagellum associated containing coiled-coil domains 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FLACC1 mRNA

NCBI chr 9:60,315,581...60,343,692
Ensembl chr 9:67,809,739...67,837,793

G

filaggrin

increases expression

ISO

Cacodylic Acid results in increased expression of FLG mRNA

NCBI chr 2:181,583,801...181,596,464
Ensembl chr 2:181,583,808...181,595,968

G

Fli-1 proto-oncogene, ETS transcription factor

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FLI1 mRNA

NCBI chr 8:30,831,422...30,950,468
Ensembl chr 8:39,089,533...39,208,557

G

filamin C

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FLNC mRNA

NCBI chr 4:58,034,088...58,061,882
Ensembl chr 4:58,999,547...59,027,240

G

Fms related receptor tyrosine kinase 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FLT3 mRNA

NCBI chr12:12,660,035...12,735,584
Ensembl chr12:12,659,946...12,735,581

G

fibronectin type III domain containing 10

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FNDC10 mRNA

NCBI chr 5:166,299,587...166,311,477
Ensembl chr 5:171,580,033...171,595,399

G

Fos proto-oncogene, AP-1 transcription factor subunit

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of FOS mRNA
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of FOS mRNA

PMID:23192986 PMID:34876320

NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598

G

forkhead box Q1

increases expression

EXP

Cacodylic Acid results in increased expression of FOXQ1 mRNA

NCBI chr17:32,912,744...32,915,377
Ensembl chr17:33,121,545...33,123,720

G

formyl peptide receptor 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of FPR1 mRNA

NCBI chr 1:58,745,019...58,756,776
Ensembl chr 1:67,421,313...67,422,520

G

fascin actin-bundling protein 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FSCN1 mRNA

NCBI chr12:16,710,601...16,723,734
Ensembl chr12:16,710,601...16,723,734

G

ferritin heavy chain 1

increases expression

EXP

Cacodylic Acid results in increased expression of FTH1 mRNA

NCBI chr 1:216,052,037...216,054,325
Ensembl chr 1:216,051,998...216,055,214

G

ferritin light chain 1

increases expression

EXP
ISO

Cacodylic Acid results in increased expression of FTL1 mRNA
Cacodylic Acid results in increased expression of FTL mRNA

PMID:16122865 PMID:38630284

NCBI chr 1:95,936,387...95,938,234
Ensembl chr X:45,399,355...45,399,915
Ensembl chr 2:45,399,355...45,399,915
Ensembl chr 1:45,399,355...45,399,915

G

fucosyltransferase 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of FUT1 mRNA

NCBI chr 1:105,223,399...105,226,817
Ensembl chr 1:105,223,390...105,227,513

G

fucosyltransferase 11

decreases expression

ISO

Cacodylic Acid results in decreased expression of POFUT4 mRNA

NCBI chr15:3,598,768...3,602,328
Ensembl chr15:3,643,009...3,651,610

G

growth arrest and DNA-damage-inducible, alpha

increases expression
multiple interactions

EXP
ISO

Cacodylic Acid results in increased expression of GADD45A mRNA
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of GADD45A mRNA
Cacodylic Acid analog results in increased expression of GADD45A protein

PMID:16122865 PMID:23994116 PMID:34876320

NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:97,484,502...97,486,807

G

cyclin G associated kinase

increases expression

EXP

Cacodylic Acid results in increased expression of GAK mRNA

NCBI chr14:1,234,272...1,308,492
Ensembl chr14:1,234,266...1,323,974

G

growth arrest specific 6

decreases expression

EXP

Cacodylic Acid results in decreased expression of GAS6 mRNA

NCBI chr16:76,045,430...76,075,904
Ensembl chr16:82,747,345...82,778,088

G

golgi associated kinase 1B

decreases expression

EXP

Cacodylic Acid results in decreased expression of FAM198B mRNA

NCBI chr 2:165,047,689...165,112,479
Ensembl chr 2:167,345,809...167,410,603

G

GATA binding protein 5

decreases expression

EXP

Cacodylic Acid results in decreased expression of GATA5 mRNA

NCBI chr 3:167,418,563...167,426,751
Ensembl chr 3:187,796,142...187,804,327

G

guanylate binding protein 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GBP4 mRNA

NCBI chr 2:233,978,163...233,992,124
Ensembl chr 2:233,978,486...233,992,120

G

guanylate binding protein family member 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GBP9 mRNA

NCBI chr14:4,730,286...4,756,508
Ensembl chr14:4,968,325...4,983,692
Ensembl chr14:4,968,325...4,983,692

G

GTP cyclohydrolase 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of GCH1 mRNA

NCBI chr15:22,884,006...22,917,412
Ensembl chr15:22,884,006...22,917,412

G

glutamate-cysteine ligase, catalytic subunit

multiple interactions

ISO

[Cacodylic Acid results in increased abundance of Arsenic] which results in increased expression of GCLC protein

NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893

G

glutamate cysteine ligase, modifier subunit

multiple interactions

ISO

[Cacodylic Acid results in increased abundance of Arsenic] which results in increased expression of GCLM protein

NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:213,031,838...213,055,003

G

germinal center-associated, signaling and motility

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GCSAM mRNA

NCBI chr11:55,195,757...55,207,011
Ensembl chr11:68,660,438...68,669,584

G

growth differentiation factor 15

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GDF15 mRNA

NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,838,436...18,842,022

G

GDP dissociation inhibitor 2

increases expression

EXP

Cacodylic Acid results in increased expression of GDI2 mRNA

NCBI chr17:71,559,460...71,586,147
Ensembl chr17:71,559,461...71,586,147

G

GDNF family receptor alpha 2

decreases expression

EXP

Cacodylic Acid results in decreased expression of GFRA2 mRNA

NCBI chr15:45,941,841...46,033,715
Ensembl chr15:52,351,514...52,477,782

G

GTPase, IMAP family member 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GIMAP6 mRNA

NCBI chr 4:77,653,703...77,659,112
Ensembl chr 4:78,983,504...78,990,010

G

GTPase, IMAP family member 8

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GIMAP8 mRNA

NCBI chr 4:77,600,104...77,611,593
Ensembl chr 4:78,931,029...78,942,488

G

gap junction protein, beta 1

increases expression

EXP

Cacodylic Acid results in increased expression of GJB1 mRNA

NCBI chr X:70,541,845...70,549,776
Ensembl chr X:70,541,862...70,549,843

G

gap junction protein, beta 4

increases expression

ISO

Cacodylic Acid results in increased expression of GJB4 mRNA

NCBI chr 5:139,675,776...139,679,551
Ensembl chr 5:144,951,184...144,964,097

G

GLI family zinc finger 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GLI1 mRNA

NCBI chr 7:65,042,237...65,054,888
Ensembl chr 7:65,042,237...65,054,540

G

glycine receptor, beta

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of GLRB mRNA

NCBI chr 2:166,134,616...166,207,498
Ensembl chr 2:168,432,736...168,505,614

G

glutaredoxin

increases expression

EXP

Cacodylic Acid results in increased expression of GLRX mRNA

NCBI chr 2:7,073,737...7,083,548
Ensembl chr 2:7,073,759...7,083,543

G

glutaminase 2

increases expression

ISO

Cacodylic Acid results in increased expression of GLS2 mRNA

NCBI chr 7:617,252...633,424
Ensembl chr 7:1,201,838...1,218,013

G

G protein subunit alpha 15

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GNA15 mRNA

NCBI chr 7:8,184,632...8,205,508
Ensembl chr 7:8,835,357...8,856,268

G

G protein subunit alpha transducin 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GNAT1 mRNA

NCBI chr 8:108,350,935...108,355,671
Ensembl chr 8:117,229,575...117,234,311

G

G protein subunit gamma 5

increases expression

ISO

Cacodylic Acid results in increased expression of GNG5 mRNA

NCBI chr 2:235,394,680...235,403,177
Ensembl chr11:58,096,362...58,096,565
Ensembl chr 2:58,096,362...58,096,565

G

glutamic-oxaloacetic transaminase 1

multiple interactions

ISO

[Arsenic results in increased abundance of Cacodylic Acid] which affects the secretion of GOT1 protein

NCBI chr 1:252,306,541...252,337,622
Ensembl chr 1:252,284,434...252,329,871

G

glycoprotein Ib platelet subunit beta

multiple interactions

ISO

[Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of GP1BB mRNA

NCBI chr11:82,378,216...82,379,393

G

glypican 3

decreases expression

EXP

Cacodylic Acid results in decreased expression of GPC3 mRNA

NCBI chr X:136,789,770...137,157,598
Ensembl chr X:136,789,770...137,157,639

G

G protein-coupled receptor 132

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GPR132 mRNA

NCBI chr 6:131,924,061...131,943,327
Ensembl chr 6:137,745,241...137,763,157

G

G protein-coupled receptor 141

decreases expression

ISO

Cacodylic Acid results in decreased expression of GPR141 mRNA

NCBI chr17:45,117,818...45,180,053
Ensembl chr17:49,733,713...49,875,719

G

G protein-coupled receptor 157

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GPR157 mRNA

NCBI chr 5:160,550,703...160,566,432
Ensembl chr 5:165,833,673...165,851,280

G

G protein-coupled receptor 17

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of GPR17 mRNA

NCBI chr18:23,576,232...23,583,153
Ensembl chr18:23,850,107...23,857,702

G

G protein-coupled receptor 174

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GPR174 mRNA

NCBI chr X:72,355,452...72,396,146
Ensembl chr X:76,377,973...76,468,985

G

G protein-coupled receptor 179

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GPR179 mRNA

NCBI chr10:82,324,568...82,340,448
Ensembl chr10:82,821,113...82,836,833

G

G protein-coupled receptor 18

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GPR18 mRNA

NCBI chr15:98,997,427...99,001,177
Ensembl chr15:105,404,077...105,408,836

G

G protein-coupled receptor 183

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GPR183 mRNA

NCBI chr15:99,037,764...99,050,550
Ensembl chr15:105,437,561...105,466,977

G

G protein-coupled receptor 34

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GPR34 mRNA

NCBI chr X:9,104,829...9,113,796
Ensembl chr X:11,776,371...11,843,240

G

glutamic--pyruvic transaminase

multiple interactions

ISO

[Arsenic results in increased abundance of Cacodylic Acid] which affects the secretion of GPT protein

NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160

G

glutathione peroxidase 1

increases expression

EXP

Cacodylic Acid results in increased expression of GPX1 mRNA

NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581

G

glutathione peroxidase 2

increases expression

EXP

Cacodylic Acid results in increased expression of GPX2 mRNA

NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:101,226,745...101,230,862

G

glutathione peroxidase 7

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of GPX7 mRNA

NCBI chr 5:123,145,151...123,153,141
Ensembl chr 5:128,372,875...128,381,725

G

GRAM domain containing 2A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GRAMD2A mRNA

NCBI chr 8:60,079,744...60,117,788
Ensembl chr 8:69,003,807...69,013,573

G

GRB2-related adaptor protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GRAP mRNA

NCBI chr10:46,298,965...46,352,057
Ensembl chr10:46,832,390...46,851,523

G

granulin precursor

increases expression

EXP

Cacodylic Acid results in increased expression of GRN mRNA

NCBI chr10:87,887,834...87,893,938
Ensembl chr10:87,886,122...87,893,936

G

GrpE-like 1, mitochondrial

increases expression

EXP

Cacodylic Acid results in increased expression of GRPEL1 mRNA

NCBI chr14:74,292,023...74,298,243
Ensembl chr14:78,517,052...78,522,861

G

glutathione-disulfide reductase

multiple interactions

ISO

[Cacodylic Acid results in increased abundance of Arsenic] which results in increased expression of GSR protein

NCBI chr16:58,482,209...58,525,256
Ensembl chr16:65,185,574...65,228,394

G

glutathione S-transferase alpha 2

decreases expression
increases expression

EXP

Cacodylic Acid results in decreased expression of GSTA2 mRNA; Cacodylic Acid results in decreased expression of GSTA2 protein
Cacodylic Acid results in increased expression of GSTA2 mRNA

PMID:16436460 PMID:17481689

NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:88,064,616...88,077,092

G

glutathione S-transferase alpha 4

increases expression

ISO

Cacodylic Acid results in increased expression of GSTA4 mRNA

NCBI chr 8:79,066,967...79,084,193
Ensembl chr 8:87,930,566...87,964,488

G

glutathione S-transferase mu 1

increases expression
multiple interactions

EXP
ISO

Cacodylic Acid results in increased expression of GSTM1 mRNA; Cacodylic Acid results in increased expression of GSTM1 protein
Cacodylic Acid results in increased expression of GSTM5 mRNA
[GSTM1 gene polymorphism affects the metabolism of Arsenic] which affects the abundance of Cacodylic Acid

PMID:15345372 PMID:16436460 PMID:32650499

NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:198,338,008...198,343,569

G

glutathione S-transferase omega 2

multiple interactions

ISO

[GSTO2 gene polymorphism affects the metabolism of Arsenic] which affects the abundance of Cacodylic Acid

NCBI chr 1:246,731,314...246,757,592
Ensembl chr 1:256,673,274...256,695,146

G

glutathione S-transferase pi 1

increases expression
decreases expression

EXP
ISO

Cacodylic Acid results in increased expression of GSTP1 mRNA; Cacodylic Acid results in increased expression of GSTP2 mRNA; Cacodylic Acid results in increased expression of GSTP2 protein
Cacodylic Acid results in decreased expression of GSTP1 mRNA

PMID:16122865 PMID:16436460 PMID:17481689 PMID:32052077

NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:210,767,237...210,769,705

G

glutathione S-transferase theta 1

affects metabolic processing
multiple interactions
affects response to substance

ISO

GSTT1 protein affects the metabolism of Cacodylic Acid
[GSTT1 gene polymorphism affects the metabolism of Arsenic] which affects the abundance of Cacodylic Acid
GSTT1 gene affects the susceptibility to Cacodylic Acid

PMID:17431481 PMID:32650499

NCBI chr20:12,856,068...12,873,020
Ensembl chr20:12,856,083...12,873,019

G

general transcription factor IIF subunit 2

increases expression

EXP

Cacodylic Acid results in increased expression of GTF2F2 mRNA

NCBI chr15:51,206,027...51,327,166
Ensembl chr15:57,614,841...57,736,516

G

guanylate cyclase activator 1B

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of GUCA1B mRNA

NCBI chr 9:13,599,619...13,607,455
Ensembl chr 9:21,097,274...21,105,107

G

glucoside xylosyltransferase 2

decreases expression

EXP

Cacodylic Acid results in decreased expression of GXYLT2 mRNA

NCBI chr 4:133,347,230...133,449,708
Ensembl chr 4:134,903,859...134,987,956

G

granzyme K

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GZMK mRNA

NCBI chr 2:46,573,997...46,582,015
Ensembl chr 2:46,573,997...46,582,015

G

H1.0 linker histone

increases expression

EXP

Cacodylic Acid results in increased expression of H1F0 mRNA

NCBI chr 7:110,592,834...110,594,694
Ensembl chr 7:112,473,222...112,475,006

G

3-hydroxyanthranilate 3,4-dioxygenase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HAAO mRNA

NCBI chr 6:16,598,325...16,617,590
Ensembl chr 6:16,598,087...16,617,356

G

3-hydroxyacyl-CoA dehydratase 4

decreases expression

EXP

Cacodylic Acid results in decreased expression of HACD4 mRNA

NCBI chr 5:102,887,597...102,915,376
Ensembl chr 5:107,934,937...107,962,836

G

hyaluronan and proteoglycan link protein 2

decreases expression

EXP

Cacodylic Acid results in decreased expression of HAPLN2 mRNA

NCBI chr 2:175,786,767...175,794,515
Ensembl chr 2:175,789,009...175,794,438

G

hematopoietic cell specific Lyn substrate 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HCLS1 mRNA

NCBI chr11:77,322,873...77,346,333
Ensembl chr11:77,322,873...77,346,387

G

hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HCN2 mRNA

NCBI chr 7:10,620,422...10,639,457
Ensembl chr 7:10,620,422...10,639,457

G

histidine decarboxylase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HDC mRNA

NCBI chr 3:113,847,256...113,865,334
Ensembl chr 3:134,300,632...134,318,711

G

hedgehog acyltransferase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HHAT mRNA

NCBI chr13:104,024,507...104,283,580
Ensembl chr13:106,541,866...106,811,563

G

hematopoietically expressed homeobox

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HHEX mRNA

NCBI chr 1:244,602,945...244,608,532
Ensembl chr 1:244,602,825...244,608,604

G

Hedgehog-interacting protein

decreases expression

EXP

Cacodylic Acid results in decreased expression of HHIP mRNA

NCBI chr19:27,863,684...27,952,528
Ensembl chr19:44,767,536...44,862,795

G

HIG1 hypoxia inducible domain family, member 2A

decreases expression

ISO

Cacodylic Acid results in decreased expression of HIGD2A mRNA

NCBI chr17:10,021,853...10,022,777
Ensembl chr17:10,026,961...10,027,874

G

hexokinase 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of HK2 mRNA

NCBI chr 4:115,234,509...115,283,530
Ensembl chr 4:116,792,258...116,841,275

G

3-hydroxy-3-methylglutaryl-CoA synthase 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HMGCS1 mRNA

NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:53,382,643...53,399,802

G

3-hydroxy-3-methylglutaryl-CoA synthase 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HMGCS2 mRNA

NCBI chr 2:185,875,609...185,903,505
Ensembl chr 2:188,547,767...188,592,242

G

heme oxygenase 1

increases expression
multiple interactions

ISO

Cacodylic Acid results in increased expression of HMOX1 mRNA
[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of HMOX1 mRNA

PMID:15345372 PMID:23192986

NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818

G

4-hydroxy-2-oxoglutarate aldolase 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HOGA1 mRNA

NCBI chr 1:240,856,991...240,884,243
Ensembl chr 1:250,806,255...250,833,869

G

homeobox A1

decreases expression

EXP

Cacodylic Acid results in decreased expression of HOXA1 mRNA

NCBI chr 4:82,586,505...82,589,209
Ensembl chr 4:82,586,505...82,589,209

G

homeobox A2

decreases expression

EXP

Cacodylic Acid results in decreased expression of HOXA2 mRNA

NCBI chr 4:82,593,389...82,597,589
Ensembl chr 4:82,593,389...82,595,692

G

hippocalcin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of HPCA mRNA

NCBI chr 5:146,739,978...146,750,961
Ensembl chr 5:146,739,978...146,749,983

G

heparan sulfate-glucosamine 3-sulfotransferase 3B1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of HS3ST3B1 mRNA

NCBI chr10:48,561,473...48,593,970
Ensembl chr10:49,060,693...49,093,185

G

heat shock transcription factor 2 binding protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HSF2BP mRNA

NCBI chr20:10,035,562...10,123,059
Ensembl chr20:10,035,263...10,121,826

G

heat shock protein family A (Hsp70) member 1A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of HSPA1A mRNA

NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,855,780...3,877,979

G

heat shock protein family A (Hsp70) member 1B

multiple interactions
decreases expression

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of HSPA1B mRNA; OGG1 protein inhibits the reaction [Cacodylic Acid results in decreased expression of HSPA1B mRNA]

PMID:17441966 PMID:34876320

NCBI chr20:3,859,756...3,863,800
Ensembl chr20:3,855,780...3,877,979

G

heat shock protein family A (Hsp70) member 4 like

multiple interactions
decreases expression

ISO

OGG1 protein inhibits the reaction [Cacodylic Acid results in decreased expression of HSPA4L mRNA]

NCBI chr 2:123,740,384...123,793,088
Ensembl chr 2:125,668,236...125,720,986

G

heat shock protein family A (Hsp70) member 5

increases expression

EXP

Cacodylic Acid results in increased expression of HSPA5 mRNA

NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790

G

heat shock protein family A (Hsp70) member 8

decreases expression
multiple interactions

ISO

Cacodylic Acid results in decreased expression of HSPA8 mRNA
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of HSPA8 mRNA; OGG1 protein inhibits the reaction [Cacodylic Acid results in decreased expression of HSPA8 mRNA]

PMID:17441966 PMID:34876320

NCBI chr 8:50,080,514...50,084,376
Ensembl chr 8:50,080,199...50,084,372

G

heat shock protein family B (small) member 1

decreases expression
multiple interactions

ISO

Cacodylic Acid results in decreased expression of HSPB1 mRNA
OGG1 protein inhibits the reaction [Cacodylic Acid results in decreased expression of HSPB1 mRNA]

NCBI chr12:26,430,640...26,432,301
Ensembl chr12:26,430,640...26,432,301

G

heat shock protein family B (small) member 6

decreases expression

EXP

Cacodylic Acid results in decreased expression of HSPB6 mRNA

NCBI chr 1:85,806,898...85,809,072
Ensembl chr 1:94,933,543...94,936,512

G

heat shock protein family B (small) member 7

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HSPB7 mRNA

NCBI chr 5:153,727,782...153,731,268
Ensembl chr 5:159,010,629...159,014,243

G

heat shock protein family D (Hsp60) member 1

increases expression

EXP

Cacodylic Acid results in increased expression of HSPD1 mRNA

NCBI chr 9:64,073,610...64,084,332
Ensembl chr 9:64,073,611...64,084,037

G

heat shock protein family E (Hsp10) member 1

increases expression

EXP

Cacodylic Acid results in increased expression of HSPE1 mRNA

NCBI chr 9:56,589,912...56,593,000
Ensembl chr 9:64,085,068...64,087,502

G

heat shock protein family H (Hsp110) member 1

decreases expression
multiple interactions

ISO

Cacodylic Acid results in decreased expression of HSPH1 mRNA
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of HSPH1 mRNA; OGG1 protein inhibits the reaction [Cacodylic Acid results in decreased expression of HSPH1 mRNA]

PMID:17441966 PMID:34876320

NCBI chr12:5,390,916...5,410,224
Ensembl chr12:10,427,297...10,446,891

G

HtrA serine peptidase 3

decreases expression

EXP

Cacodylic Acid results in decreased expression of HTRA3 mRNA

NCBI chr14:75,068,917...75,097,315
Ensembl chr14:79,293,541...79,321,936

G

hydrogen voltage-gated channel 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HVCN1 mRNA

NCBI chr12:34,341,673...34,370,010
Ensembl chr12:40,001,498...40,042,020

G

intercellular adhesion molecule 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ICAM1 mRNA

NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617

G

intercellular adhesion molecule 5

multiple interactions

ISO

[Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of ICAM5 mRNA

NCBI chr 8:27,843,563...27,851,767
Ensembl chr 8:27,844,780...27,857,104

G

inducible T-cell co-stimulator

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ICOS mRNA

NCBI chr 9:62,368,075...62,406,900
Ensembl chr 9:69,877,785...69,900,960

G

insulin-like growth factor 1

decreases expression

EXP

Cacodylic Acid results in decreased expression of IGF1 mRNA

NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764

G

insulin-like growth factor 1 receptor

increases expression

EXP

Cacodylic Acid results in increased expression of IGF1R mRNA

NCBI chr 1:130,959,787...131,248,664
Ensembl chr 1:130,959,997...131,248,664

G

insulin-like growth factor binding protein 1

increases expression

ISO

Cacodylic Acid results in increased expression of IGFBP1 mRNA

NCBI chr14:86,261,277...86,266,344
Ensembl chr14:86,261,277...86,266,344

G

insulin-like growth factor binding protein 4

decreases expression

EXP

Cacodylic Acid results in decreased expression of IGFBP4 mRNA

NCBI chr10:83,995,253...84,007,272
Ensembl chr10:84,485,775...84,503,473

G

immunoglobulin heavy chain like 16

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of IGHV4-1 mRNA

NCBI chr 6:134,212,480...134,234,464

G

immunoglobulin kappa variable like, pseudogene 13

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IGKV1-133 mRNA

NCBI chr 4:96,968,574...96,969,477

G

immunoglobulin superfamily, member 10

decreases expression

EXP

Cacodylic Acid results in decreased expression of IGSF10 mRNA

NCBI chr 2:143,575,710...143,605,044
Ensembl chr 2:145,725,878...145,754,579

G

inhibitor of nuclear factor kappa B kinase subunit beta

increases expression

EXP

Cacodylic Acid results in increased expression of IKBKB protein

NCBI chr16:76,021,968...76,075,717
Ensembl chr16:76,022,008...76,081,911

G

IKAROS family zinc finger 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IKZF1 mRNA

NCBI chr14:90,468,696...90,556,522
Ensembl chr14:90,469,172...90,557,574

G

interleukin 10 receptor subunit alpha

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL10RA mRNA

NCBI chr 8:45,563,009...45,578,041
Ensembl chr 8:54,459,882...54,475,028

G

interleukin 13 receptor subunit alpha 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL13RA2 mRNA

NCBI chr X:115,814,620...115,886,080
Ensembl chr X:115,814,622...115,841,455

G

interleukin 17A

multiple interactions

ISO

[Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of IL17A mRNA

NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:30,640,844...30,644,331

G

interleukin 18 receptor accessory protein

multiple interactions

ISO

[Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of IL18RAP mRNA

NCBI chr 9:50,263,723...50,296,583
Ensembl chr 9:50,263,733...50,296,583

G

interleukin 1 beta

increases secretion

EXP

Cacodylic Acid results in increased secretion of IL1B protein

NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601

G

interleukin 20 receptor subunit beta

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL20RB mRNA

NCBI chr 8:100,979,085...101,010,829
Ensembl chr 8:109,854,012...109,889,363

G

interleukin 21 receptor

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL21R mRNA

NCBI chr 1:189,598,682...189,626,340
Ensembl chr 1:189,598,558...189,626,342

G

interleukin 22 receptor subunit alpha 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL22RA2 mRNA

NCBI chr 1:14,353,736...14,377,844
Ensembl chr 1:16,184,113...16,197,950

G

interleukin 24

increases expression

ISO

Cacodylic Acid results in increased expression of IL24 mRNA

NCBI chr13:42,353,089...42,358,487
Ensembl chr13:44,905,363...44,910,760

G

interleukin 27 receptor subunit alpha

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL27RA mRNA

NCBI chr19:24,109,963...24,121,977
Ensembl chr19:41,014,730...41,026,760

G

interleukin 33

decreases expression

EXP

Cacodylic Acid results in decreased expression of IL33 mRNA

NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:237,115,572...237,150,901

G

interleukin 36, beta

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL36B mRNA

NCBI chr 3:7,024,881...7,030,388
Ensembl chr 3:27,423,171...27,428,678

G

interleukin 5 receptor subunit alpha

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL5RA mRNA

NCBI chr 4:141,186,749...141,221,348
Ensembl chr 4:141,171,158...141,220,943

G

interleukin 7 receptor

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL7R mRNA

NCBI chr 2:60,179,561...60,204,937
Ensembl chr 2:60,181,382...60,211,027

G

interleukin 9 receptor

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL9R mRNA

NCBI chr10:15,431,706...15,444,144
Ensembl chr10:15,936,156...15,947,613

G

inhibin subunit beta E

decreases expression

EXP

Cacodylic Acid results in decreased expression of INHBE mRNA

NCBI chr 7:63,176,221...63,179,209
Ensembl chr 7:65,061,531...65,064,519

G

insulin induced gene 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of INSIG1 mRNA

NCBI chr 4:8,049,339...8,057,812
Ensembl chr 4:8,049,556...8,057,778

G

interferon regulatory factor 1

increases expression

EXP

Cacodylic Acid results in increased expression of IRF1 mRNA

NCBI chr10:38,417,935...38,424,946
Ensembl chr10:38,417,148...38,424,947

G

interferon regulatory factor 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IRF4 mRNA

NCBI chr17:33,930,460...33,948,842
Ensembl chr17:33,930,471...33,948,730

G

interferon regulatory factor 5

decreases expression

ISO

Cacodylic Acid results in decreased expression of IRF5 mRNA

NCBI chr 4:59,092,914...59,104,596
Ensembl chr 4:59,081,357...59,112,552

G

integrin subunit alpha 10

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ITGA10 mRNA

NCBI chr 2:184,182,869...184,202,172
Ensembl chr 2:186,871,711...186,891,012

G

integrin subunit alpha 11

decreases expression

EXP

Cacodylic Acid results in decreased expression of ITGA11 mRNA

NCBI chr 8:63,145,998...63,254,714
Ensembl chr 8:72,016,652...72,150,137

G

integrin subunit alpha 8

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ITGA8 mRNA

NCBI chr17:75,304,004...75,501,510
Ensembl chr17:80,213,143...80,410,633

G

integrin subunit alpha L

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ITGAL mRNA

NCBI chr 1:191,348,424...191,386,228
Ensembl chr 1:191,348,542...191,386,225

G

integrin subunit beta 1

decreases expression
increases expression

EXP

Cacodylic Acid results in decreased expression of ITGB1 mRNA
Cacodylic Acid results in increased expression of ITGB1 mRNA

PMID:16122865 PMID:17720352

NCBI chr19:73,602,277...73,650,271
Ensembl chr19:73,602,126...73,650,269

G

integrin subunit beta 6

decreases expression

EXP

Cacodylic Acid results in decreased expression of ITGB6 mRNA

NCBI chr 3:65,454,964...65,579,179
Ensembl chr 3:65,456,713...65,530,333

G

integrin subunit beta 8

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ITGB8 mRNA

NCBI chr 6:140,125,002...140,208,261
Ensembl chr 6:146,165,484...146,351,245

G

inter-alpha trypsin inhibitor, heavy chain 3

increases expression

EXP

Cacodylic Acid results in increased expression of ITIH3 mRNA

NCBI chr16:6,101,922...6,117,154
Ensembl chr16:6,108,382...6,123,374

G

integral membrane protein 2A

decreases expression

EXP

Cacodylic Acid results in decreased expression of ITM2A mRNA

NCBI chr X:72,486,383...72,492,344
Ensembl chr X:76,559,181...76,565,437

G

ITPRIP like 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ITPRIPL2 mRNA

NCBI chr 1:172,801,152...172,803,047
Ensembl chr 1:182,231,093...182,245,858

G

IZUMO1 receptor, JUNO

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IZUMO1R mRNA

NCBI chr 8:11,744,384...11,748,131
Ensembl chr 8:20,025,831...20,029,578

G

jagged canonical Notch ligand 1

decreases expression

EXP

Cacodylic Acid results in decreased expression of JAG1 mRNA

NCBI chr 3:144,859,453...144,894,883
Ensembl chr 3:144,859,453...144,894,872

G

Janus kinase 2

decreases expression
multiple interactions

EXP

Cacodylic Acid results in decreased expression of JAK2 mRNA
Cacodylic Acid results in increased expression of and results in increased phosphorylation of JAK2 protein

PMID:17720352 PMID:32890875

NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:236,408,662...236,468,762

G

junction mediating and regulatory protein, p53 cofactor

increases expression

ISO

Cacodylic Acid results in increased expression of JMY mRNA

NCBI chr 2:24,662,104...24,730,955
Ensembl chr 2:26,409,969...26,465,649

G

Jun proto-oncogene, AP-1 transcription factor subunit

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of JUN mRNA

NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285

G

potassium voltage-gated channel subfamily D member 3

decreases expression

EXP

Cacodylic Acid results in decreased expression of KCND3 mRNA

NCBI chr 2:192,937,950...193,155,345
Ensembl chr 2:195,626,316...195,843,690

G

potassium voltage-gated channel modifier subfamily G member 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KCNG1 mRNA

NCBI chr 3:156,960,717...156,992,877
Ensembl chr 3:177,392,031...177,411,507

G

potassium voltage-gated channel interacting protein 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KCNIP4 mRNA

NCBI chr14:61,380,699...62,531,399
Ensembl chr14:65,593,366...66,743,993

G

potassium inwardly-rectifying channel, subfamily J, member 13

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of KCNJ13 mRNA

NCBI chr 9:88,063,003...88,071,112
Ensembl chr 9:95,510,877...95,520,817

G

potassium two pore domain channel subfamily K member 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of KCNK6 mRNA

NCBI chr 1:84,525,613...84,533,948

G

potassium calcium-activated channel subfamily M regulatory beta subunit 1

decreases expression

EXP

Cacodylic Acid results in decreased expression of KCNMB1 mRNA

NCBI chr10:18,557,510...18,614,824
Ensembl chr10:19,062,291...19,073,204

G

lysine demethylase 5D

increases expression

ISO

Cacodylic Acid results in increased expression of KDM5D mRNA

NCBI chr Y:527,069...624,019
Ensembl chr Y:564,261...660,970

G

kinesin family member 11

increases expression

EXP

Cacodylic Acid results in increased expression of KIF11 mRNA

NCBI chr 1:244,494,916...244,589,250
Ensembl chr 1:244,494,875...244,589,250

G

kinesin family member 1B

increases expression

EXP

Cacodylic Acid results in increased expression of KIF1B mRNA

NCBI chr 5:159,607,697...159,742,778
Ensembl chr 5:164,894,763...165,008,841

G

kinesin family member 20A

increases expression

EXP

Cacodylic Acid results in increased expression of KIF20A mRNA

NCBI chr18:26,230,294...26,238,780
Ensembl chr18:26,504,072...26,512,909

G

kinesin family member 20B

increases expression

EXP

Cacodylic Acid results in increased expression of KIF20B mRNA

NCBI chr 1:232,428,293...232,483,798
Ensembl chr 1:241,840,987...241,896,451

G

kinesin family member 4A

increases expression

EXP

Cacodylic Acid results in increased expression of KIF4A mRNA

NCBI chr X:69,761,803...69,864,335
Ensembl chr X:69,761,883...69,864,335

G

kelch-like family member 30

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KLHL30 mRNA

NCBI chr 9:91,942,475...91,952,756
Ensembl chr 9:99,390,014...99,400,295

G

kelch-like family member 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KLHL6 mRNA

NCBI chr11:94,475,262...94,514,653
Ensembl chr11:94,475,262...94,514,623

G

killer cell lectin like receptor B1A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KLRB1 mRNA

NCBI chr 4:163,576,672...163,590,201
Ensembl chr 4:163,576,672...163,619,374

G

kynurenine 3-monooxygenase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KMO mRNA

NCBI chr13:90,089,340...90,121,108
Ensembl chr13:90,089,463...90,125,151

G

kinetochore scaffold 1

increases expression

EXP

Cacodylic Acid results in increased expression of KNL1 mRNA

NCBI chr 3:126,483,498...126,545,774
Ensembl chr 3:126,483,544...126,545,774

G

karyopherin subunit beta 1

increases expression
multiple interactions

ISO

Cacodylic Acid results in increased expression of KPNB1 mRNA
OGG1 protein inhibits the reaction [Cacodylic Acid results in increased expression of KPNB1 mRNA]

NCBI chr10:82,642,082...82,670,856
Ensembl chr10:82,642,082...82,670,856

G

keratin 10

increases expression

ISO

Cacodylic Acid results in increased expression of KRT10 mRNA

NCBI chr10:84,338,695...84,343,279
Ensembl chr10:84,834,840...84,839,160

G

keratin 12

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KRT12 mRNA

NCBI chr10:84,370,803...84,378,103
Ensembl chr10:84,866,965...84,874,265

G

keratin 13

increases expression

ISO

Cacodylic Acid results in increased expression of KRT13 mRNA

NCBI chr10:85,552,287...85,556,499
Ensembl chr10:85,552,287...85,556,499

G

keratin 14

increases expression

EXP

Cacodylic Acid results in increased expression of KRT14 mRNA; Cacodylic Acid results in increased expression of KRT14 protein

PMID:33211169 PMID:37567419

NCBI chr10:85,137,786...85,142,054

G

keratin 15

increases expression

ISO

Cacodylic Acid results in increased expression of KRT15 mRNA

NCBI chr10:85,066,797...85,070,614
Ensembl chr10:85,567,202...85,571,142

G

keratin 17

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KRT17 mRNA

NCBI chr10:85,178,673...85,183,392
Ensembl chr10:85,679,070...85,683,787

G

keratin 18

decreases expression
increases expression

EXP
ISO

Cacodylic Acid results in decreased expression of KRT18 mRNA
Cacodylic Acid results in increased expression of KRT18 mRNA

PMID:17481689 PMID:32052077

NCBI chr 7:135,036,168...135,039,844
Ensembl chr 7:135,035,982...135,039,848
Ensembl chr10:135,035,982...135,039,848

G

keratin 20

decreases expression

EXP

Cacodylic Acid results in decreased expression of KRT20 mRNA

NCBI chr10:84,384,790...84,394,125
Ensembl chr10:84,880,952...84,890,285

G

keratin 25

increases expression

ISO

Cacodylic Acid results in increased expression of KRT25 mRNA

NCBI chr10:84,267,399...84,275,025
Ensembl chr10:84,763,573...84,771,197

G

keratin 27

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KRT27 mRNA

NCBI chr10:84,298,684...84,303,967
Ensembl chr10:84,794,684...84,800,131

G

keratin 4

increases expression

ISO

Cacodylic Acid results in increased expression of KRT4 mRNA

NCBI chr 7:133,046,067...133,052,027
Ensembl chr 7:134,924,753...134,930,713

G

keratin 5

increases expression

ISO

Cacodylic Acid results in increased expression of KRT5 mRNA

NCBI chr 7:132,846,132...132,851,861
Ensembl chr 7:134,724,840...134,730,569

G

keratin 8

increases expression

ISO

Cacodylic Acid results in increased expression of KRT8 mRNA; Cacodylic Acid results in increased expression of KRT8 protein

NCBI chr 7:135,002,886...135,010,339
Ensembl chr 7:135,002,894...135,010,403

G

keratin associated protein 14

increases expression

ISO

Cacodylic Acid results in increased expression of KRTAP14 mRNA

NCBI chr11:28,126,660...28,127,502
Ensembl chr11:41,612,876...41,613,718

G

keratin associated protein 8-1

increases expression

ISO

Cacodylic Acid results in increased expression of KRTAP8-1 mRNA

NCBI chr11:28,717,798...28,718,355
Ensembl chr11:42,204,006...42,204,563

G

keratinocyte associated protein 2

decreases expression

ISO

Cacodylic Acid results in decreased expression of KRTCAP2 mRNA

NCBI chr 2:176,952,167...176,956,163
Ensembl chr 2:176,949,809...176,956,163

G

L3MBTL histone methyl-lysine binding protein 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of L3MBTL3 mRNA

NCBI chr 1:18,988,763...19,089,247
Ensembl chr 1:20,808,973...20,908,608

G

ladinin 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LAD1 mRNA

NCBI chr13:47,249,605...47,263,967
Ensembl chr13:49,800,472...49,815,709

G

leucyl-tRNA synthetase 2, mitochondrial

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LARS2 mRNA

NCBI chr 8:123,010,271...123,106,395
Ensembl chr 8:131,887,753...131,983,866

G

lymphocyte transmembrane adaptor 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LAX1 mRNA

NCBI chr13:45,134,825...45,145,381
Ensembl chr13:47,686,849...47,697,460

G

lipopolysaccharide binding protein

decreases expression

ISO

Cacodylic Acid results in decreased expression of LBP mRNA

NCBI chr 3:146,953,889...146,981,032
Ensembl chr 3:167,373,924...167,401,518

G

lymphocyte cytosolic protein 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LCP1 mRNA

NCBI chr15:56,846,375...56,954,090
Ensembl chr15:56,847,433...56,954,092

G

low density lipoprotein receptor

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LDLR mRNA

NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:28,546,146...28,570,675

G

lymphoid enhancer binding factor 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LEF1 mRNA

NCBI chr 2:222,340,541...222,453,931
Ensembl chr 2:222,340,704...222,453,929

G

galectin 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LGALS2 mRNA

NCBI chr 7:110,403,171...110,410,046
Ensembl chr 7:112,282,822...112,285,392

G

galectin 3

increases expression

EXP

Cacodylic Acid results in increased expression of LGALS3 mRNA

NCBI chr15:20,620,083...20,632,019
Ensembl chr15:23,086,841...23,111,737

G

galectin 8

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of LGALS8 mRNA

NCBI chr17:62,716,368...62,744,272
Ensembl chr17:62,719,828...62,744,482

G

leucine rich repeat containing G protein coupled receptor 5

decreases expression

EXP

Cacodylic Acid results in decreased expression of LGR5 mRNA

NCBI chr 7:51,087,059...51,221,882
Ensembl chr 7:52,974,332...53,108,163

G

LHFPL tetraspan subfamily member 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of LHFPL2 mRNA

NCBI chr 2:25,281,771...25,428,128
Ensembl chr 2:27,016,700...27,162,859

G

lipase C, hepatic type

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LIPC mRNA

NCBI chr 8:80,390,470...80,516,463
Ensembl chr 8:80,390,471...80,516,285

G

lectin, mannose-binding, 1

increases expression

EXP

Cacodylic Acid results in increased expression of LMAN1 mRNA

NCBI chr18:59,508,996...59,530,873
Ensembl chr18:61,772,917...61,800,820

G

lysophosphatidylcholine acyltransferase 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of LPCAT4 mRNA

NCBI chr 3:99,044,729...99,052,963
Ensembl chr 3:119,499,128...119,507,362

G

lipoprotein lipase

decreases expression

ISO
EXP

Cacodylic Acid results in decreased expression of LPL mRNA

PMID:23221991 PMID:37567419

NCBI chr16:25,596,205...25,621,928
Ensembl chr16:25,596,211...25,622,107

G

leupaxin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LPXN mRNA

NCBI chr 1:209,928,297...209,963,085
Ensembl chr 1:219,353,708...219,387,742

G

lecithin retinol acyltransferase

decreases expression

EXP

Cacodylic Acid results in decreased expression of LRAT mRNA

NCBI chr 2:168,264,093...168,273,155
Ensembl chr 2:170,565,543...170,571,148

G

leucine rich repeat containing 31

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LRRC31 mRNA

NCBI chr 2:112,702,844...112,725,431
Ensembl chr 2:114,631,136...114,652,269

G

leucine rich repeat containing 55

decreases expression

EXP

Cacodylic Acid results in decreased expression of LRRC55 mRNA

NCBI chr 3:70,269,908...70,280,651
Ensembl chr 3:90,680,160...90,685,280

G

leucine-rich repeat kinase 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LRRK2 mRNA

NCBI chr 7:124,706,246...124,867,234
Ensembl chr 7:124,706,080...124,867,239

G

leucine rich repeat neuronal 4

decreases expression

EXP

Cacodylic Acid results in decreased expression of LRRN4 mRNA

NCBI chr 3:120,138,093...120,150,877
Ensembl chr 3:140,592,076...140,605,574

G

lanosterol synthase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LSS mRNA

NCBI chr20:12,091,138...12,118,858
Ensembl chr20:12,073,543...12,118,253

G

lymphotoxin alpha

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LTA mRNA

NCBI chr20:3,622,291...3,625,852
Ensembl chr20:3,623,527...3,625,533

G

lymphotoxin beta

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LTB mRNA

NCBI chr20:3,627,536...3,629,381
Ensembl chr20:3,632,210...3,634,054

G

leukotriene B4 receptor 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LTB4R2 mRNA

NCBI chr15:33,228,634...33,230,453
Ensembl chr15:33,228,634...33,230,453

G

lumican

decreases expression

EXP

Cacodylic Acid results in decreased expression of LUM mRNA

NCBI chr 7:32,358,990...32,365,794
Ensembl chr 7:34,245,360...34,252,508

G

lymphocyte antigen 6 family member D

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LY6D mRNA

NCBI chr 7:108,532,207...108,533,943
Ensembl chr 7:108,532,215...108,533,716

G

lymphocyte antigen 6 family member G6C

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of LY6G6C mRNA

NCBI chr20:3,753,632...3,757,205
Ensembl chr20:3,758,290...3,762,927

G

lymphocyte antigen 9

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LY9 mRNA

NCBI chr13:84,079,345...84,100,783
Ensembl chr13:86,611,784...86,657,293

G

LYL1, basic helix-loop-helix family member

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LYL1 mRNA

NCBI chr19:23,452,140...23,455,007
Ensembl chr19:40,354,819...40,359,834

G

Ly6/Plaur domain containing 3

increases expression

EXP

Cacodylic Acid results in increased expression of LYPD3 mRNA

NCBI chr 1:80,226,449...80,230,901
Ensembl chr 1:89,354,335...89,358,810

G

mal, T-cell differentiation protein-like

increases expression

EXP

Cacodylic Acid results in increased expression of MALL mRNA

NCBI chr 3:114,927,897...114,950,840
Ensembl chr 3:135,377,410...135,404,066

G

microtubule-associated protein 1B

decreases expression

EXP

Cacodylic Acid results in decreased expression of MAP1B mRNA

NCBI chr 2:32,551,423...32,644,471
Ensembl chr 2:32,551,423...32,657,094

G

mitogen activated protein kinase kinase kinase 12

decreases expression

ISO

Cacodylic Acid results in decreased expression of MAP3K12 mRNA

NCBI chr 7:133,630,267...133,648,464
Ensembl chr 7:135,508,790...135,515,137

G

mitogen-activated protein kinase kinase kinase 14

increases expression

ISO

Cacodylic Acid results in increased expression of MAP3K14 mRNA

NCBI chr10:88,665,417...88,715,669
Ensembl chr10:88,665,417...88,715,592

G

mitogen-activated protein kinase kinase kinase 19

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MAP3K19 mRNA

NCBI chr13:41,852,633...41,896,078
Ensembl chr13:41,852,531...41,895,565

G

mitogen-activated protein kinase kinase kinase 5

increases expression

ISO

Cacodylic Acid results in increased expression of MAP3K5 mRNA

NCBI chr 1:14,685,776...14,904,935
Ensembl chr 1:16,505,596...16,723,898

G

mitogen-activated protein kinase kinase kinase 6

decreases expression

ISO

Cacodylic Acid results in decreased expression of MAP3K6 mRNA

NCBI chr 5:145,440,126...145,452,213
Ensembl chr 5:150,724,216...150,736,111

G

mitogen-activated protein kinase kinase kinase 9

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MAP3K9 mRNA

NCBI chr 6:101,423,754...101,488,822
Ensembl chr 6:107,161,534...107,220,061

G

mitogen activated protein kinase kinase kinase kinase 1

decreases expression
multiple interactions

ISO

Cacodylic Acid results in decreased expression of MAP4K1 mRNA
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MAP4K1 mRNA

PMID:17720352 PMID:34876320

NCBI chr 1:84,270,951...84,292,496
Ensembl chr 1:93,398,454...93,419,993

G

mitogen activated protein kinase 1

multiple interactions
increases phosphorylation

ISO
EXP

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of MAPK1 mRNA
Cacodylic Acid results in increased phosphorylation of MAPK1 protein
Cacodylic Acid results in increased expression of and results in increased phosphorylation of MAPK1 protein

PMID:23192986 PMID:32890875 PMID:36000705

NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825

G

mitogen-activated protein kinase 15

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MAPK15 mRNA

NCBI chr 7:109,575,619...109,595,339
Ensembl chr 7:109,575,561...109,595,346

G

mitogen activated protein kinase 3

multiple interactions
increases phosphorylation

EXP
ISO

Cacodylic Acid results in increased expression of and results in increased phosphorylation of MAPK3 protein
Cacodylic Acid results in increased phosphorylation of MAPK3 protein

PMID:32890875 PMID:36000705

NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411

G

mitogen-activated protein kinase 8

increases expression
increases phosphorylation
decreases expression

ISO
EXP

Cacodylic Acid results in increased expression of MAPK8 mRNA
Cacodylic Acid results in increased phosphorylation of MAPK8 protein
Cacodylic Acid results in decreased expression of MAPK8 mRNA

PMID:17441966 PMID:17481689 PMID:36000705

NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427

G

microtubule-associated protein, RP/EB family, member 2

decreases expression

EXP

Cacodylic Acid results in decreased expression of MAPRE2 mRNA

NCBI chr18:15,303,502...15,444,306
Ensembl chr18:15,303,533...15,442,796

G

MAS1 proto-oncogene, G protein-coupled receptor

decreases expression

ISO

Cacodylic Acid results in decreased expression of MAS1 mRNA

NCBI chr 1:50,428,064...50,459,537
Ensembl chr 1:50,425,257...50,500,561

G

matrilin 2

decreases expression

EXP

Cacodylic Acid results in decreased expression of MATN2 mRNA

NCBI chr 7:65,494,996...65,644,613
Ensembl chr 7:67,380,168...67,530,153

G

membrane-bound transcription factor peptidase, site 1

increases expression

EXP

Cacodylic Acid results in increased expression of MBTPS1 mRNA

NCBI chr19:47,561,598...47,612,769
Ensembl chr19:64,470,545...64,521,342

G

melanin-concentrating hormone receptor 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MCHR1 mRNA

NCBI chr 7:112,761,554...112,764,746
Ensembl chr 7:114,641,580...114,644,919

G

MDM2 proto-oncogene

increases expression
multiple interactions

EXP
ISO

Cacodylic Acid results in increased expression of MDM2 mRNA
[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of MDM2 mRNA

PMID:17481689 PMID:23192986

NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:55,176,560...55,200,791

G

myocyte enhancer factor 2C

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MEF2C mRNA

NCBI chr 2:15,708,732...15,871,639
Ensembl chr 2:15,708,924...15,871,640

G

meiosis specific with coiled-coil domain

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MEIOC mRNA

NCBI chr10:87,628,807...87,646,485
Ensembl chr10:88,128,990...88,147,829

G

microfibril associated protein 2

decreases expression

ISO

Cacodylic Acid results in decreased expression of MFAP2 mRNA

NCBI chr 5:153,312,068...153,320,266
Ensembl chr 5:158,597,512...158,610,656

G

microfibril associated protein 5

decreases expression

EXP

Cacodylic Acid results in decreased expression of MFAP5 mRNA

NCBI chr 4:155,727,925...155,750,458
Ensembl chr 4:157,395,597...157,422,448

G

milk fat globule EGF and factor V/VIII domain containing

increases expression
multiple interactions

EXP
ISO

Cacodylic Acid results in increased expression of MFGE8 mRNA
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MFGE8 mRNA

PMID:16122865 PMID:34876320

NCBI chr 1:133,064,665...133,080,069
Ensembl chr 1:142,474,028...142,489,431

G

major facilitator superfamily domain containing 12

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MFSD12 mRNA

NCBI chr 7:8,345,171...8,354,050
Ensembl chr 7:8,998,050...9,004,724

G

MFSD2 lysolipid transporter B, sphingolipid

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MFSD2B mRNA

NCBI chr 6:27,870,182...27,883,768
Ensembl chr 6:33,589,852...33,601,626

G

microsomal glutathione S-transferase 1

increases expression

EXP

Cacodylic Acid results in increased expression of MGST1 mRNA

NCBI chr 4:171,029,666...171,044,893
Ensembl chr 4:172,760,886...172,776,875

G

microRNA 145

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MIR145A mRNA

NCBI chr18:57,369,983...57,370,070

G

Mir155 host gene

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MIR155HG mRNA

NCBI chr11:23,773,468...23,775,697

G

microRNA 192

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MIR192 mRNA

NCBI chr 1:212,994,209...212,994,318
Ensembl chr 1:212,994,209...212,994,318

G

marker of proliferation Ki-67

increases expression

EXP

Cacodylic Acid results in increased expression of MKI67 mRNA

NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:199,926,150...199,952,593

G

mohawk homeobox

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MKX mRNA

NCBI chr17:55,077,073...55,156,877
Ensembl chr17:59,773,570...59,850,345

G

mixed lineage kinase domain like pseudokinase

increases phosphorylation

ISO

Cacodylic Acid results in increased phosphorylation of MLKL protein

NCBI chr19:39,277,526...39,304,555
Ensembl chr19:56,186,860...56,213,858

G

matrix metallopeptidase 13

increases expression
multiple interactions

ISO
EXP

Cacodylic Acid results in increased expression of MMP13 mRNA
OGG1 protein inhibits the reaction [Cacodylic Acid results in increased expression of MMP13 mRNA]

PMID:17441966 PMID:37567419

NCBI chr 8:4,497,960...4,508,239
Ensembl chr 8:12,782,813...12,793,105

G

matrix metallopeptidase 14

increases expression

ISO

Cacodylic Acid results in increased expression of MMP14 mRNA

NCBI chr15:31,857,824...31,867,049
Ensembl chr15:31,857,546...31,869,893

G

matrix metallopeptidase 17

increases expression

ISO

Cacodylic Acid results in increased expression of MMP17 mRNA

NCBI chr12:27,074,398...27,099,317
Ensembl chr12:32,710,504...32,735,414

G

matrix metallopeptidase 9

increases expression
multiple interactions

ISO
EXP

Cacodylic Acid results in increased expression of MMP9 mRNA
Cacodylic Acid results in increased expression of MMP9 mRNA; Cacodylic Acid results in increased expression of MMP9 protein
monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [Cacodylic Acid results in increased expression of MMP9 protein]

PMID:17441966 PMID:32474354

NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442

G

maestro heat-like repeat family member 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MROH6 mRNA

NCBI chr 7:107,566,212...107,576,469
Ensembl chr 7:109,449,268...109,455,087

G

maestro heat-like repeat family member 7

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MROH7 mRNA

NCBI chr 5:121,463,826...121,509,233
Ensembl chr 5:126,692,649...126,731,161

G

membrane spanning 4-domains A1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MS4A1 mRNA

NCBI chr 1:217,331,274...217,351,934
Ensembl chr 1:217,331,274...217,343,447

G

membrane spanning 4-domains A18

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MS4A18 mRNA

NCBI chr 1:217,069,752...217,090,869
Ensembl chr 1:217,069,884...217,090,754

G

mutS homolog 2

decreases expression

EXP

Cacodylic Acid results in decreased expression of MSH2 mRNA

NCBI chr 6:12,567,368...12,626,534
Ensembl chr 6:12,567,368...12,626,503

G

misato mitochondrial distribution and morphology regulator 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MSTO1 mRNA

NCBI chr 2:176,603,755...176,608,037
Ensembl chr 2:176,599,671...176,608,026

G

metallothionein 1, pseudogene 3

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of MT1E mRNA

NCBI chr17:74,786,652...74,787,040
Ensembl chr17:79,695,809...79,696,200

G

metallothionein 1A

increases expression
multiple interactions

EXP
ISO

Cacodylic Acid results in increased expression of MT1A mRNA
Cacodylic Acid results in increased expression of MT1 mRNA
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MT1 mRNA

PMID:16122865 PMID:17441966 PMID:34876320

NCBI chr19:10,831,959...10,832,975
Ensembl chr17:79,695,809...79,696,200
Ensembl chr X:79,695,809...79,696,200
Ensembl chr19:79,695,809...79,696,200

G

metallothionein 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MT4 mRNA

NCBI chr19:10,863,813...10,865,909
Ensembl chr19:10,869,735...10,871,831

G

metastasis associated 1

increases expression

EXP

Cacodylic Acid results in increased expression of MTA1 mRNA

NCBI chr 6:132,178,608...132,217,641
Ensembl chr 6:137,999,915...138,038,696

G

5-methyltetrahydrofolate-homocysteine methyltransferase

multiple interactions

ISO

[MTR gene SNP affects the susceptibility to Arsenic] which affects the abundance of Cacodylic Acid

NCBI chr17:62,911,705...62,996,544
Ensembl chr17:62,911,771...62,996,541

G

mevalonate diphosphate decarboxylase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MVD mRNA

NCBI chr19:67,404,911...67,414,974
Ensembl chr19:67,404,911...67,422,366

G

mevalonate kinase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MVK mRNA

NCBI chr12:47,802,002...47,819,503
Ensembl chr12:47,802,002...47,819,503

G

MX dynamin like GTPase 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MX1 mRNA

NCBI chr11:36,799,659...36,825,209
Ensembl chr11:50,269,057...50,292,904

G

Max dimerization protein 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MXD3 mRNA

NCBI chr17:9,301,430...9,305,156
Ensembl chr17:9,302,321...9,310,278

G

MYB proto-oncogene, transcription factor

decreases expression

ISO

Cacodylic Acid results in decreased expression of MYB mRNA

NCBI chr 1:17,759,309...17,793,306
Ensembl chr 1:17,759,309...17,792,547

G

MYB proto-oncogene like 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MYBL1 mRNA

NCBI chr 5:9,582,905...9,618,179
Ensembl chr 5:14,365,768...14,399,588

G

MYC proto-oncogene, bHLH transcription factor

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of MYC mRNA

NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028

G

myosin IG

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MYO1G mRNA

NCBI chr14:81,386,701...81,401,843
Ensembl chr14:85,600,619...85,615,760

G

myotilin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MYOT mRNA

NCBI chr18:36,705,244...36,724,849
Ensembl chr18:36,956,191...36,976,265

G

marginal zone B and B1 cell-specific protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MZB1 mRNA

NCBI chr18:27,513,087...27,515,148
Ensembl chr18:27,513,089...27,515,182

G

N(alpha)-acetyltransferase 80, NatH catalytic subunit

decreases expression

ISO

Cacodylic Acid results in decreased expression of NAA80 mRNA

NCBI chr 8:117,132,957...117,136,207
Ensembl chr 8:117,133,494...117,136,207

G

N-acetylated alpha-linked acidic dipeptidase-like 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NAALADL1 mRNA

NCBI chr 1:212,829,917...212,843,474
Ensembl chr 1:212,829,916...212,843,474

G

napsin A aspartic peptidase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NAPSA mRNA

NCBI chr 1:95,064,726...95,077,101
Ensembl chr 1:104,200,960...104,213,608

G

NBL1, DAN family BMP antagonist

increases expression

EXP

Cacodylic Acid results in increased expression of NBL1 mRNA

NCBI chr 5:151,318,752...151,329,948
Ensembl chr 5:156,601,986...156,613,186

G

neural cell adhesion molecule 1

decreases expression

EXP

Cacodylic Acid results in decreased expression of NCAM1 mRNA

NCBI chr 8:58,762,088...59,062,131
Ensembl chr 8:58,762,116...59,061,971

G

non-SMC condensin I complex, subunit G

increases expression

EXP

Cacodylic Acid results in increased expression of NCAPG mRNA

NCBI chr14:69,616,473...69,645,445
Ensembl chr14:69,616,473...69,645,445

G

neutrophil cytosolic factor 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NCF1 mRNA

NCBI chr12:28,121,816...28,131,080
Ensembl chr12:28,121,366...28,131,079

G

neutrophil cytosolic factor 2

increases expression

ISO

Cacodylic Acid results in increased expression of NCF2 mRNA

NCBI chr13:67,505,492...67,536,015
Ensembl chr13:67,505,375...67,536,149

G

noncompact myelin associated protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NCMAP mRNA

NCBI chr 5:147,608,042...147,623,266
Ensembl chr 5:152,894,316...152,902,414

G

N-myc downstream regulated 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NDRG1 mRNA

NCBI chr 7:100,573,526...100,614,902
Ensembl chr 7:100,573,523...100,614,913

G

N-deacetylase and N-sulfotransferase 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NDST3 mRNA

NCBI chr 2:211,702,728...211,868,159
Ensembl chr 2:214,389,447...214,539,164

G

nuclear paraspeckle assembly transcript 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of NEAT1 mRNA

NCBI chr 1:203,129,229...203,140,014

G

nebulin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NEB mRNA

NCBI chr 3:36,613,677...36,811,618
Ensembl chr 3:57,022,822...57,220,709

G

nectin cell adhesion molecule 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NECTIN1 mRNA

NCBI chr 8:44,101,776...44,164,863
Ensembl chr 8:52,998,662...53,086,664

G

neogenin 1

increases expression

ISO

Cacodylic Acid results in increased expression of NEO1 mRNA

NCBI chr 8:59,273,860...59,426,486
Ensembl chr 8:68,169,716...68,322,152

G

NFE2 like bZIP transcription factor 2

multiple interactions

ISO

[Cacodylic Acid results in increased abundance of Arsenic] which results in increased expression of and affects the localization of NFE2L2 protein; [Cacodylic Acid results in increased abundance of Arsenic] which results in increased expression of NFE2L2 protein; Cacodylic Acid results in increased expression of and affects the localization of NFE2L2 protein; NFE2L2 mutant form inhibits the reaction [Cacodylic Acid results in increased expression of NQO1 protein]

PMID:24161444 PMID:33434570

NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090

G

nuclear factor I/A

increases expression

EXP

Cacodylic Acid results in increased expression of NFIA mRNA

NCBI chr 5:112,436,655...112,781,878
Ensembl chr 5:117,359,077...117,891,395

G

nuclear factor I/C

increases expression

EXP

Cacodylic Acid results in increased expression of NFIC mRNA

NCBI chr 7:8,278,210...8,309,936
Ensembl chr 7:8,904,117...8,963,409

G

nuclear factor, interleukin 3 regulated

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of NFIL3 mRNA

NCBI chr17:12,280,499...12,295,728
Ensembl chr17:12,432,198...12,450,826

G

nuclear factor kappa B subunit 1

multiple interactions
increases expression

ISO
EXP

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of NFKB1 mRNA
Cacodylic Acid results in increased expression of NFKB1 mRNA
Cacodylic Acid results in increased expression of and affects the localization of NFKB1 protein

PMID:23192986 PMID:26617437

NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:226,689,745...226,783,088

G

niban apoptosis regulator 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of NIBAN3 mRNA

NCBI chr16:18,307,122...18,318,589
Ensembl chr16:18,341,141...18,352,575

G

ninjurin 1

increases expression

EXP

Cacodylic Acid results in increased expression of NINJ1 mRNA

NCBI chr17:15,659,208...15,668,115
Ensembl chr17:15,659,200...15,668,063

G

NIPA-like domain containing 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NIPAL4 mRNA

NCBI chr10:30,583,926...30,600,640
Ensembl chr10:31,085,267...31,101,979

G

NLR family, pyrin domain containing 9

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of NLRP9B mRNA

NCBI chr 1:68,291,180...68,341,512
Ensembl chr 1:77,319,218...77,378,658

G

neuromedin U

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NMU mRNA

NCBI chr14:32,198,789...32,226,397
Ensembl chr14:32,198,943...32,226,632

G

nocturnin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of NOCT mRNA

NCBI chr 2:135,271,189...135,291,407
Ensembl chr 2:137,422,074...137,442,282

G

nucleotide-binding oligomerization domain containing 2

multiple interactions

ISO

[Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of NOD2 mRNA

NCBI chr19:34,555,832...34,596,281
Ensembl chr19:34,555,832...34,722,846

G

Nodal modulator 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NOMO1 mRNA

NCBI chr 1:96,505,460...96,556,280
Ensembl chr 1:105,641,879...105,692,707

G

notch receptor 1

affects expression

EXP

Cacodylic Acid affects the expression of NOTCH1 mRNA

NCBI chr 3:29,676,040...29,721,613
Ensembl chr 3:29,676,171...29,721,613

G

notch receptor 3

increases expression

EXP

Cacodylic Acid results in increased expression of NOTCH3 mRNA

NCBI chr 7:11,783,550...11,834,585
Ensembl chr 7:11,784,272...11,834,778

G

neuronal PAS domain protein 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of NPAS4 mRNA

NCBI chr 1:202,281,260...202,298,681
Ensembl chr 1:211,711,338...211,716,102

G

neuropeptide FF receptor 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NPFFR1 mRNA

NCBI chr20:29,539,795...29,573,951
Ensembl chr20:30,082,604...30,114,998

G

natriuretic peptide A

increases expression

ISO

Cacodylic Acid results in increased expression of NPPA mRNA

NCBI chr 5:163,712,184...163,713,493
Ensembl chr 5:163,712,184...163,713,493

G

neuropeptide Y receptor Y5

decreases expression

ISO

Cacodylic Acid results in decreased expression of NPY5R mRNA

NCBI chr16:27,822,055...27,830,012
Ensembl chr16:27,816,065...27,830,290

G

NAD(P)H quinone dehydrogenase 1

increases expression
multiple interactions

ISO

Cacodylic Acid results in increased expression of NQO1 mRNA
Cacodylic Acid promotes the reaction [sulforaphane results in increased expression of and results in increased activity of NQO1 protein]; Cacodylic Acid promotes the reaction [sulforaphane results in increased expression of NQO1 mRNA]; Cacodylic Acid promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of NQO1 protein]; Cacodylic Acid promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA]; Cacodylic Acid results in increased expression of and results in increased activity of NQO1 protein; NFE2L2 mutant form inhibits the reaction [Cacodylic Acid results in increased expression of NQO1 protein]

PMID:15345372 PMID:24161444

NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260

G

nuclear receptor subfamily 0, group B, member 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of NR0B2 mRNA

NCBI chr 5:151,063,160...151,066,475
Ensembl chr 5:151,063,160...151,066,475

G

neuregulin 1

increases expression

ISO

Cacodylic Acid results in increased expression of NRG1 mRNA

NCBI chr16:65,954,084...67,007,484
Ensembl chr16:65,953,865...66,999,849

G

neuropilin 2

decreases expression

EXP

Cacodylic Acid results in decreased expression of NRP2 mRNA

NCBI chr 9:71,616,602...71,731,869
Ensembl chr 9:71,616,657...71,731,871

G

5' nucleotidase, ecto

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of NT5E mRNA

NCBI chr 8:89,271,046...89,314,918
Ensembl chr 8:98,150,900...98,195,645

G

NUF2 component of NDC80 kinetochore complex

increases expression

EXP

Cacodylic Acid results in increased expression of NUF2 mRNA

NCBI chr13:84,226,448...84,290,957
Ensembl chr13:84,226,509...84,255,598

G

nuclear GTPase, germinal center associated

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NUGGC mRNA

NCBI chr15:39,821,851...39,866,122
Ensembl chr15:43,997,438...44,041,643

G

nuclear mitotic apparatus protein 1

multiple interactions

EXP

3,3'-diindolylmethane inhibits the reaction [[Butylhydroxybutylnitrosamine co-treated with Cacodylic Acid] results in increased expression of NUMA1 protein]; [Butylhydroxybutylnitrosamine co-treated with Cacodylic Acid] results in increased expression of NUMA1 protein; lupeol inhibits the reaction [[Butylhydroxybutylnitrosamine co-treated with Cacodylic Acid] results in increased expression of NUMA1 protein]

NCBI chr 1:165,709,893...165,784,848
Ensembl chr 1:165,709,905...165,784,848

G

neurexophilin and PC-esterase domain family, member 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NXPE3 mRNA

NCBI chr11:44,726,905...44,777,694
Ensembl chr11:58,195,976...58,248,644

G

neurexophilin and PC-esterase domain family member 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NXPE4 mRNA

NCBI chr 8:48,502,697...48,744,101
Ensembl chr 8:57,631,895...57,644,186

G

nyctalopin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of NYX mRNA

NCBI chr X:9,280,864...9,301,900
Ensembl chr X:11,953,018...11,974,810

G

2'-5' oligoadenylate synthetase 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of OAS2 mRNA

NCBI chr12:35,802,824...35,830,778
Ensembl chr12:41,467,315...41,495,881

G

ornithine decarboxylase antizyme 1

decreases expression

ISO

Cacodylic Acid results in decreased expression of OAZ1 mRNA

NCBI chr 7:8,883,855...8,886,315
Ensembl chr 7:9,533,811...9,536,990

G

8-oxoguanine DNA glycosylase

multiple interactions
increases expression

ISO
EXP

OGG1 protein inhibits the reaction [Cacodylic Acid results in decreased expression of HSPA1B mRNA]; OGG1 protein inhibits the reaction [Cacodylic Acid results in decreased expression of HSPA4L mRNA]; OGG1 protein inhibits the reaction [Cacodylic Acid results in decreased expression of HSPA8 mRNA]; OGG1 protein inhibits the reaction [Cacodylic Acid results in decreased expression of HSPB1 mRNA]; OGG1 protein inhibits the reaction [Cacodylic Acid results in decreased expression of HSPH1 mRNA]; OGG1 protein inhibits the reaction [Cacodylic Acid results in increased expression of AOC3 mRNA]; OGG1 protein inhibits the reaction [Cacodylic Acid results in increased expression of CCNC mRNA]; OGG1 protein inhibits the reaction [Cacodylic Acid results in increased expression of CDH4 mRNA]; OGG1 protein inhibits the reaction [Cacodylic Acid results in increased expression of CFD mRNA]; OGG1 protein inhibits the reaction [Cacodylic Acid results in increased expression of CYP7B1 mRNA]; OGG1 protein inhibits the reaction [Cacodylic Acid results in increased expression of KPNB1 mRNA]; OGG1 protein inhibits the reaction [Cacodylic Acid results in increased expression of MMP13 mRNA]
Cacodylic Acid results in increased expression of OGG1 mRNA

PMID:17441966 PMID:17481689

NCBI chr 4:146,474,701...146,481,959
Ensembl chr 4:148,030,349...148,037,604

G

osteoglycin

decreases expression

EXP

Cacodylic Acid results in decreased expression of OGN mRNA

NCBI chr17:15,032,069...15,052,626
Ensembl chr17:15,238,500...15,259,252

G

olfactomedin-like 2B

decreases expression

EXP

Cacodylic Acid results in decreased expression of OLFML2B mRNA

NCBI chr13:82,869,414...82,906,607
Ensembl chr13:85,402,169...85,439,342

G

opioid binding protein/cell adhesion molecule-like

decreases expression

EXP

Cacodylic Acid results in decreased expression of OPCML mRNA

NCBI chr 8:26,788,988...27,304,551
Ensembl chr 8:34,451,500...35,558,966

G

olfactory receptor family 10 subfamily J member 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of OR10J2 mRNA

NCBI chr13:88,255,644...88,256,634
Ensembl chr13:88,255,644...88,256,634

G

olfactory receptor family 6 subfamily C member 6I

increases expression

EXP

Cacodylic Acid results in increased expression of OR6C6I mRNA

NCBI chr 7:1,969,945...1,970,889
Ensembl chr 7:2,598,438...2,599,382

G

odd-skipped related transcription factor 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of OSR2 mRNA

NCBI chr 7:66,487,841...66,495,003
Ensembl chr 7:68,373,049...68,380,805

G

3-oxoacid CoA transferase 2A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of OXCT2A mRNA

NCBI chr 5:135,600,812...135,602,570
Ensembl chr 5:140,874,503...140,902,881

G

P2Y receptor family member 10

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of P2RY10 mRNA

NCBI chr X:72,121,558...72,207,174
Ensembl chr X:76,184,001...76,280,953

G

purinergic receptor P2Y13

decreases expression

EXP

Cacodylic Acid results in decreased expression of P2RY13 mRNA

NCBI chr 2:143,470,437...143,476,360
Ensembl chr 2:145,619,655...145,622,787

G

purinergic receptor P2Y2

decreases expression

ISO

Cacodylic Acid results in decreased expression of P2RY2 mRNA

NCBI chr 1:164,764,119...164,779,578
Ensembl chr 1:164,759,213...164,781,852

G

prolyl 4-hydroxylase subunit alpha 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of P4HA1 mRNA

NCBI chr20:27,302,046...27,352,098
Ensembl chr20:27,845,141...27,895,404

G

protein kinase C and casein kinase substrate in neurons 2

increases expression

EXP

Cacodylic Acid results in increased expression of PACSIN2 mRNA

NCBI chr 7:114,505,525...114,599,087
Ensembl chr 7:116,384,190...116,478,537

G

p21 (RAC1) activated kinase 2

decreases expression

EXP

Cacodylic Acid results in decreased expression of PAK2 mRNA

NCBI chr11:82,212,896...82,273,803
Ensembl chr11:82,212,951...82,273,803

G

pappalysin

increases expression

ISO

Cacodylic Acid results in increased expression of PAPPA mRNA

NCBI chr 5:78,497,660...78,735,873
Ensembl chr 5:83,513,358...83,751,361

G

parvin, gamma

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PARVG mRNA

NCBI chr 7:115,456,183...115,475,707
Ensembl chr 7:117,336,187...117,362,155

G

paired box 5

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PAX5 mRNA

NCBI chr 5:63,554,784...63,741,380
Ensembl chr 5:63,560,722...63,739,987

G

paired box 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PAX6 mRNA

NCBI chr 3:112,590,034...112,611,771
Ensembl chr 3:112,590,391...112,611,763

G

phosphatidylethanolamine binding protein 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PBP2 mRNA

NCBI chr 4:168,155,827...168,157,121
Ensembl chr 4:169,856,292...169,889,596

G

protocadherin 1

decreases expression

ISO

Cacodylic Acid results in decreased expression of PCDH1 mRNA

NCBI chr18:30,011,692...30,039,679
Ensembl chr18:30,258,154...30,290,436

G

protocadherin related 15

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PCDH15 mRNA

NCBI chr20:13,997,094...15,496,446
Ensembl chr20:13,999,116...15,493,958

G

protocadherin gamma subfamily B, 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PCDHGB1 mRNA

NCBI chr18:29,501,739...29,508,024

G

PC-esterase domain containing 1B

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PCED1B mRNA

NCBI chr 7:128,394,388...128,528,231
Ensembl chr 7:130,270,554...130,410,365

G

phosphoenolpyruvate carboxykinase 1

increases expression

ISO

Cacodylic Acid results in increased expression of PCK1 mRNA

NCBI chr 3:182,348,572...182,354,521
Ensembl chr 3:182,348,572...182,354,561

G

proliferating cell nuclear antigen

increases expression

EXP

Cacodylic Acid results in increased expression of PCNA mRNA; Cacodylic Acid results in increased expression of PCNA protein

PMID:17481689 PMID:24832369

NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901

G

proprotein convertase subtilisin/kexin type 9

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PCSK9 mRNA

NCBI chr 5:126,440,102...126,462,507
Ensembl chr 5:126,440,102...126,462,507

G

programmed cell death 2

increases expression

EXP

Cacodylic Acid results in increased expression of PDCD2 mRNA

NCBI chr 1:56,484,947...56,490,437
Ensembl chr 1:65,158,034...65,163,524

G

phosphodiesterase 3B

decreases expression

EXP

Cacodylic Acid results in decreased expression of PDE3B mRNA

NCBI chr 1:168,606,762...168,770,078
Ensembl chr 1:178,041,207...178,204,503

G

platelet derived growth factor receptor alpha

decreases expression

EXP

Cacodylic Acid results in decreased expression of PDGFRA mRNA

NCBI chr14:33,360,027...33,408,604
Ensembl chr14:33,360,028...33,408,516

G

pyruvate dehydrogenase kinase 4

decreases expression
increases expression

EXP

Cacodylic Acid results in decreased expression of PDK4 mRNA
Cacodylic Acid results in increased expression of PDK4 mRNA

PMID:16122865 PMID:37567419

NCBI chr 4:33,591,796...33,601,798
Ensembl chr 4:34,556,330...34,568,381

G

period circadian regulator 1

decreases expression

ISO

Cacodylic Acid results in decreased expression of PER1 mRNA

NCBI chr10:53,800,126...53,814,963
Ensembl chr10:54,302,641...54,314,211

G

phosphate regulating endopeptidase X-linked

decreases expression

ISO

Cacodylic Acid results in decreased expression of PHEX mRNA

NCBI chr X:37,607,553...37,856,183
Ensembl chr X:41,426,101...41,671,226

G

pleckstrin homology-like domain, family A, member 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PHLDA1 mRNA

NCBI chr 7:48,853,690...48,855,894
Ensembl chr 7:48,853,260...48,857,542

G

peptidase inhibitor 15

decreases expression

EXP

Cacodylic Acid results in decreased expression of PI15 mRNA

NCBI chr 5:1,395,094...1,423,213
Ensembl chr 5:6,174,963...6,247,841

G

polymeric immunoglobulin receptor

decreases expression

ISO

Cacodylic Acid results in decreased expression of PIGR mRNA

NCBI chr13:42,298,905...42,326,877
Ensembl chr13:44,851,182...44,879,141

G

paired-like homeodomain 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PITX1 mRNA

NCBI chr17:8,794,051...8,805,477
Ensembl chr17:8,799,319...8,805,476

G

phospholipase A2 group IB

decreases expression

ISO

Cacodylic Acid results in decreased expression of PLA2G1B mRNA

NCBI chr12:46,802,932...46,814,511
Ensembl chr12:46,802,939...46,813,693

G

phospholipase A2 group IIA

multiple interactions
decreases expression

ISO
EXP

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PLA2G2A mRNA
Cacodylic Acid results in decreased expression of PLA2G2A mRNA

PMID:34876320 PMID:37567419

NCBI chr 5:156,359,725...156,362,302
Ensembl chr 5:156,359,725...156,362,297

G

phospholipase A2, group IID

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PLA2G2D mRNA

NCBI chr 5:156,299,374...156,305,816
Ensembl chr 5:156,297,777...156,305,812

G

phospholipase A2, group IVF

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PLA2G4F mRNA

NCBI chr 3:107,249,053...107,266,201
Ensembl chr 3:127,703,841...127,718,348

G

phospholipase A2 group VII

increases expression

ISO

Cacodylic Acid results in increased expression of PLA2G7 mRNA

NCBI chr 9:17,362,214...17,404,476
Ensembl chr 9:24,859,502...24,901,747

G

PLAG1 like zinc finger 1

decreases expression

EXP

Cacodylic Acid results in decreased expression of PLAGL1 mRNA

NCBI chr 1:7,477,295...7,517,229
Ensembl chr 1:9,330,204...9,337,394

G

plasminogen activator, urokinase

multiple interactions

ISO

[Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of PLAU mRNA

NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,505,487...3,512,030

G

plasminogen activator, urokinase receptor

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PLAUR mRNA

NCBI chr 1:89,181,363...89,196,308
Ensembl chr 1:89,178,453...89,198,130

G

phospholipase B1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PLB1 mRNA

NCBI chr 6:29,807,127...29,945,607
Ensembl chr 6:29,809,290...29,930,183

G

phospholipase D2

increases expression

EXP

Cacodylic Acid results in increased expression of PLD2 mRNA

NCBI chr10:55,256,326...55,274,192
Ensembl chr10:55,754,988...55,771,435

G

phospholipase D family, member 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PLD4 mRNA

NCBI chr 6:131,818,860...131,827,457
Ensembl chr 6:137,639,945...137,649,024

G

pleckstrin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PLEK mRNA

NCBI chr14:95,598,650...95,631,326
Ensembl chr14:95,598,654...95,655,721

G

pleckstrin homology and RhoGEF domain containing G4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PLEKHG4 mRNA

NCBI chr19:33,251,788...33,266,490
Ensembl chr19:50,159,754...50,182,133

G

pleckstrin homology, MyTH4 and FERM domain containing H2

decreases expression

EXP

Cacodylic Acid results in decreased expression of PLEKHH2 mRNA

NCBI chr 6:15,783,179...15,893,479
Ensembl chr 6:15,784,645...15,893,537

G

placenta expressed transcript 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PLET1 mRNA

NCBI chr 8:50,842,242...50,853,666
Ensembl chr 8:59,738,529...59,750,406

G

polo-like kinase 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PLK3 mRNA

NCBI chr 5:135,843,725...135,848,900
Ensembl chr 5:135,843,725...135,848,900

G

phospholipid transfer protein

decreases expression

EXP

Cacodylic Acid results in decreased expression of PLTP mRNA

NCBI chr 3:153,574,825...153,592,647
Ensembl chr 3:173,994,162...174,012,505

G

plexin C1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PLXNC1 mRNA

NCBI chr 7:29,390,038...29,543,985
Ensembl chr 7:31,276,978...31,431,092

G

phorbol-12-myristate-13-acetate-induced protein 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PMAIP1 mRNA

NCBI chr18:62,255,970...62,262,384
Ensembl chr18:62,255,598...62,262,382

G

patatin-like phospholipase domain containing 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PNPLA1 mRNA

NCBI chr20:6,917,993...6,952,157
Ensembl chr20:6,919,115...6,955,143

G

patatin-like phospholipase domain containing 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PNPLA3 mRNA

NCBI chr 7:117,173,485...117,194,065
Ensembl chr 7:117,173,516...117,194,594

G

DNA polymerase alpha 1, catalytic subunit

increases expression

ISO

Cacodylic Acid results in increased expression of POLA1 mRNA

NCBI chr X:58,034,617...58,348,612
Ensembl chr X:62,028,476...62,342,355

G

DNA polymerase delta 1, catalytic subunit

increases expression

EXP

Cacodylic Acid results in increased expression of POLD1 mRNA

NCBI chr 1:104,161,984...104,178,074
Ensembl chr 1:104,162,016...104,172,982

G

DNA polymerase delta 4, accessory subunit

increases expression

ISO

Cacodylic Acid results in increased expression of POLD4 mRNA

NCBI chr 1:201,526,591...201,528,406
Ensembl chr 1:210,956,099...210,957,860

G

DNA polymerase epsilon 2, accessory subunit

increases expression

ISO

Cacodylic Acid results in increased expression of POLE2 mRNA

NCBI chr 6:93,410,713...93,448,782
Ensembl chr 6:93,410,758...93,435,361

G

DNA polymerase gamma, catalytic subunit

increases expression

ISO

Cacodylic Acid results in increased expression of POLG mRNA

NCBI chr 1:142,792,119...142,808,933
Ensembl chr 1:142,792,119...142,808,838

G

DNA polymerase iota

increases expression

ISO

Cacodylic Acid results in increased expression of POLI mRNA

NCBI chr18:64,116,774...64,134,373
Ensembl chr18:66,364,236...66,409,819

G

paraoxonase 1

increases expression

ISO

Cacodylic Acid results in increased expression of PON1 mRNA

NCBI chr 4:34,261,312...34,292,327
Ensembl chr 4:34,261,289...34,287,924

G

POU class 2 homeobox associating factor 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of POU2AF1 mRNA

NCBI chr 8:51,521,813...51,548,819
Ensembl chr 8:60,436,844...60,445,176

G

POU class 2 homeobox 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of POU2F2 mRNA

NCBI chr 1:80,682,330...80,769,756
Ensembl chr 1:89,812,093...89,897,564

G

POU class 3 homeobox 1

decreases expression

EXP

Cacodylic Acid results in decreased expression of POU3F1 mRNA

NCBI chr 5:142,195,090...142,198,070
Ensembl chr 5:142,194,066...142,202,704

G

peroxisome proliferator-activated receptor gamma

decreases expression
multiple interactions

ISO

Cacodylic Acid results in decreased expression of PPARG mRNA
[Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of PPARG mRNA

PMID:23221991 PMID:28793237

NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104

G

protein phosphatase 1, regulatory subunit 12B

decreases expression

ISO

Cacodylic Acid results in decreased expression of PPP1R12B mRNA

NCBI chr13:46,199,418...46,397,108
Ensembl chr13:48,751,477...48,948,922

G

protein phosphatase 1, regulatory subunit 16B

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PPP1R16B mRNA

NCBI chr 3:147,323,652...147,419,658
Ensembl chr 3:167,743,952...167,839,242

G

PRAME like 34

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PRAMEL34 mRNA

NCBI chr14:13,850,057...13,852,806
Ensembl chr14:14,153,477...14,156,758

G

protein regulator of cytokinesis 1

increases expression

EXP

Cacodylic Acid results in increased expression of PRC1 mRNA

NCBI chr 1:143,659,312...143,681,019
Ensembl chr 1:143,659,481...143,681,012

G

peroxiredoxin 2

increases expression

EXP

Cacodylic Acid results in increased expression of PRDX2 mRNA

NCBI chr19:23,180,927...23,186,217
Ensembl chr19:40,084,430...40,091,006

G

prolactin regulatory element binding

increases expression

EXP

Cacodylic Acid results in increased expression of PREB mRNA

NCBI chr 6:31,138,757...31,142,544
Ensembl chr 6:31,138,743...31,142,540

G

protein kinase C, alpha

increases expression

EXP

Cacodylic Acid results in increased expression of PRKCA mRNA

NCBI chr10:93,388,991...93,787,617
Ensembl chr10:93,388,991...93,787,572

G

protein kinase C, gamma

increases expression

EXP

Cacodylic Acid results in increased expression of PRKCG mRNA

NCBI chr 1:65,832,851...65,860,676
Ensembl chr 1:74,748,272...74,774,814

G

protein kinase C, zeta

increases expression

EXP

Cacodylic Acid results in increased expression of PRKCZ mRNA

NCBI chr 5:171,101,774...171,212,694
Ensembl chr 5:171,101,774...171,212,674

G

prominin 1

increases expression

EXP

Cacodylic Acid results in increased expression of PROM1 mRNA

NCBI chr14:71,202,303...71,307,008
Ensembl chr14:71,202,336...71,307,002

G

proline rich 5 like

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PRR5L mRNA

NCBI chr 3:88,001,951...88,173,532
Ensembl chr 3:108,458,633...108,537,763

G

serine protease 16

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PRSS16 mRNA

NCBI chr17:42,514,306...42,521,885
Ensembl chr17:47,210,081...47,217,658

G

prostate stem cell antigen

increases expression

ISO

Cacodylic Acid results in increased expression of PSCA mRNA

NCBI chr 7:108,483,974...108,492,098
Ensembl chr 7:108,484,184...108,492,097

G

phosphatase and tensin homolog

multiple interactions

EXP

3,3'-diindolylmethane inhibits the reaction [[Butylhydroxybutylnitrosamine co-treated with Cacodylic Acid] results in decreased expression of PTEN protein]; [Butylhydroxybutylnitrosamine co-treated with Cacodylic Acid] results in decreased expression of PTEN protein; lupeol inhibits the reaction [[Butylhydroxybutylnitrosamine co-treated with Cacodylic Acid] results in decreased expression of PTEN protein]

NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:240,043,707...240,110,330

G

prostaglandin F receptor

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PTGFR mRNA

NCBI chr 2:240,731,185...240,766,674
Ensembl chr 2:243,393,350...243,425,623

G

prostaglandin-endoperoxide synthase 2

increases expression
multiple interactions

EXP

Cacodylic Acid results in increased expression of PTGS2 mRNA; Cacodylic Acid results in increased expression of PTGS2 protein
3,3'-diindolylmethane inhibits the reaction [[Butylhydroxybutylnitrosamine co-treated with Cacodylic Acid] results in increased expression of PTGS2 protein]; [Butylhydroxybutylnitrosamine co-treated with Cacodylic Acid] results in increased expression of PTGS2 protein; lupeol inhibits the reaction [[Butylhydroxybutylnitrosamine co-treated with Cacodylic Acid] results in increased expression of PTGS2 protein]

PMID:12151359 PMID:24832369 PMID:26251508 PMID:32890875

NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320

G

protein tyrosine kinase 2 beta

increases expression

EXP

Cacodylic Acid results in increased expression of PTK2B mRNA

NCBI chr15:44,536,275...44,656,754
Ensembl chr15:44,531,249...44,656,806

G

protein tyrosine phosphatase, non-receptor type 7

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PTPN7 mRNA

NCBI chr13:46,570,904...46,584,048
Ensembl chr13:49,122,609...49,136,094

G

protein tyrosine phosphatase, receptor type, C

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PTPRC mRNA

NCBI chr13:52,147,717...52,259,810
Ensembl chr13:52,147,717...52,259,746

G

protein tyrosine phosphatase, receptor type, C-associated protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PTPRCAP mRNA

NCBI chr 1:201,449,133...201,451,293
Ensembl chr 1:210,878,573...210,881,753

G

pyroglutamylated RFamide peptide receptor

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of QRFPR mRNA

NCBI chr 2:119,053,083...119,096,864
Ensembl chr 2:120,981,235...121,025,020

G

RAB10, member RAS oncogene family

increases expression

EXP

Cacodylic Acid results in increased expression of RAB10 mRNA

NCBI chr 6:31,974,858...32,039,554
Ensembl chr 6:31,986,921...32,039,733

G

RAB14, member RAS oncogene family

increases expression
decreases expression

EXP

Cacodylic Acid results in increased expression of RAB14 mRNA
Cacodylic Acid results in decreased expression of RAB14 mRNA

PMID:16122865 PMID:17720352

NCBI chr 3:18,501,953...18,523,253
Ensembl chr 3:38,901,400...38,912,273

G

RAB1A, member RAS oncogene family

increases expression

EXP

Cacodylic Acid results in increased expression of RAB1A mRNA

NCBI chr14:94,422,219...94,448,799
Ensembl chr14:98,623,635...98,661,582

G

RAB33A, member RAS oncogene family

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RAB33A mRNA

NCBI chr X:127,694,219...127,706,378
Ensembl chr X:132,572,148...132,584,254

G

RAB7A, member RAS oncogene family

decreases expression
increases expression

ISO
EXP

Cacodylic Acid results in decreased expression of RAB7 mRNA
Cacodylic Acid results in increased expression of RAB7 mRNA

PMID:16122865 PMID:17720352

NCBI chr 4:120,461,966...120,510,756
Ensembl chr 4:121,983,938...122,064,185

G

RAD51 paralog C

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RAD51C mRNA

NCBI chr10:72,205,032...72,231,643
Ensembl chr10:72,702,299...72,729,143

G

RPA1 related single stranded DNA binding protein, X-linked

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RADX mRNA

NCBI chr X:103,089,284...103,176,840
Ensembl chr X:107,877,920...107,965,476

G

Raf-1 proto-oncogene, serine/threonine kinase

multiple interactions
increases expression

ISO
EXP

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of RAF1 mRNA
Cacodylic Acid results in increased expression of RAF1 protein

PMID:23192986 PMID:32890875

NCBI chr 4:150,352,158...150,412,813
Ensembl chr 4:150,352,160...150,412,813

G

ral guanine nucleotide dissociation stimulator

increases expression

EXP

Cacodylic Acid results in increased expression of RALGDS mRNA

NCBI chr 3:32,237,644...32,278,045
Ensembl chr 3:32,237,786...32,278,045

G

ral guanine nucleotide dissociation stimulator like 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RGL3 mRNA

NCBI chr 8:20,500,846...20,520,471
Ensembl chr 8:28,776,909...28,796,771

G

receptor activity modifying protein 1

increases expression

EXP

Cacodylic Acid results in increased expression of RAMP1 mRNA

NCBI chr 9:91,765,481...91,816,152

G

RAN, member RAS oncogene family

increases expression

EXP

Cacodylic Acid results in increased expression of RAN mRNA

NCBI chr12:33,311,155...33,314,339
Ensembl chr12:33,311,158...33,314,317

G

Rap guanine nucleotide exchange factor like 1

decreases expression

ISO

Cacodylic Acid results in decreased expression of RAPGEFL1 mRNA

NCBI chr10:83,793,711...83,810,373
Ensembl chr10:84,289,980...84,306,614

G

retinoic acid receptor responder 2

decreases expression

EXP

Cacodylic Acid results in decreased expression of RARRES2 mRNA

NCBI chr 4:78,853,450...78,856,652
Ensembl chr 4:78,853,453...78,856,457

G

RAS protein activator like 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RASAL3 mRNA

NCBI chr 7:11,396,554...11,411,347
Ensembl chr 7:12,047,090...12,061,883

G

ras related dexamethasone induced 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RASD1 mRNA

NCBI chr10:44,766,451...44,775,773
Ensembl chr10:45,265,979...45,267,710

G

RAS guanyl releasing protein 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RASGRP3 mRNA

NCBI chr 6:19,895,361...19,993,945
Ensembl chr 6:25,647,386...25,710,591

G

RAS-like family 11 member A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RASL11A mRNA

NCBI chr12:8,258,148...8,260,909
Ensembl chr12:13,372,023...13,376,451

G

REC114 meiotic recombination protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of REC114 mRNA

NCBI chr 8:59,063,352...59,221,439
Ensembl chr 8:67,958,421...68,119,234

G

REC8 meiotic recombination protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of REC8 mRNA

NCBI chr15:33,079,818...33,087,283
Ensembl chr15:33,079,801...33,087,282

G

receptor accessory protein 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of REEP6 mRNA

NCBI chr 7:10,024,601...10,031,507
Ensembl chr 7:10,024,602...10,031,740

G

regenerating family member 3 beta

decreases expression
multiple interactions

EXP
ISO

Cacodylic Acid results in decreased expression of REG3B mRNA
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of REG3B mRNA

PMID:16122865 PMID:34876320

NCBI chr 4:110,861,775...110,865,015
Ensembl chr 4:112,419,776...112,423,014

G

regenerating family member 3 gamma

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of REG3G mRNA

NCBI chr 4:110,922,805...110,927,803
Ensembl chr 4:112,482,183...112,484,738

G

RELA proto-oncogene, NF-kB subunit

multiple interactions

ISO
EXP

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of RELA mRNA
3,3'-diindolylmethane inhibits the reaction [[Butylhydroxybutylnitrosamine co-treated with Cacodylic Acid] results in increased phosphorylation of RELA protein]; [Butylhydroxybutylnitrosamine co-treated with Cacodylic Acid] results in increased phosphorylation of RELA protein; lupeol inhibits the reaction [[Butylhydroxybutylnitrosamine co-treated with Cacodylic Acid] results in increased phosphorylation of RELA protein]

PMID:23192986 PMID:26251508

NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817

G

RELT-like 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RELL2 mRNA

NCBI chr18:29,789,996...29,793,986
Ensembl chr18:30,041,563...30,045,187

G

regulatory factor X-associated protein

decreases expression

ISO

Cacodylic Acid results in decreased expression of RFXAP mRNA

NCBI chr 2:139,008,052...139,012,235
Ensembl chr 2:141,158,215...141,162,397

G

regulator of G-protein signaling 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RGS1 mRNA

NCBI chr13:56,018,546...56,022,889
Ensembl chr13:58,568,844...58,573,187

G

ras homolog family member H

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RHOH mRNA

NCBI chr14:42,341,135...42,371,971
Ensembl chr14:42,693,413...42,749,967

G

ras homolog family member J

decreases expression

EXP

Cacodylic Acid results in decreased expression of RHOJ mRNA

NCBI chr 6:99,771,104...99,853,366
Ensembl chr 6:99,771,252...99,853,999

G

receptor-interacting serine-threonine kinase 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RIPK3 mRNA

NCBI chr15:33,253,071...33,262,025
Ensembl chr15:33,253,071...33,262,025

G

RHO family interacting cell polarization regulator 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RIPOR2 mRNA

NCBI chr17:40,751,771...40,975,611
Ensembl chr17:40,751,771...40,975,337

G

ribonuclease A family member 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RNASE6 mRNA

NCBI chr15:26,827,896...26,830,807
Ensembl chr15:26,827,009...26,830,825

G

ring finger protein 225

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RNF225 mRNA

NCBI chr 1:73,543,598...73,546,269
Ensembl chr 1:82,615,787...82,618,456

G

ring finger protein 24

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RNF24 mRNA

NCBI chr 3:118,520,459...118,575,213
Ensembl chr 3:138,973,492...139,028,177

G

Rho-associated coiled-coil containing protein kinase 1

decreases expression

EXP

Cacodylic Acid results in decreased expression of ROCK1 mRNA

NCBI chr18:1,387,360...1,509,218
Ensembl chr18:1,387,360...1,509,147

G

Rho-associated coiled-coil containing protein kinase 2

increases expression

EXP

Cacodylic Acid results in increased expression of ROCK2 mRNA

NCBI chr 6:45,407,823...45,502,773
Ensembl chr 6:45,407,965...45,502,771

G

ROS proto-oncogene 1 , receptor tyrosine kinase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ROS1 mRNA

NCBI chr20:31,432,636...31,583,998
Ensembl chr20:31,975,329...32,126,547

G

ribonuclease P RNA component H1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of RPPH1 mRNA

NCBI chr15:24,033,679...24,033,935
Ensembl chr15:26,507,215...26,507,512

G

ribonucleotide reductase regulatory subunit M2

increases expression

EXP

Cacodylic Acid results in increased expression of RRM2 mRNA

NCBI chr 6:41,339,858...41,346,774
Ensembl chr 6:47,067,690...47,075,370

G

radical S-adenosyl methionine domain containing 2

increases expression

ISO

Cacodylic Acid results in increased expression of RSAD2 mRNA

NCBI chr 6:43,046,514...43,059,737
Ensembl chr 6:48,774,985...48,788,320

G

ribosomal protein S6 kinase related

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RSKR mRNA

NCBI chr10:63,185,286...63,191,963
Ensembl chr10:63,683,479...63,687,889

G

RT1 class II, locus Da

decreases expression

EXP

Cacodylic Acid results in decreased expression of RT1-DA mRNA

NCBI chr20:4,515,393...4,520,387
Ensembl chr20:4,513,908...4,520,383

G

RT1 class II, locus DOa

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of H2-OA mRNA

NCBI chr20:4,753,587...4,756,590
Ensembl chr20:4,755,499...4,758,478

G

RT1 class II, locus DOb

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of H2-OB mRNA

NCBI chr20:4,619,418...4,625,627
Ensembl chr20:4,619,694...4,627,523

G

rubicon like autophagy enhancer

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RUBCNL mRNA

NCBI chr15:50,332,458...50,377,494
Ensembl chr15:56,741,869...56,779,649

G

ryanodine receptor 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RYR1 mRNA

NCBI chr 1:84,292,578...84,423,824
Ensembl chr 1:93,420,078...93,551,305

G

ryanodine receptor 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RYR3 mRNA

NCBI chr 3:99,431,755...99,979,125
Ensembl chr 3:119,885,878...120,433,677

G

S100 calcium binding protein G

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of S100G mRNA

NCBI chr X:35,337,636...35,340,205
Ensembl chr X:35,337,675...35,340,205

G

sphingosine-1-phosphate receptor 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of S1PR4 mRNA

NCBI chr 7:8,207,767...8,210,043
Ensembl chr 7:8,858,904...8,860,800

G

sacsin molecular chaperone

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SACS mRNA

NCBI chr15:35,285,783...35,370,335
Ensembl chr15:39,472,905...39,546,419

G

sterile alpha motif domain containing 4A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SAMD4 mRNA

NCBI chr15:20,135,994...20,352,131
Ensembl chr15:22,614,287...22,831,872

G

SAM domain, SH3 domain and nuclear localization signals, 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SAMSN1 mRNA

NCBI chr11:14,484,523...14,534,900
Ensembl chr11:27,970,564...28,021,944

G

SAM and SH3 domain containing 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SASH3 mRNA

NCBI chr X:127,326,815...127,341,521
Ensembl chr X:132,204,543...132,219,419

G

sciellin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SCEL mRNA

NCBI chr15:80,339,661...80,456,546
Ensembl chr15:86,754,373...86,871,195

G

sodium voltage-gated channel alpha subunit 2

decreases expression

EXP

Cacodylic Acid results in decreased expression of SCN2A mRNA

NCBI chr 3:70,710,862...70,845,569
Ensembl chr 3:70,710,954...70,845,279

G

sodium voltage-gated channel alpha subunit 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SCN4A mRNA

NCBI chr10:91,246,936...91,296,670
Ensembl chr10:91,746,715...91,796,324

G

sterol carrier protein 2

decreases expression

EXP

Cacodylic Acid results in decreased expression of SCP2 mRNA

NCBI chr 5:122,806,949...122,881,259
Ensembl chr 5:128,008,125...128,110,043

G

signal peptide, CUB domain and EGF like domain containing 2

decreases expression

EXP

Cacodylic Acid results in decreased expression of SCUBE2 mRNA

NCBI chr 1:163,831,876...163,899,925
Ensembl chr 1:173,264,865...173,334,372

G

secreted and transmembrane 1B

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SECTM1A mRNA

NCBI chr10:106,324,070...106,333,779
Ensembl chr10:106,822,397...106,832,104

G

selenium binding protein 1

decreases expression

EXP

Cacodylic Acid results in decreased expression of SELENBP1 mRNA

NCBI chr 2:185,183,022...185,193,612
Ensembl chr 2:185,183,004...185,194,295

G

selectin L

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SELL mRNA

NCBI chr13:78,950,100...78,969,604
Ensembl chr13:78,950,015...78,969,600

G

semaphorin 7A (John Milton Hagen blood group)

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SEMA7A mRNA

NCBI chr 8:67,244,318...67,267,060
Ensembl chr 8:67,243,824...67,267,058

G

serpin family B member 8

increases expression

EXP

Cacodylic Acid results in increased expression of SERPINB8 mRNA

NCBI chr13:23,626,936...23,650,277
Ensembl chr13:24,129,855...24,166,076

G

serpin family C member 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SERPINC1 mRNA

NCBI chr13:73,257,208...73,271,476
Ensembl chr13:75,790,546...75,817,643

G

serpin family F member 1

decreases expression

EXP

Cacodylic Acid results in decreased expression of SERPINF1 mRNA

NCBI chr10:60,748,504...60,760,898
Ensembl chr10:60,748,506...60,760,898

G

serpin family F member 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SERPINF2 mRNA

NCBI chr10:60,770,698...60,778,782
Ensembl chr10:60,770,698...60,778,996

G

serpin family G member 1

multiple interactions
decreases expression

ISO
EXP

[Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of SERPING1 mRNA
Cacodylic Acid results in decreased expression of SERPING1 mRNA

PMID:28793237 PMID:37567419

NCBI chr 3:90,249,410...90,259,299
Ensembl chr 3:90,249,423...90,258,717

G

secreted frizzled-related protein 2

decreases expression

EXP

Cacodylic Acid results in decreased expression of SFRP2 mRNA

NCBI chr 2:171,387,536...171,395,081
Ensembl chr 2:171,387,385...171,395,079

G

secreted frizzled-related protein 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SFRP4 mRNA

NCBI chr17:49,974,532...50,026,448
Ensembl chr17:50,015,812...50,026,395

G

serum/glucocorticoid regulated kinase 1

increases expression
multiple interactions

EXP
ISO

Cacodylic Acid results in increased expression of SGK1 mRNA
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SGK1 mRNA

PMID:16122865 PMID:34876320

NCBI chr 1:24,799,391...24,916,886
Ensembl chr 1:24,799,396...24,807,231

G

shugoshin 2

increases expression

EXP

Cacodylic Acid results in increased expression of SGO2 mRNA

NCBI chr 9:67,032,083...67,067,439
Ensembl chr 9:67,042,833...67,068,152

G

SH3 domain binding glutamate-rich protein like 3

decreases expression

ISO

Cacodylic Acid results in decreased expression of SH3BGRL3 mRNA

NCBI chr 5:146,354,152...146,355,525
Ensembl chr 5:151,637,674...151,639,395

G

SH3 domain containing 21

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SH3D21 mRNA

NCBI chr 5:138,429,180...138,444,540
Ensembl chr 5:143,713,718...143,729,257

G

shisa family member 6

decreases expression

EXP

Cacodylic Acid results in decreased expression of SHISA6 mRNA

NCBI chr10:50,897,740...51,192,111
Ensembl chr10:51,396,806...51,691,156

G

SHQ1, H/ACA ribonucleoprotein assembly factor

decreases expression

ISO

Cacodylic Acid results in decreased expression of SHQ1 mRNA

NCBI chr 4:133,213,357...133,305,586
Ensembl chr 4:134,769,254...134,861,945

G

shroom family member 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SHROOM4 mRNA

NCBI chr X:18,537,371...18,748,665
Ensembl chr X:18,540,913...18,748,700

G

signaling lymphocytic activation molecule family member 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLAMF1 mRNA

NCBI chr13:86,802,708...86,837,890
Ensembl chr13:86,802,708...86,837,890

G

SLAM family member 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLAMF6 mRNA

NCBI chr13:86,916,956...86,937,697
Ensembl chr13:86,916,122...86,938,354

G

SLAM family member 7

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLAMF7 mRNA

NCBI chr13:84,135,656...84,154,528
Ensembl chr13:86,668,060...86,686,341

G

solute carrier family 10 member 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC10A1 mRNA

NCBI chr 6:106,344,319...106,357,944
Ensembl chr 6:106,344,319...106,357,944

G

solute carrier family 10 member 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC10A6 mRNA

NCBI chr14:6,080,716...6,102,902
Ensembl chr14:6,385,537...6,408,894

G

solute carrier family 11 member 2

decreases expression

EXP

Cacodylic Acid results in decreased expression of SLC11A2 mRNA

NCBI chr 7:131,503,076...131,540,246
Ensembl chr 7:133,381,878...133,418,941

G

solute carrier family 13 member 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC13A1 mRNA

NCBI chr 4:52,569,179...52,647,126
Ensembl chr 4:53,534,768...53,612,704

G

solute carrier family 14 member 1 (Kidd blood group)

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC14A1 mRNA

NCBI chr18:73,840,568...73,883,925
Ensembl chr18:73,840,569...73,870,489

G

solute carrier family 15 member 4

decreases expression

ISO

Cacodylic Acid results in decreased expression of SLC15A4 mRNA

NCBI chr12:29,048,634...29,082,480
Ensembl chr12:34,698,955...34,719,819

G

solute carrier family 15, member 5

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC15A5 mRNA

NCBI chr 4:170,878,021...170,971,620
Ensembl chr 4:172,608,999...172,702,893

G

solute carrier family 16 member 8

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC16A8 mRNA

NCBI chr 7:112,698,701...112,702,496
Ensembl chr 7:112,698,701...112,702,496

G

solute carrier family 26 member 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC26A2 mRNA

NCBI chr18:54,648,276...54,666,627
Ensembl chr18:56,923,337...56,937,012

G

solute carrier family 27 member 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC27A3 mRNA

NCBI chr 2:178,150,835...178,155,503
Ensembl chr 2:178,150,835...178,155,503

G

solute carrier family 27 member 6

decreases expression

ISO

Cacodylic Acid results in decreased expression of SLC27A6 mRNA

NCBI chr18:52,040,241...52,099,622
Ensembl chr18:54,238,729...54,312,632

G

solute carrier family 28 member 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC28A2 mRNA

NCBI chr 3:109,324,815...109,387,702
Ensembl chr 3:129,807,537...129,841,291

G

solute carrier family 28 member 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC28A3 mRNA

NCBI chr17:6,062,563...6,112,965
Ensembl chr17:6,068,060...6,120,417

G

solute carrier family 29 member 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC29A4 mRNA

NCBI chr12:16,967,047...16,998,276
Ensembl chr12:16,967,047...16,988,338

G

solute carrier family 2 member 1

decreases expression

ISO

Cacodylic Acid results in decreased expression of SLC2A1 mRNA

NCBI chr 5:138,002,522...138,030,742
Ensembl chr 5:138,002,522...138,030,742

G

solute carrier family 2 member 4

increases expression

EXP

Cacodylic Acid results in increased expression of SLC2A4 mRNA

NCBI chr10:55,164,721...55,170,289
Ensembl chr10:55,164,721...55,170,270

G

solute carrier family 2 member 5

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC2A5 mRNA

NCBI chr 5:165,857,412...165,892,928
Ensembl chr 5:165,866,172...165,894,038

G

solute carrier family 34 member 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC34A2 mRNA

NCBI chr14:57,910,931...57,930,236
Ensembl chr14:62,123,316...62,143,360

G

solute carrier family 35 member D1

increases expression

ISO

Cacodylic Acid results in increased expression of SLC35D1 mRNA

NCBI chr 5:117,928,628...117,981,289
Ensembl chr 5:123,155,407...123,210,073

G

solute carrier family 38, member 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC38A3 mRNA

NCBI chr 8:117,202,534...117,220,310
Ensembl chr 8:117,202,536...117,218,630

G

solute carrier family 38, member 8

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC38A8 mRNA

NCBI chr19:47,522,781...47,561,443
Ensembl chr19:64,437,013...64,463,960

G

solute carrier family 39 member 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC39A2 mRNA

NCBI chr15:27,063,699...27,066,349
Ensembl chr15:27,064,237...27,066,349

G

solute carrier family 41, member 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC41A3 mRNA

NCBI chr 4:123,109,555...123,154,766
Ensembl chr 4:124,666,808...124,711,967

G

solute carrier family 5 member 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC5A3 mRNA

NCBI chr11:44,799,787...44,802,233
Ensembl chr11:44,790,297...44,818,157

G

solute carrier family 5 member 9

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC5A9 mRNA

NCBI chr 5:126,709,762...126,733,468
Ensembl chr 5:131,938,216...131,961,922

G

solute carrier family 6 member 14

increases expression

ISO

Cacodylic Acid results in increased expression of SLC6A14 mRNA

NCBI chr X:112,314,643...112,375,412
Ensembl chr X:117,108,947...117,169,828

G

solute carrier family 6 member 18

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC6A18 mRNA

NCBI chr 1:29,607,288...29,621,925
Ensembl chr 1:31,436,630...31,450,478

G

solute carrier family 6 member 6

increases expression

EXP

Cacodylic Acid results in increased expression of SLC6A6 mRNA

NCBI chr 4:125,752,340...125,826,033
Ensembl chr 4:125,752,372...125,826,032

G

solute carrier family 7 member 11

increases expression

EXP

Cacodylic Acid results in increased expression of SLC7A11 mRNA

NCBI chr 2:136,532,912...136,668,560
Ensembl chr 2:136,532,246...136,695,695

G

solute carrier family 7 member 9

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC7A9 mRNA

NCBI chr 1:88,109,517...88,132,653
Ensembl chr 1:97,247,547...97,269,543

G

solute carrier family 8 member A3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC8A3 mRNA

NCBI chr 6:106,605,611...106,739,208
Ensembl chr 6:106,605,621...106,721,412

G

solute carrier family 9 member A3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC9A3 mRNA

NCBI chr 1:29,124,633...29,167,912
Ensembl chr 1:30,953,216...30,996,002

G

solute carrier organic anion transporter family, member 5A1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLCO5A1 mRNA

NCBI chr 5:11,012,001...11,141,180
Ensembl chr 5:11,012,075...11,141,177

G

synuclein alpha

decreases expression

EXP

Cacodylic Acid results in decreased expression of SNCA

NCBI chr 4:91,026,474...91,127,444
Ensembl chr 4:91,026,474...91,126,315

G

stannin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SNN mRNA

NCBI chr10:4,572,933...4,581,606
Ensembl chr 1:82,440,586...82,441,390
Ensembl chr10:82,440,586...82,441,390

G

small nucleolar RNA, H/ACA box 69

increases expression

ISO

Cacodylic Acid results in increased expression of SNORA69 mRNA

NCBI chr20:43,610,465...43,610,598
Ensembl chr20:45,164,974...45,165,107

G

sterol O-acyltransferase 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SOAT2 mRNA

NCBI chr 7:133,281,818...133,294,915
Ensembl chr 7:135,160,402...135,173,513

G

superoxide dismutase 1

increases expression
decreases expression

EXP
ISO

Cacodylic Acid results in increased expression of SOD1 mRNA
Cacodylic Acid results in decreased expression of SOD1 mRNA

PMID:16122865 PMID:17441966

NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399

G

SP100 nuclear antigen

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SP140 mRNA

NCBI chr 9:86,310,990...86,377,036
Ensembl chr 9:93,759,075...93,825,068

G

sperm associated antigen 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SPAG1 mRNA

NCBI chr 7:67,361,474...67,421,369
Ensembl chr 7:69,246,582...69,306,482

G

spermatogenesis associated 6-like

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SPATA6L mRNA

NCBI chr 1:226,630,470...226,682,979
Ensembl chr 1:236,033,147...236,096,730

G

spermatogenesis associated, serine-rich 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SPATS1 mRNA

NCBI chr 9:15,527,179...15,562,286
Ensembl chr 9:23,024,609...23,059,730

G

spondin 1

decreases expression

EXP

Cacodylic Acid results in decreased expression of SPON1 mRNA

NCBI chr 1:167,929,049...168,228,239
Ensembl chr 1:177,363,197...177,662,676

G

small proline-rich protein 1A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SPRR1A mRNA

NCBI chr 2:180,750,709...180,752,625
Ensembl chr 2:180,750,709...180,752,991

G

small proline rich protein 2A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SPRR2H mRNA

NCBI chr 2:180,511,568...180,511,840

G

sprouty RTK signaling antagonist 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SPRY4 mRNA

NCBI chr18:30,436,513...30,451,426
Ensembl chr18:30,687,039...30,704,173

G

serine palmitoyltransferase, small subunit B

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SPTSSB mRNA

NCBI chr 2:154,133,728...154,162,127
Ensembl chr 2:156,432,512...156,460,909

G

squalene epoxidase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SQLE mRNA

NCBI chr 7:92,758,175...92,773,049
Ensembl chr 7:92,757,409...92,773,050

G

SRC proto-oncogene, non-receptor tyrosine kinase

multiple interactions

ISO
EXP

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of SRC mRNA
Cacodylic Acid results in increased expression of and results in increased phosphorylation of SRC protein

PMID:23192986 PMID:32890875

NCBI chr 3:166,511,616...166,559,463
Ensembl chr 3:166,511,985...166,559,462

G

sterol regulatory element binding transcription factor 1

decreases expression

ISO

Cacodylic Acid results in decreased expression of SREBF1 mRNA

NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,507,152...45,529,164

G

sterol regulatory element binding transcription factor 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SREBF2 mRNA

NCBI chr 7:115,542,774...115,600,945
Ensembl chr 7:115,543,290...115,600,943

G

SRSF protein kinase 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SRPK3 mRNA

NCBI chr X:151,510,452...151,515,208
Ensembl chr X:156,661,875...156,666,531

G

sushi-repeat-containing protein, X-linked

decreases expression

EXP

Cacodylic Acid results in decreased expression of SRPX mRNA

NCBI chr X:15,349,498...15,420,389
Ensembl chr X:15,349,440...15,420,392

G

ST3 beta-galactoside alpha-2,3-sialyltransferase 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ST3GAL4 mRNA

NCBI chr 8:33,415,666...33,465,319
Ensembl chr 8:41,673,510...41,712,551

G

ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ST6GALNAC3 mRNA

NCBI chr 2:242,129,755...242,645,120
Ensembl chr 2:244,789,627...245,304,977

G

ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ST8SIA4 mRNA

NCBI chr 9:95,990,131...96,084,661
Ensembl chr 9:103,437,479...103,532,008

G

ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ST8SIA6 mRNA

NCBI chr17:76,740,755...76,884,178
Ensembl chr17:81,653,687...81,792,732

G

signal transducing adaptor family member 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of STAP1 mRNA

NCBI chr14:22,301,278...22,336,218
Ensembl chr14:22,236,616...22,342,652

G

signal transducer and activator of transcription 3

multiple interactions

ISO
EXP

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of STAT3 mRNA
Cacodylic Acid results in increased expression of and results in increased phosphorylation of STAT3 protein

PMID:23192986 PMID:32890875

NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359

G

stanniocalcin 1

decreases expression

ISO

Cacodylic Acid results in decreased expression of STC1 mRNA

NCBI chr15:50,709,439...50,720,093
Ensembl chr15:50,709,415...50,720,082

G

stathmin 2

decreases expression

EXP

Cacodylic Acid results in decreased expression of STMN2 mRNA

NCBI chr 2:95,112,017...95,159,642
Ensembl chr 2:95,112,019...95,159,335

G

sulfotransferase family 1B member 1

increases expression

EXP

Cacodylic Acid results in increased expression of SULT1B1 mRNA

NCBI chr14:20,492,763...20,505,491
Ensembl chr14:20,771,868...20,785,549

G

sushi domain containing 2

decreases expression

EXP

Cacodylic Acid results in decreased expression of SUSD2 mRNA

NCBI chr20:13,017,516...13,024,820
Ensembl chr20:13,016,907...13,024,264

G

sushi domain containing 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SUSD3 mRNA

NCBI chr17:15,400,845...15,417,851
Ensembl chr17:15,606,906...15,624,262

G

synaptonemal complex protein 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SYCP2 mRNA

NCBI chr 3:165,431,715...165,502,134
Ensembl chr 3:185,814,035...185,876,492

G

synaptotagmin 5

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SYT5 mRNA

NCBI chr 1:78,320,034...78,327,750
Ensembl chr 1:78,320,034...78,327,746

G

synaptotagmin 8

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SYT8 mRNA

NCBI chr 1:207,017,602...207,023,076
Ensembl chr 1:207,017,461...207,023,076

G

TBC1 domain family, member 10C

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TBC1D10C mRNA

NCBI chr 1:210,906,621...210,913,649
Ensembl chr 1:210,906,616...210,994,356

G

T-box transcription factor 20

decreases expression

EXP

Cacodylic Acid results in decreased expression of TBX20 mRNA

NCBI chr 8:23,200,104...23,258,218
Ensembl chr 8:31,475,963...31,534,009

G

transcription factor 23

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TCF23 mRNA

NCBI chr 6:31,117,839...31,126,575
Ensembl chr 6:31,120,127...31,125,878

G

transcription factor 24

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TCF24 mRNA

NCBI chr 5:9,274,659...9,282,876
Ensembl chr 5:14,058,039...14,063,345

G

t-complex protein 10b

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TCP10A mRNA

NCBI chr 1:52,937,823...52,961,307
Ensembl chr 1:55,485,411...55,508,836

G

terminal nucleotidyltransferase 5B

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TENT5B mRNA

NCBI chr 5:145,695,358...145,702,668
Ensembl chr11:27,212,316...27,214,238
Ensembl chr 5:27,212,316...27,214,238

G

transferrin receptor

increases expression

EXP

Cacodylic Acid results in increased expression of TFRC mRNA

NCBI chr11:81,668,478...81,690,318
Ensembl chr11:81,668,478...81,690,318

G

transforming growth factor alpha

increases expression

ISO

Cacodylic Acid results in increased expression of TGFA mRNA

NCBI chr 4:120,175,549...120,258,342
Ensembl chr 4:120,175,593...120,258,339

G

transforming growth factor, beta 1

multiple interactions
increases secretion

ISO
EXP

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of TGFB1 mRNA
Cacodylic Acid results in increased secretion of TGFB1 protein

PMID:23192986 PMID:24832369

NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899

G

transforming growth factor, beta induced

decreases expression

EXP

Cacodylic Acid results in decreased expression of TGFBI mRNA

NCBI chr17:7,955,603...7,984,903
Ensembl chr17:7,960,516...7,990,471

G

transforming growth factor, beta receptor 1

decreases expression

ISO

Cacodylic Acid results in decreased expression of TGFBR1 mRNA

NCBI chr 5:66,449,348...66,506,371
Ensembl chr 5:66,449,293...66,527,260

G

transforming growth factor, beta receptor 2

increases expression

EXP

Cacodylic Acid results in increased expression of TGFBR2 mRNA

NCBI chr 8:124,672,677...124,761,741
Ensembl chr 8:124,674,986...124,761,469

G

transglutaminase 2

decreases expression

EXP

Cacodylic Acid results in decreased expression of TGM2 mRNA

NCBI chr 3:167,192,612...167,221,845
Ensembl chr 3:167,192,612...167,304,240

G

transglutaminase 7

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TGM7 mRNA

NCBI chr 3:108,051,890...108,068,116
Ensembl chr 3:128,505,650...128,529,939

G

thrombomodulin

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of THBD mRNA

NCBI chr 3:156,316,526...156,320,178
Ensembl chr 3:156,306,632...156,320,582

G

thrombospondin 2

decreases expression

EXP
ISO

Cacodylic Acid results in decreased expression of THBS2 mRNA

PMID:37567419 PMID:38630284

NCBI chr 1:64,343,523...64,372,918
Ensembl chr 1:64,343,523...64,372,918

G

thymocyte selection associated

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of THEMIS mRNA

NCBI chr 1:18,251,136...18,483,851
Ensembl chr 1:18,272,056...18,483,502

G

Thy-1 cell surface antigen

multiple interactions
decreases expression

ISO
EXP

[Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of THY1 mRNA
Cacodylic Acid results in decreased expression of THY1 mRNA

PMID:28793237 PMID:37567419

NCBI chr 8:44,389,495...44,394,688
Ensembl chr 8:53,286,148...53,291,540

G

TRAF-interacting protein with forkhead-associated domain

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TIFA mRNA

NCBI chr 2:216,257,926...216,267,635
Ensembl chr 2:218,909,915...218,956,224

G

toll-like receptor 8

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TLR8 mRNA

NCBI chr X:27,091,780...27,116,092
Ensembl chr X:30,708,033...30,737,079

G

toll-like receptor 9

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TLR9 mRNA

NCBI chr 8:115,743,407...115,747,523
Ensembl chr 8:115,742,889...115,750,148

G

transmembrane 4 L six family member 20

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TM4SF20 mRNA

NCBI chr 9:84,038,715...84,052,615
Ensembl chr 9:91,486,847...91,500,745

G

transmembrane p24 trafficking protein 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TMED6 mRNA

NCBI chr19:34,966,813...34,972,900
Ensembl chr19:51,876,561...51,882,648

G

transmembrane protein 140

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TMEM140 mRNA

NCBI chr 4:64,503,621...64,514,620
Ensembl chr 4:64,500,439...64,521,990

G

transmembrane protein 156

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TMEM156 mRNA

NCBI chr14:43,221,464...43,252,453
Ensembl chr14:43,577,023...43,606,109

G

transmembrane protein 17

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TMEM17 mRNA

NCBI chr14:96,483,648...96,524,238
Ensembl chr14:100,685,093...100,725,470

G

transmembrane protein 266

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TMEM266 mRNA

NCBI chr 8:55,707,122...55,820,692
Ensembl chr 8:64,603,186...64,716,769

G

transmembrane protein 71

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TMEM71 mRNA

NCBI chr 7:98,276,975...98,323,161
Ensembl chr 7:100,166,516...100,204,969

G

transmembrane protein 98

decreases expression

ISO

Cacodylic Acid results in decreased expression of TMEM98 mRNA

NCBI chr10:65,796,173...65,807,082
Ensembl chr10:66,293,867...66,304,803

G

tenascin C

decreases expression

EXP

Cacodylic Acid results in decreased expression of TNC mRNA

NCBI chr 5:82,391,340...82,476,197
Ensembl chr 5:82,391,340...82,476,131

G

tumor necrosis factor

decreases secretion
multiple interactions
decreases expression

ISO
EXP

Cacodylic Acid results in decreased secretion of TNF protein
3,3'-diindolylmethane inhibits the reaction [[Butylhydroxybutylnitrosamine co-treated with Cacodylic Acid] results in increased expression of TNF protein]; [Butylhydroxybutylnitrosamine co-treated with Cacodylic Acid] results in increased expression of TNF protein; lupeol inhibits the reaction [[Butylhydroxybutylnitrosamine co-treated with Cacodylic Acid] results in increased expression of TNF protein]
Cacodylic Acid results in decreased expression of TNF protein

PMID:9548797 PMID:24832369 PMID:26251508

NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303

G

TNF receptor superfamily member 13B

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TNFRSF13B mRNA

NCBI chr10:46,301,336...46,322,460
Ensembl chr10:46,301,316...46,324,408

G

TNF receptor superfamily member 13C

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TNFRSF13C mRNA

NCBI chr 7:113,736,046...113,738,523
Ensembl chr 7:115,616,303...115,618,620

G

TNF receptor superfamily member 1A

decreases expression

EXP

Cacodylic Acid results in decreased expression of TNFRSF1A mRNA

NCBI chr 4:159,837,119...159,849,817
Ensembl chr 4:159,837,032...159,849,816

G

TNF receptor superfamily member 25

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TNFRSF25 mRNA

NCBI chr 5:162,621,669...162,626,341
Ensembl chr 5:167,904,786...167,909,052

G

TNF superfamily member 10

decreases expression

EXP

Cacodylic Acid results in decreased expression of TNFSF10 mRNA

NCBI chr 2:112,136,550...112,155,903

G

TNF superfamily member 11

multiple interactions

ISO

[Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of TNFSF11 mRNA
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TNFSF11 mRNA

PMID:28793237 PMID:34876320

NCBI chr15:60,083,008...60,114,479
Ensembl chr15:60,083,008...60,114,479

G

TNF superfamily member 8

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TNFSF8 mRNA

NCBI chr 5:82,266,436...82,292,858
Ensembl chr 5:82,266,436...82,292,858

G

troponin I2, fast skeletal type

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TNNI2 mRNA

NCBI chr 1:197,595,012...197,597,554
Ensembl chr 1:207,024,416...207,027,038

G

troponin T3, fast skeletal type

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TNNT3 mRNA

NCBI chr 1:197,652,535...197,669,736
Ensembl chr 1:207,081,812...207,099,423

G

DNA topoisomerase II alpha

increases expression
decreases expression

ISO
EXP

Cacodylic Acid results in increased expression of TOP2A mRNA
Cacodylic Acid results in decreased expression of TOP2A mRNA

PMID:17441966 PMID:17720352 PMID:37567419

NCBI chr10:84,441,954...84,473,093
Ensembl chr10:84,441,954...84,473,366

G

tumor protein p53

increases expression
multiple interactions

EXP
ISO

Cacodylic Acid results in increased expression of TP53 mRNA
[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of TP53 mRNA

PMID:17720352 PMID:23192986

NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299

G

tubulin polymerization promoting protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TPPP mRNA

NCBI chr 1:31,085,680...31,109,703
Ensembl chr 1:31,089,824...31,109,654

G

TPX2, microtubule nucleation factor

increases expression

EXP

Cacodylic Acid results in increased expression of TPX2 mRNA

NCBI chr 3:161,778,709...161,820,941
Ensembl chr 3:161,778,742...161,820,724

G

transformer 2 alpha

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TRA2A mRNA

NCBI chr 4:78,220,838...78,239,737
Ensembl chr 4:79,551,542...79,570,619

G

TNF receptor-associated factor 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TRAF1 mRNA

NCBI chr 3:18,222,024...18,242,163
Ensembl chr 3:38,619,506...38,636,264

G

Tnf receptor-associated factor 3

decreases expression

ISO

Cacodylic Acid results in decreased expression of TRAF3 mRNA

NCBI chr 6:130,199,696...130,307,168
Ensembl chr 6:136,027,157...136,128,363

G

TRAF3 interacting protein 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TRAF3IP3 mRNA

NCBI chr13:104,694,802...104,719,655
Ensembl chr13:107,223,502...107,248,155

G

tetratricopeptide repeat and ankyrin repeat containing 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TRANK1 mRNA

NCBI chr 8:111,275,973...111,355,491
Ensembl chr 8:120,154,362...120,234,087

G

T cell receptor associated transmembrane adaptor 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TRAT1 mRNA

NCBI chr11:52,035,750...52,077,805
Ensembl chr11:65,498,742...65,542,381

G

tripartite motif containing 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TRIM6 mRNA

NCBI chr 1:158,683,746...158,696,936
Ensembl chr 1:168,095,564...168,109,719

G

transient receptor potential cation channel, subfamily C, member 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TRPC3 mRNA

NCBI chr 2:119,481,313...119,619,333
Ensembl chr 2:121,409,436...121,475,823

G

transient receptor potential cation channel, subfamily V, member 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TRPV3 mRNA

NCBI chr10:57,883,546...57,915,865
Ensembl chr10:58,382,054...58,411,800

G

transient receptor potential cation channel, subfamily V, member 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TRPV6 mRNA

NCBI chr 4:70,507,347...70,523,013
Ensembl chr 4:71,474,007...71,489,671

G

thyroid stimulating hormone receptor

decreases expression

EXP

Cacodylic Acid results in decreased expression of TSHR mRNA

NCBI chr 6:116,072,321...116,206,009
Ensembl chr 6:116,072,281...116,206,010

G

tetraspanin 32

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TSPAN32 mRNA

NCBI chr 1:198,190,128...198,204,447
Ensembl chr 1:207,619,567...207,656,946

G

tubulin tyrosine ligase like 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TTLL2 mRNA

NCBI chr 1:52,967,183...52,976,690
Ensembl chr 1:55,515,397...55,524,071

G

tubulin tyrosine ligase like 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TTLL3 mRNA

NCBI chr 4:146,532,958...146,558,425
Ensembl chr 4:148,089,575...148,113,499

G

tubulin tyrosine ligase like 9

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TTLL9 mRNA

NCBI chr 3:141,429,351...141,475,965
Ensembl chr 3:161,876,685...161,936,215

G

titin

increases expression

ISO

Cacodylic Acid results in increased expression of TTN mRNA

NCBI chr 3:82,059,648...82,332,130
Ensembl chr 3:82,059,648...82,332,171

G

tweety family member 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TTYH3 mRNA

NCBI chr12:13,996,831...14,025,457
Ensembl chr12:19,110,824...19,139,371

G

TXK tyrosine kinase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TXK mRNA

NCBI chr14:35,463,369...35,519,448
Ensembl chr14:35,817,893...35,873,460

G

thioredoxin 1

increases expression
multiple interactions

EXP
ISO

Cacodylic Acid results in increased expression of TXN1 mRNA
[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of TXN mRNA

PMID:16122865 PMID:23192986

NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:77,507,321...77,520,307

G

thioredoxin 2

increases expression

EXP

Cacodylic Acid results in increased expression of TXN2 mRNA

NCBI chr 7:109,496,772...109,510,378
Ensembl chr 7:111,386,805...111,390,022

G

thioredoxin reductase 1

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of TXNRD1 mRNA

NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:22,719,317...22,739,817

G

ubiquitin D

increases expression

EXP

Cacodylic Acid results in increased expression of UBD mRNA

NCBI chr20:1,385,487...1,387,438
Ensembl chr20:1,390,600...1,413,965

G

ubiquitin-conjugating enzyme E2D 3

increases expression

EXP

Cacodylic Acid results in increased expression of UBE2D3 mRNA

NCBI chr 2:223,868,397...223,899,606
Ensembl chr 2:226,540,531...226,573,144

G

ubiquitin-conjugating enzyme E2G 2

decreases expression

ISO

Cacodylic Acid results in decreased expression of UBE2G2 mRNA

NCBI chr20:10,983,734...11,005,468
Ensembl chr20:10,983,325...11,005,187

G

uncoupling protein 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of UCP2 mRNA

NCBI chr 1:164,251,373...164,257,742
Ensembl chr 1:164,251,373...164,257,743

G

UDP glucuronosyltransferase 1 family, polypeptide A2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of UGT1A2 mRNA

NCBI chr 9:88,791,216...88,808,465
Ensembl chr 9:96,144,786...96,256,264

G

UDP glucuronosyltransferase family 1 member A5

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of UGT1A5 mRNA

NCBI chr 9:96,210,053...96,256,264
Ensembl chr 9:96,144,786...96,256,264

G

UL16 binding protein 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ULBP1 mRNA

NCBI chr 1:3,506,106...3,527,982

G

uroplakin 1A

decreases expression

ISO

Cacodylic Acid results in decreased expression of UPK1A mRNA

NCBI chr 1:85,859,672...85,870,147
Ensembl chr 1:94,987,108...94,997,787

G

uroplakin 3B like 1

increases expression

EXP

Cacodylic Acid results in increased expression of UPK3BL mRNA

NCBI chr12:20,610,353...20,616,366
Ensembl chr12:26,246,960...26,252,973

G

upstream transcription factor 2, c-fos interacting

increases expression

EXP

Cacodylic Acid results in increased expression of USF2 mRNA

NCBI chr 1:86,174,703...86,185,942
Ensembl chr 1:95,302,105...95,313,119

G

ubiquitin specific peptidase 2

increases expression

EXP

Cacodylic Acid results in increased expression of USP2 mRNA

NCBI chr 8:53,308,264...53,336,800
Ensembl chr 8:53,308,303...53,336,794

G

ubiquitin specific peptidase 7

increases expression

ISO

Cacodylic Acid results in increased expression of USP7 mRNA

NCBI chr10:6,880,684...6,925,355
Ensembl chr10:7,367,604...7,432,013

G

ubiquitously transcribed tetratricopeptide repeat containing, Y-linked

increases expression

ISO

Cacodylic Acid results in increased expression of UTY mRNA

NCBI chr Y:942,838...1,105,313
Ensembl chr Y:1,010,273...1,178,355

G

vascular cell adhesion molecule 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of VCAM1 mRNA

NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:206,723,044...206,742,801

G

vitamin D receptor

decreases expression

EXP

Cacodylic Acid results in decreased expression of VDR mRNA

NCBI chr 7:130,864,764...130,916,757
Ensembl chr 7:130,866,745...130,916,757

G

vascular endothelial growth factor A

increases expression
multiple interactions

EXP
ISO

Cacodylic Acid results in increased expression of VEGFA protein
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of VEGFA mRNA

PMID:32890875 PMID:34876320

NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194

G

vascular endothelial growth factor C

increases expression

ISO

Cacodylic Acid results in increased expression of VEGFC mRNA

NCBI chr16:37,712,251...37,827,845
Ensembl chr16:44,445,293...44,560,887

G

vascular endothelial growth factor D

decreases expression

EXP

Cacodylic Acid results in decreased expression of VEGFD mRNA

NCBI chr X:30,073,122...30,108,413
Ensembl chr X:33,706,055...33,740,167

G

vanin 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of VNN1 mRNA

NCBI chr 1:23,356,324...23,366,629
Ensembl chr 1:23,356,330...23,366,629

G

V-set pre-B cell surrogate light chain 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of VPREB3 mRNA

NCBI chr20:12,717,421...12,718,785

G

vacuolar protein sorting 25 homolog

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of VPS25 mRNA

NCBI chr10:86,196,062...86,201,606
Ensembl chr10:86,696,157...86,701,871

G

von Willebrand factor A domain containing 5A

increases expression

EXP

Cacodylic Acid results in increased expression of VWA5A mRNA

NCBI chr 8:38,815,176...38,848,674
Ensembl chr 8:47,712,369...47,736,307

G

WASP actin nucleation promoting factor

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of WAS mRNA

NCBI chr X:17,077,057...17,085,802
Ensembl chr X:17,073,314...17,085,802

G

WDFY family member 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of WDFY4 mRNA

NCBI chr16:8,221,853...8,450,494
Ensembl chr16:8,228,147...8,456,761

G

WD repeat domain 31

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of WDR31 mRNA

NCBI chr 5:75,897,074...75,917,461
Ensembl chr 5:80,908,726...80,933,046

G

WD repeat domain 54

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of WDR54 mRNA

NCBI chr 4:115,654,968...115,677,979
Ensembl chr 4:117,212,677...117,219,270

G

WD repeat domain 83 opposite strand

decreases expression

ISO

Cacodylic Acid results in decreased expression of WDR83OS mRNA

NCBI chr19:23,075,373...23,076,745
Ensembl chr19:39,980,247...39,982,737

G

WAP four-disulfide core domain 21

decreases expression

EXP

Cacodylic Acid results in decreased expression of WFDC21 mRNA

NCBI chr10:68,627,836...68,633,705
Ensembl chr10:69,125,320...69,131,201

G

Wnt family member 1

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of WNT1 mRNA

NCBI chr 7:131,817,558...131,821,605
Ensembl chr 7:131,817,558...131,821,605

G

X-box binding protein 1

increases expression

ISO

Cacodylic Acid results in increased expression of XBP1 mRNA; Cacodylic Acid results in increased expression of XBP1 mRNA alternative form

NCBI chr14:80,390,629...80,395,713
Ensembl chr14:84,604,107...84,609,706

G

X inactive specific transcript

decreases expression

ISO

Cacodylic Acid results in decreased expression of XIST mRNA

NCBI chr X:68,474,987...68,492,500

G

XK related 8

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of XKR8 mRNA

NCBI chr 5:144,938,061...144,945,195
Ensembl chr 5:150,222,061...150,228,564

G

X-prolyl aminopeptidase 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of XPNPEP2 mRNA

NCBI chr X:132,165,696...132,194,937
Ensembl chr X:132,165,701...132,195,126

G

tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta

increases expression

EXP

Cacodylic Acid results in increased expression of YWHAQ mRNA

NCBI chr 6:40,935,714...40,966,240
Ensembl chr 6:46,664,358...46,694,875

G

zeta chain of T cell receptor associated protein kinase 70

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ZAP70 mRNA

NCBI chr 9:46,485,605...46,507,552
Ensembl chr 9:46,485,598...46,509,062

G

zinc finger and BTB domain containing 16

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ZBTB16 mRNA

NCBI chr 8:57,885,886...58,073,507
Ensembl chr 8:57,891,081...58,073,507

G

zinc finger and BTB domain containing 40

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ZBTB40 mRNA

NCBI chr 5:149,216,496...149,283,746
Ensembl chr 5:154,503,128...154,537,863

G

zinc finger CCCH type containing 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ZC3H6 mRNA

NCBI chr 3:116,203,466...116,254,186
Ensembl chr 3:136,657,414...136,706,504

G

zinc finger DHHC-type palmitoyltransferase 19

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ZDHHC19 mRNA

NCBI chr11:68,277,847...68,289,110
Ensembl chr11:81,782,903...81,794,008

G

zinc finger homeobox 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ZFHX2 mRNA

NCBI chr15:32,501,755...32,541,720
Ensembl chr15:32,503,115...32,535,085

G

zinc finger protein 503

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ZFP503 mRNA

NCBI chr15:2,313,060...2,316,848
Ensembl chr15:2,362,427...2,366,238

G

zinc finger protein 831

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ZFP831 mRNA

NCBI chr 3:163,393,787...163,510,654
Ensembl chr 3:183,811,648...183,927,253

G

ZFP92 zinc finger protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ZFP92 mRNA

NCBI chr X:151,116,794...151,142,451
Ensembl chr X:156,268,234...156,294,516

G

zinc finger protein 950

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ZFP950 mRNA

NCBI chr 1:260,248,231...260,265,211

G

zinc finger, matrin type 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ZMAT4 mRNA

NCBI chr16:74,671,975...75,063,805
Ensembl chr16:74,671,979...75,063,750

G

zinc finger MYM-type containing 3

decreases expression

ISO

Cacodylic Acid results in decreased expression of ZMYM3 mRNA

NCBI chr X:66,528,585...66,544,234
Ensembl chr X:70,568,573...70,584,768

dimethylarsinous acid

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

ATP binding cassette subfamily C member 1

decreases response to substance

ISO

ABCC1 protein results in decreased susceptibility to dimethylarsinous acid

NCBI chr10:1,022,041...1,162,431
Ensembl chr10:1,038,947...1,162,404

G

abhydrolase domain containing 2, acylglycerol lipase

increases expression

ISO

dimethylarsinous acid results in increased expression of ABHD2 mRNA

NCBI chr 1:133,217,403...133,298,564
Ensembl chr 1:142,626,732...142,712,674

G

acyl-CoA synthetase short-chain family member 2

decreases expression

ISO

dimethylarsinous acid results in decreased expression of ACSS2 mRNA

NCBI chr 3:164,464,124...164,507,607
Ensembl chr 3:164,464,055...164,519,830

G

ADAM metallopeptidase domain 12

increases expression

ISO

dimethylarsinous acid results in increased expression of ADAM12 mRNA

NCBI chr 1:188,686,984...189,014,206
Ensembl chr 1:198,116,975...198,447,552

G

ADAM metallopeptidase with thrombospondin type 1 motif, 6

increases expression

ISO

dimethylarsinous acid results in increased expression of ADAMTS6 mRNA

NCBI chr 2:35,421,483...35,633,305
Ensembl chr 2:37,155,288...37,367,070

G

ALF transcription elongation factor 4

increases expression

ISO

dimethylarsinous acid results in increased expression of AFF4 mRNA

NCBI chr10:37,498,825...37,579,751
Ensembl chr10:37,999,579...38,080,580

G

AHNAK nucleoprotein 2

decreases expression

ISO

dimethylarsinous acid results in decreased expression of AHNAK2 mRNA

NCBI chr 6:131,830,668...131,876,311
Ensembl chr 6:137,652,537...137,675,546

G

aldo-keto reductase family 1, member C1

increases expression

ISO

dimethylarsinous acid results in increased expression of AKR1C1 mRNA

NCBI chr17:65,810,474...65,837,385
Ensembl chr17:70,720,398...70,747,247

G

AKT serine/threonine kinase 3

decreases expression

ISO

dimethylarsinous acid results in decreased expression of AKT3 mRNA

NCBI chr13:91,475,839...91,758,060
Ensembl chr13:91,475,839...91,748,020

G

aldehyde dehydrogenase 1 family, member A3

increases expression

ISO

dimethylarsinous acid results in increased expression of ALDH1A3 mRNA

NCBI chr 1:129,392,516...129,436,552
Ensembl chr 1:129,392,516...129,427,777

G

aldehyde dehydrogenase 2 family member

increases expression

ISO

dimethylarsinous acid results in increased expression of ALDH2 mRNA

NCBI chr12:40,610,244...40,643,220
Ensembl chr12:40,610,224...40,643,219

G

arachidonate 5-lipoxygenase activating protein

decreases expression

ISO

dimethylarsinous acid results in decreased expression of ALOX5AP mRNA

NCBI chr12:5,748,941...5,772,986
Ensembl chr12:10,785,257...10,817,038

G

ankyrin repeat domain 1

increases expression

ISO

dimethylarsinous acid results in increased expression of ANKRD1 mRNA

NCBI chr 1:233,815,851...233,834,891
Ensembl chr 1:243,228,448...243,263,751

G

annexin A1

increases expression

ISO

dimethylarsinous acid results in increased expression of ANXA1 mRNA

NCBI chr 1:227,287,713...227,306,739
Ensembl chr 1:227,287,717...227,306,831

G

annexin A10

increases expression

ISO

dimethylarsinous acid results in increased expression of ANXA10 mRNA

NCBI chr16:27,738,712...27,805,648
Ensembl chr16:32,467,126...32,571,961

G

apolipoprotein E

affects response to substance

ISO

APOE protein affects the susceptibility to dimethylarsinous acid

NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:88,481,385...88,485,855

G

ARF like GTPase 15

decreases expression

ISO

dimethylarsinous acid results in decreased expression of ARL15 mRNA

NCBI chr 2:45,438,221...45,822,562
Ensembl chr 2:47,094,900...47,555,666

G

ARF like GTPase 4C

decreases expression

ISO

dimethylarsinous acid results in decreased expression of ARL4C mRNA

NCBI chr 9:89,300,335...89,303,770
Ensembl chr 9:96,745,069...96,752,772

G

arsenite methyltransferase

increases chemical synthesis
affects response to substance
multiple interactions

ISO

AS3MT protein results in increased chemical synthesis of dimethylarsinous acid
AS3MT affects the susceptibility to dimethylarsinous acid
[AS3MT gene SNP affects the susceptibility to Arsenic] which affects the abundance of dimethylarsinous acid; [AS3MT protein binds to and results in increased methylation of arsenite] which results in increased chemical synthesis of dimethylarsinous acid; [AS3MT protein polymorphism results in increased metabolism of arsenite] which results in increased chemical synthesis of dimethylarsinous acid; [AS3MT protein polymorphism results in increased metabolism of monomethylarsonic acid] which results in increased chemical synthesis of dimethylarsinous acid; [AS3MT protein results in increased metabolism of arsenite] which results in increased chemical synthesis of dimethylarsinous acid; [AS3MT protein results in increased metabolism of monomethylarsonic acid] which results in increased chemical synthesis of dimethylarsinous acid; [AS3MT protein results in increased methylation of arsenite] which results in increased chemical synthesis of dimethylarsinous acid; [AS3MT protein results in increased methylation of monomethylarsonous acid] which results in increased chemical synthesis of dimethylarsinous acid; Cysteine promotes the reaction [AS3MT protein results in increased chemical synthesis of dimethylarsinous acid]; Glutathione promotes the reaction [[AS3MT protein polymorphism results in increased metabolism of arsenite] which results in increased chemical synthesis of dimethylarsinous acid]; Glutathione promotes the reaction [AS3MT protein results in increased chemical synthesis of dimethylarsinous acid]; tris(2-carboxyethyl)phosphine promotes the reaction [AS3MT protein results in increased chemical synthesis of dimethylarsinous acid]; Unithiol inhibits the reaction [[AS3MT protein results in increased methylation of arsenite] which results in increased chemical synthesis of dimethylarsinous acid]; Unithiol inhibits the reaction [[AS3MT protein results in increased methylation of monomethylarsonous acid] which results in increased chemical synthesis of dimethylarsinous acid]

PMID:22868225 PMID:22955273 PMID:23376817 PMID:25194983 PMID:25349987 More...

NCBI chr 1:245,595,939...245,628,921
Ensembl chr 1:255,537,109...255,569,249

G

asparagine synthetase (glutamine-hydrolyzing)

increases expression

ISO

dimethylarsinous acid results in increased expression of ASNS mRNA

PMID:23487506 PMID:23876855

NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:36,751,802...36,776,050

G

aspartate-beta-hydroxylase

increases expression

ISO

dimethylarsinous acid results in increased expression of ASPH mRNA

NCBI chr 5:22,601,581...22,814,107
Ensembl chr 5:27,398,949...27,611,215

G

activating transcription factor 4

increases expression

EXP

dimethylarsinous acid results in increased expression of ATF4 mRNA

NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:113,684,681...113,686,739

G

aurora kinase B

affects localization

ISO

dimethylarsinous acid affects the localization of AURKB protein

NCBI chr10:54,243,116...54,249,675
Ensembl chr10:54,242,850...54,252,285

G

BCL2 associated X, apoptosis regulator

multiple interactions

ISO

dimethylarsinous acid affects the expression of and affects the cleavage of BAX protein

NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429

G

BCL2, apoptosis regulator

increases expression

ISO

dimethylarsinous acid results in increased expression of BCL2 protein

NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900

G

basic helix-loop-helix family, member e41

decreases expression

ISO

dimethylarsinous acid results in decreased expression of BHLHE41 mRNA

NCBI chr 4:178,834,264...178,838,618
Ensembl chr 4:180,565,003...180,569,355

G

BLACAT1 overlapping LEMD1 locus

decreases expression

ISO

dimethylarsinous acid results in decreased expression of BLACAT1 mRNA

Ensembl chr13:46,197,208...46,197,306

G

similar to human chromosome 2 open reading frame 68

decreases expression

ISO

dimethylarsinous acid results in decreased expression of C2ORF68 mRNA

NCBI chr 4:104,402,553...104,408,317
Ensembl chr 4:105,960,751...105,966,508

G

carbonic anhydrase 9

decreases expression

ISO

dimethylarsinous acid results in decreased expression of CA9 mRNA

NCBI chr 5:62,559,024...62,565,626
Ensembl chr 5:62,558,823...62,565,626

G

caldesmon 1

decreases expression

ISO

dimethylarsinous acid results in decreased expression of CALD1 mRNA

NCBI chr 4:63,265,781...63,446,938
Ensembl chr 4:64,233,171...64,414,085

G

calcium/calmodulin-dependent protein kinase II inhibitor 1

decreases expression

ISO

dimethylarsinous acid results in decreased expression of CAMK2N1 mRNA

NCBI chr 5:155,958,116...155,959,897
Ensembl chr 5:155,957,878...155,961,058

G

calcium/calmodulin-dependent protein kinase IV

decreases expression

ISO

dimethylarsinous acid results in decreased expression of CAMK4 mRNA

NCBI chr18:24,582,988...24,811,918
Ensembl chr18:24,857,146...25,077,193

G

caspase 1

affects expression

ISO

dimethylarsinous acid affects the expression of CASP1 mRNA

NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:10,746,333...10,882,275

G

caspase 14

decreases expression

ISO

dimethylarsinous acid results in decreased expression of CASP14 mRNA

NCBI chr 7:10,929,759...10,932,591
Ensembl chr 7:11,580,339...11,583,171

G

caspase 3

multiple interactions

ISO

[monomethylarsonous acid co-treated with dimethylarsinous acid co-treated with Arsenic Trioxide] results in increased activity of and results in increased cleavage of CASP3 protein; Acetylcysteine inhibits the reaction [[monomethylarsonous acid co-treated with dimethylarsinous acid co-treated with Arsenic Trioxide] results in increased cleavage of CASP3 protein]; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[monomethylarsonous acid co-treated with dimethylarsinous acid co-treated with Arsenic Trioxide] results in increased cleavage of CASP3 protein]

NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732

G

caspase 9

increases activity

ISO

dimethylarsinous acid results in increased activity of CASP9 protein

Ensembl chr 5:159,391,188...159,409,648

G

catalase

decreases oxidation
multiple interactions
affects activity

EXP
ISO

CAT protein results in decreased oxidation of dimethylarsinous acid
[CAT protein results in decreased oxidation of dimethylarsinous acid] which results in decreased chemical synthesis of Cacodylic Acid
dimethylarsinous acid affects the activity of CAT protein

PMID:18619986 PMID:23353816

NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526

G

caveolin 2

decreases expression

ISO

dimethylarsinous acid results in decreased expression of CAV2 mRNA

NCBI chr 4:46,582,681...46,590,058
Ensembl chr 4:46,582,096...46,591,425

G

coiled-coil domain containing 9B

decreases expression

ISO

dimethylarsinous acid results in decreased expression of CCDC9B mRNA

NCBI chr 3:105,736,120...105,745,039
Ensembl chr 3:126,192,232...126,199,580

G

C-C motif chemokine ligand 2

decreases expression

ISO

dimethylarsinous acid results in decreased expression of CCL2 mRNA

NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875

G

cyclin A1

decreases expression

ISO

dimethylarsinous acid results in decreased expression of CCNA1 mRNA

NCBI chr 2:139,231,738...139,278,066
Ensembl chr 2:141,382,468...141,393,300

G

cyclin D1

increases expression
decreases expression

ISO

dimethylarsinous acid results in increased expression of CCND1 mRNA
dimethylarsinous acid results in decreased expression of CCND1 mRNA

PMID:19945496 PMID:23487506

NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810

G

CD109 molecule

decreases expression

ISO

dimethylarsinous acid results in decreased expression of CD109 mRNA

NCBI chr 8:79,454,480...79,569,195
Ensembl chr 8:88,334,736...88,449,462

G

CD44 molecule

increases expression

ISO

dimethylarsinous acid results in increased expression of CD44 mRNA

NCBI chr 3:109,610,824...109,699,776
Ensembl chr 3:109,612,054...109,699,424

G

cadherin 6

decreases expression

ISO

dimethylarsinous acid results in decreased expression of CDH6 mRNA

NCBI chr 2:62,079,139...62,225,298
Ensembl chr 2:63,806,135...63,952,287

G

cyclin-dependent kinase 16

increases expression

ISO

dimethylarsinous acid results in increased expression of CDK16 mRNA

NCBI chr X:4,046,330...4,057,825
Ensembl chr X:4,026,866...4,057,380

G

cyclin-dependent kinase 4

decreases expression

ISO

dimethylarsinous acid results in decreased expression of CDK4 mRNA

NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:64,771,147...64,775,163

G

cyclin-dependent kinase inhibitor 1A

increases expression

ISO

dimethylarsinous acid results in increased expression of CDKN1A mRNA

NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969

G

cyclin-dependent kinase inhibitor 2B

decreases expression

ISO

dimethylarsinous acid results in decreased expression of CDKN2B mRNA

NCBI chr 5:104,009,839...104,019,082
Ensembl chr 5:109,114,322...109,134,855

G

CCAAT/enhancer binding protein beta

decreases expression
increases expression

ISO

dimethylarsinous acid results in decreased expression of CEBPB mRNA
dimethylarsinous acid results in increased expression of CEBPB mRNA

PMID:16507463 PMID:23487506

NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:176,816,859...176,838,072

G

centrosomal protein 78

decreases expression

ISO

dimethylarsinous acid results in decreased expression of CEP78 mRNA

NCBI chr 1:213,246,183...213,275,275
Ensembl chr 1:222,674,194...222,702,120

G

claudin 14

increases expression

ISO

dimethylarsinous acid results in increased expression of CLDN14 mRNA

NCBI chr11:33,232,281...33,329,440
Ensembl chr11:46,701,940...46,799,096

G

clusterin

increases expression

ISO

dimethylarsinous acid results in increased expression of CLU mRNA

PMID:20886546 PMID:23876855

NCBI chr15:44,336,619...44,375,861
Ensembl chr15:44,359,914...44,375,860

G

collagen type XIII alpha 1 chain

decreases expression

ISO

dimethylarsinous acid results in decreased expression of COL13A1 mRNA

NCBI chr20:29,783,965...29,924,116
Ensembl chr20:30,326,744...30,466,800

G

collagen type I alpha 1 chain

decreases expression
increases expression

ISO

dimethylarsinous acid results in decreased expression of COL1A1 mRNA
dimethylarsinous acid results in increased expression of COL1A1 mRNA

PMID:16507463 PMID:23876855

NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460

G

collagen type IV alpha 1 chain

decreases expression

ISO

dimethylarsinous acid results in decreased expression of COL4A1 mRNA

NCBI chr16:84,885,597...84,996,482
Ensembl chr16:84,885,597...84,996,482

G

collagen type IV alpha 2 chain

decreases expression

ISO

dimethylarsinous acid results in decreased expression of COL4A2 mRNA

NCBI chr16:78,047,591...78,183,360
Ensembl chr16:84,749,672...84,885,520

G

cAMP responsive element binding protein 1

decreases expression

ISO

dimethylarsinous acid results in decreased expression of CREB1 mRNA

NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:73,397,306...73,466,339

G

crystallin, alpha B

increases expression

ISO

dimethylarsinous acid results in increased expression of CRYAB mRNA

PMID:20886546 PMID:23876855

NCBI chr 8:59,989,885...59,995,532
Ensembl chr 8:59,989,814...59,995,528

G

cystathionine gamma-lyase

increases expression

ISO

dimethylarsinous acid results in increased expression of CTH mRNA

NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:249,634,731...249,661,066

G

catenin, beta-interacting protein 1

decreases expression

ISO

dimethylarsinous acid results in decreased expression of CTNNBIP1 mRNA

NCBI chr 5:159,961,961...160,010,942
Ensembl chr 5:165,245,098...165,293,991

G

C-X-C motif chemokine ligand 14

increases expression

ISO

dimethylarsinous acid results in increased expression of CXCL14 mRNA

NCBI chr17:8,323,150...8,331,176
Ensembl chr17:8,323,143...8,331,172

G

C-X-C motif chemokine ligand 2

increases expression

ISO

dimethylarsinous acid results in increased expression of CXCL2 mRNA

NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,465,242...17,467,255

G

cytoglobin

decreases expression

ISO

dimethylarsinous acid results in decreased expression of CYGB mRNA

NCBI chr10:101,877,675...101,887,442
Ensembl chr10:102,376,507...102,386,272

G

cytochrome P450, family 1, subfamily a, polypeptide 1

increases expression

ISO

dimethylarsinous acid results in increased expression of CYP1A1 mRNA

NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012

G

cytochrome P450, family 3, subfamily a, polypeptide 2

increases expression
increases activity

ISO

dimethylarsinous acid results in increased expression of CYP3A4 mRNA; dimethylarsinous acid results in increased expression of CYP3A4 protein
dimethylarsinous acid results in increased activity of CYP3A4 protein

NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857

G

death associated protein kinase 1

affects expression

ISO

dimethylarsinous acid affects the expression of DAPK1 mRNA

NCBI chr17:3,930,223...4,090,991
Ensembl chr17:3,935,625...4,096,581

G

DNA-damage inducible transcript 3

decreases expression
increases expression

ISO
EXP

dimethylarsinous acid results in decreased expression of DDIT3 mRNA
dimethylarsinous acid results in increased expression of DDIT3 mRNA

PMID:16507463 PMID:22425709 PMID:23487506

NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509

G

DEAD-box helicase 17

decreases expression

ISO

dimethylarsinous acid results in decreased expression of DDX17 mRNA

NCBI chr 7:111,091,127...111,109,353
Ensembl chr 7:112,971,523...112,989,747

G

DEAD-box helicase 3, X-linked

increases expression

ISO

dimethylarsinous acid results in increased expression of DDX3X mRNA

NCBI chr X:9,479,532...9,493,169
Ensembl chr X:12,152,346...12,165,983

G

DEP domain containing 1

increases expression

ISO

dimethylarsinous acid results in increased expression of DEPDC1 mRNA

NCBI chr 2:248,684,508...248,717,951
Ensembl chr 2:251,343,281...251,376,709

G

dehydrogenase/reductase 2

increases expression

ISO

dimethylarsinous acid results in increased expression of DHRS2 mRNA

NCBI chr15:32,658,855...32,673,591
Ensembl chr15:32,659,223...32,673,588

G

DnaJ heat shock protein family (Hsp40) member A4

increases expression

ISO

dimethylarsinous acid results in increased expression of DNAJA4 mRNA

NCBI chr 8:63,975,177...63,998,836
Ensembl chr 8:63,981,559...63,998,836

G

DnaJ heat shock protein family (Hsp40) member B9

increases expression

ISO

dimethylarsinous acid results in increased expression of DNAJB9 mRNA

NCBI chr 6:61,270,385...61,276,795
Ensembl chr 6:66,997,842...67,009,344

G

dolichyl-phosphate mannosyltransferase subunit 3, regulatory

decreases expression

ISO

dimethylarsinous acid results in decreased expression of DPM3 mRNA

NCBI chr 2:176,974,290...176,974,805
Ensembl chr15:52,612,418...52,612,696

G

dual specificity phosphatase 1

increases expression

ISO

dimethylarsinous acid results in increased expression of DUSP1 mRNA

NCBI chr10:17,184,853...17,187,646
Ensembl chr10:17,184,823...17,187,644

G

dual specificity phosphatase 5

increases expression

ISO

dimethylarsinous acid results in increased expression of DUSP5 mRNA

NCBI chr 1:252,538,408...252,555,320
Ensembl chr 1:262,543,738...262,562,417

G

endothelin 1

increases expression

ISO

dimethylarsinous acid results in increased expression of EDN1 mRNA

NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687

G

early growth response 1

decreases expression

ISO

dimethylarsinous acid results in decreased expression of EGR1 mRNA

NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843

G

eukaryotic translation initiation factor 2 alpha kinase 3

multiple interactions
increases phosphorylation

EXP

Cycloheximide inhibits the reaction [dimethylarsinous acid results in increased phosphorylation of EIF2AK3 protein]

NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:104,363,833...104,425,268

G

extracellular leucine-rich repeat and fibronectin type III domain containing 2

decreases expression

ISO

dimethylarsinous acid results in decreased expression of ELFN2 mRNA

NCBI chr 7:110,220,293...110,272,770
Ensembl chr 7:112,074,331...112,153,451

G

ELOVL fatty acid elongase 6

decreases expression

ISO

dimethylarsinous acid results in decreased expression of ELOVL6 mRNA

NCBI chr 2:218,063,682...218,174,767
Ensembl chr 2:220,738,064...220,845,549

G

endoplasmic reticulum to nucleus signaling 1

increases expression

ISO

dimethylarsinous acid results in increased expression of ERN1 mRNA

NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,830,428...91,920,791

G

endoplasmic reticulum oxidoreductase 1 beta

increases expression

ISO

dimethylarsinous acid results in increased expression of ERO1B mRNA

NCBI chr17:92,913,696...92,987,401
Ensembl chr17:92,814,368...92,987,555

G

ETS variant transcription factor 1

decreases expression

ISO

dimethylarsinous acid results in decreased expression of ETV1 mRNA

NCBI chr 6:55,590,149...55,681,784
Ensembl chr 6:61,317,429...61,408,959

G

fatty acid 2-hydroxylase

increases expression

ISO

dimethylarsinous acid results in increased expression of FA2H mRNA

NCBI chr19:39,312,904...39,364,153
Ensembl chr19:56,222,242...56,273,623

G

family with sequence similarity 210, member B

decreases expression

ISO

dimethylarsinous acid results in decreased expression of FAM210B mRNA

NCBI chr 3:161,118,228...161,128,400
Ensembl chr 3:181,536,673...181,546,834

G

flap structure-specific endonuclease 1

decreases expression

ISO

dimethylarsinous acid results in decreased expression of FEN1 mRNA

NCBI chr 1:216,270,016...216,274,873
Ensembl chr 1:216,269,163...216,275,016

G

FER tyrosine kinase

decreases expression

ISO

dimethylarsinous acid results in decreased expression of FER mRNA

NCBI chr 9:110,967,317...111,274,315
Ensembl chr 9:110,967,390...111,274,315

G

FYVE, RhoGEF and PH domain containing 6

increases expression

ISO

dimethylarsinous acid results in increased expression of FGD6 mRNA

NCBI chr 7:28,597,609...28,712,908
Ensembl chr 7:30,484,600...30,595,806

G

fibroblast growth factor binding protein 1

decreases expression

ISO

dimethylarsinous acid results in decreased expression of FGFBP1 mRNA

PMID:23487506 PMID:23876855

NCBI chr14:67,103,686...67,107,492
Ensembl chr14:71,317,065...71,320,309

G

Fibroblast growth factor receptor 1

decreases expression

ISO

dimethylarsinous acid results in decreased expression of FGFR1 mRNA

NCBI chr16:73,194,631...73,249,855
Ensembl chr16:73,194,631...73,249,855

G

formin homology 2 domain containing 3

decreases expression

ISO

dimethylarsinous acid results in decreased expression of FHOD3 mRNA

NCBI chr18:16,267,830...16,700,508
Ensembl chr18:16,267,977...16,700,508

G

FKBP prolyl isomerase 4

increases expression

ISO

dimethylarsinous acid results in increased expression of FKBP4 mRNA

NCBI chr 4:163,389,464...163,397,918
Ensembl chr 4:163,389,464...163,397,918

G

fibronectin 1

increases expression
decreases expression

ISO

dimethylarsinous acid results in increased expression of FN1 mRNA
dimethylarsinous acid results in decreased expression of FN1 mRNA

PMID:20886546 PMID:23487506

NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:80,645,507...80,714,137

G

Fos proto-oncogene, AP-1 transcription factor subunit

decreases expression

ISO

dimethylarsinous acid results in decreased expression of FOS mRNA

NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598

G

FosB proto-oncogene, AP-1 transcription factor subunit

increases expression

ISO

dimethylarsinous acid results in increased expression of FOSB mRNA

NCBI chr 1:88,082,324...88,089,506
Ensembl chr 1:88,082,127...88,089,477

G

FOS like 2, AP-1 transcription factor subunit

increases expression

ISO

dimethylarsinous acid results in increased expression of FOSL2 mRNA

NCBI chr 6:30,017,952...30,039,269
Ensembl chr 6:30,021,916...30,039,406

G

ferritin light chain 1

increases expression

ISO

dimethylarsinous acid results in increased expression of FTL mRNA

NCBI chr 1:95,936,387...95,938,234
Ensembl chr X:45,399,355...45,399,915
Ensembl chr 2:45,399,355...45,399,915
Ensembl chr 1:45,399,355...45,399,915

G

GATA binding protein 6

decreases expression

ISO

dimethylarsinous acid results in decreased expression of GATA6 mRNA

NCBI chr18:2,460,909...2,492,322
Ensembl chr18:2,458,253...2,492,322

G

glutamine amidotransferase class 1 domain containing 1

decreases expression

ISO

dimethylarsinous acid results in decreased expression of GATD1 mRNA

NCBI chr 1:196,504,533...196,512,561
Ensembl chr 1:205,936,687...205,942,779

G

growth differentiation factor 15

increases expression

ISO

dimethylarsinous acid results in increased expression of GDF15 mRNA

NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,838,436...18,842,022

G

gap junction protein, alpha 1

decreases expression

ISO

dimethylarsinous acid results in decreased expression of GJA1 mRNA

NCBI chr20:36,302,490...36,315,010
Ensembl chr20:36,302,352...36,319,689

G

glycerol-3-phosphate acyltransferase 3

increases expression

ISO

dimethylarsinous acid results in increased expression of GPAT3 mRNA

NCBI chr14:8,715,367...8,768,051

G

glutathione S-transferase, mu 5

increases expression

ISO

dimethylarsinous acid results in increased expression of GSTM3 mRNA

NCBI chr 2:195,531,599...195,534,562
Ensembl chr 2:198,219,647...198,222,731

G

G-2 and S-phase expressed 1

increases expression

ISO

dimethylarsinous acid results in increased expression of GTSE1 mRNA

NCBI chr 7:116,949,997...116,966,826
Ensembl chr 7:118,829,903...118,846,661

G

H1.5 linker histone, cluster member

increases expression

ISO

dimethylarsinous acid results in increased expression of H1-5 mRNA

NCBI chr17:42,726,132...42,727,162
Ensembl chr17:47,421,843...47,477,387

G

H2B clustered histone 3

increases expression

ISO

dimethylarsinous acid results in increased expression of H2BC3 mRNA

NCBI chr17:41,380,056...41,380,686

G

H3 clustered histone 1

increases expression

ISO

dimethylarsinous acid results in increased expression of H3C1 mRNA

NCBI chr17:41,796,236...41,796,759
Ensembl chr17:41,795,396...41,797,281
Ensembl chr17:41,795,396...41,797,281

G

heparin-binding EGF-like growth factor

decreases expression
increases expression

ISO

dimethylarsinous acid results in decreased expression of HBEGF mRNA
dimethylarsinous acid results in increased expression of HBEGF mRNA

PMID:16507463 PMID:23487506

NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,380,337...28,390,220

G

homocysteine inducible ER protein with ubiquitin like domain 1

increases expression

ISO

dimethylarsinous acid results in increased expression of HERPUD1 mRNA

NCBI chr19:10,598,411...10,609,002
Ensembl chr19:10,604,362...10,624,081

G

hypoxia inducible factor 1 subunit alpha

decreases expression

ISO

dimethylarsinous acid results in decreased expression of HIF1A mRNA

NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323

G

histone cluster 1 H2A family member F

increases expression

ISO

dimethylarsinous acid results in increased expression of H2AC8 mRNA

NCBI chr17:41,379,404...41,379,796

G

histone cluster 1, H2bc

decreases expression

ISO

dimethylarsinous acid results in decreased expression of H2BC21 mRNA

NCBI chr17:42,692,335...42,696,601
Ensembl chr17:47,404,375...47,419,020

G

high mobility group box 1

decreases expression

ISO

dimethylarsinous acid results in decreased expression of HMGB1 mRNA

NCBI chr12:11,009,236...11,015,941
Ensembl chr16:39,039,050...39,041,327
Ensembl chr12:39,039,050...39,041,327

G

hyaluronan-mediated motility receptor

increases expression

ISO

dimethylarsinous acid results in increased expression of HMMR mRNA

NCBI chr10:25,132,933...25,163,029
Ensembl chr10:25,635,915...25,665,390

G

heme oxygenase 1

increases expression

ISO

dimethylarsinous acid results in increased expression of HMOX1 mRNA

PMID:19945496 PMID:23876855

NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818

G

hook microtubule-tethering protein 3

decreases expression

ISO

dimethylarsinous acid results in decreased expression of HOOK3 mRNA

NCBI chr16:72,656,929...72,751,696
Ensembl chr16:72,657,019...72,764,071

G

heat shock protein family A (Hsp70) member 13

increases expression

ISO

dimethylarsinous acid results in increased expression of HSPA13 mRNA

NCBI chr11:14,375,669...14,389,853
Ensembl chr11:27,862,593...27,876,898

G

heat shock protein family B (small) member 1

increases expression

ISO

dimethylarsinous acid results in increased expression of HSPB1 mRNA

NCBI chr12:26,430,640...26,432,301
Ensembl chr12:26,430,640...26,432,301

G

HtrA serine peptidase 1

decreases expression

ISO

dimethylarsinous acid results in decreased expression of HTRA1 mRNA

NCBI chr 1:185,497,815...185,547,380
Ensembl chr 1:194,927,687...194,977,620

G

hypoxia up-regulated 1

increases expression

ISO

dimethylarsinous acid results in increased expression of HYOU1 mRNA

NCBI chr 8:53,602,882...53,614,998
Ensembl chr 8:53,602,604...53,614,997

G

immediate early response 5-like

decreases expression

ISO

dimethylarsinous acid results in decreased expression of IER5L mRNA

NCBI chr 3:13,744,056...13,745,647
Ensembl chr 3:34,139,672...34,144,452

G

interferon-induced protein 44

decreases expression

ISO

dimethylarsinous acid results in decreased expression of IFI44 mRNA

NCBI chr 2:240,626,058...240,643,879
Ensembl chr 2:243,286,052...243,306,877

G

interferon-induced protein 44-like

decreases expression

ISO

dimethylarsinous acid results in decreased expression of IFI44L mRNA

NCBI chr 2:240,668,742...240,706,425
Ensembl chr 2:243,328,723...243,366,404

G

interferon-induced protein with tetratricopeptide repeats 2

decreases expression

ISO

dimethylarsinous acid results in decreased expression of IFIT2 mRNA

NCBI chr 1:232,102,570...232,108,638
Ensembl chr 1:241,515,709...241,521,798

G

interferon-induced protein with tetratricopeptide repeats 3

increases expression

ISO

dimethylarsinous acid results in increased expression of IFIT3 mRNA

NCBI chr 1:232,114,166...232,119,311
Ensembl chr 1:241,526,880...241,532,521

G

insulin-like growth factor binding protein 5

decreases expression

ISO

dimethylarsinous acid results in decreased expression of IGFBP5 mRNA

NCBI chr 9:81,901,605...81,914,187
Ensembl chr 9:81,897,616...81,914,390

G

IKAROS family zinc finger 5

increases expression

ISO

dimethylarsinous acid results in increased expression of IKZF5 mRNA

NCBI chr 1:186,169,108...186,188,847
Ensembl chr 1:195,600,967...195,619,013

G

interleukin 1 alpha

decreases expression
increases expression

ISO

dimethylarsinous acid results in decreased expression of IL1A mRNA
dimethylarsinous acid results in increased expression of IL1A mRNA

PMID:19945496 PMID:23487506

NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:136,979,805...136,998,013

G

interleukin 1 receptor type 2

increases expression

ISO

dimethylarsinous acid results in increased expression of IL1R2 mRNA

NCBI chr 9:49,879,928...49,920,374
Ensembl chr 9:49,877,266...49,920,374

G

interleukin 24

increases expression

ISO

dimethylarsinous acid results in increased expression of IL24 mRNA

NCBI chr13:42,353,089...42,358,487
Ensembl chr13:44,905,363...44,910,760

G

interleukin 6

multiple interactions
increases expression

ISO

[dimethylarsinous acid co-treated with Lipopolysaccharides] results in increased secretion of IL6 protein
dimethylarsinous acid results in increased expression of IL6 mRNA

PMID:23487506 PMID:23876855 PMID:24140498

NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610

G

inflammation and lipid regulator with UBA-like and NBR1-like domains

increases expression

ISO

dimethylarsinous acid results in increased expression of ILRUN mRNA

NCBI chr20:5,809,931...5,876,197
Ensembl chr20:5,811,734...5,877,978

G

insulin 1

multiple interactions

ISO

3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester inhibits the reaction [dimethylarsinous acid inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; dimethylarsinous acid inhibits the reaction [3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester promotes the reaction [Glucose results in increased secretion of INS1 protein]]; dimethylarsinous acid inhibits the reaction [Glucose results in increased secretion of INS1 protein]; dimethylarsinous acid inhibits the reaction [Potassium Chloride results in increased secretion of INS1 protein]; Tolbutamide inhibits the reaction [dimethylarsinous acid inhibits the reaction [Glucose results in increased secretion of INS1 protein]]

NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:261,186,119...261,186,682

G

IQ motif containing GTPase activating protein 1

decreases expression

ISO

dimethylarsinous acid results in decreased expression of IQGAP1 mRNA

NCBI chr 1:144,088,788...144,178,989
Ensembl chr 1:144,088,793...144,179,043

G

integrin subunit beta 3

decreases expression
increases expression

ISO

dimethylarsinous acid results in decreased expression of ITGB3 mRNA
dimethylarsinous acid results in increased expression of ITGB3 mRNA

PMID:16507463 PMID:23876855

NCBI chr10:90,009,927...90,067,787
Ensembl chr10:90,009,900...90,067,800

G

junction mediating and regulatory protein, p53 cofactor

increases expression

ISO

dimethylarsinous acid results in increased expression of JMY mRNA

NCBI chr 2:24,662,104...24,730,955
Ensembl chr 2:26,409,969...26,465,649

G

kirre like nephrin family adhesion molecule 1

decreases expression

ISO

dimethylarsinous acid results in decreased expression of KIRREL1 mRNA

NCBI chr 2:174,819,564...174,912,998
Ensembl chr 2:174,819,572...174,912,960

G

karyopherin subunit alpha 4

increases expression

ISO

dimethylarsinous acid results in increased expression of KPNA4 mRNA

NCBI chr 2:153,319,380...153,381,085
Ensembl chr 2:155,634,247...155,691,053

G

keratin 15

decreases expression

ISO

dimethylarsinous acid results in decreased expression of KRT15 mRNA

PMID:23487506 PMID:23876855

NCBI chr10:85,066,797...85,070,614
Ensembl chr10:85,567,202...85,571,142

G

keratin 19

decreases expression

ISO

dimethylarsinous acid results in decreased expression of KRT19 mRNA

NCBI chr10:85,075,835...85,080,552
Ensembl chr10:85,576,235...85,580,952

G

keratin 34

increases expression

ISO

dimethylarsinous acid results in increased expression of KRT34 mRNA

NCBI chr10:84,969,988...84,974,098
Ensembl chr10:85,470,391...85,474,501

G

keratin 75

increases expression

ISO

dimethylarsinous acid results in increased expression of KRT75 mRNA

NCBI chr 7:132,687,101...132,697,360
Ensembl chr 7:134,565,826...134,576,074

G

lymphocyte cytosolic protein 1

increases expression

ISO

dimethylarsinous acid results in increased expression of LCP1 mRNA

NCBI chr15:56,846,375...56,954,090
Ensembl chr15:56,847,433...56,954,092

G

LIM and calponin homology domains 1

decreases expression

ISO

dimethylarsinous acid results in decreased expression of LIMCH1 mRNA

NCBI chr14:41,466,433...41,779,477
Ensembl chr14:41,466,433...41,778,837

G

latent transforming growth factor beta binding protein 2

decreases expression

ISO

dimethylarsinous acid results in decreased expression of LTBP2 mRNA

NCBI chr 6:104,429,947...104,530,498
Ensembl chr 6:110,161,029...110,257,298

G

mannosidase, alpha, class 2A, member 2

decreases expression

ISO

dimethylarsinous acid results in decreased expression of MAN2A2 mRNA

NCBI chr 1:134,304,714...134,327,611
Ensembl chr 1:143,716,072...143,736,562

G

melanophilin

decreases expression

ISO

dimethylarsinous acid results in decreased expression of MLPH mRNA

NCBI chr 9:91,507,410...91,542,984
Ensembl chr 9:98,955,141...98,990,556

G

matrix metallopeptidase 1

increases expression

ISO

dimethylarsinous acid results in increased expression of MMP1 mRNA

PMID:23487506 PMID:23876855

NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:12,943,453...12,963,964

G

matrix metallopeptidase 10

increases expression

ISO

dimethylarsinous acid results in increased expression of MMP10 mRNA

NCBI chr 8:4,689,840...4,697,748
Ensembl chr 8:12,974,707...12,982,613

G

matrix metallopeptidase 2

decreases expression

ISO

dimethylarsinous acid results in decreased expression of MMP2 mRNA

NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856

G

matrix metallopeptidase 9

increases expression

ISO

dimethylarsinous acid results in increased expression of MMP9 mRNA

NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442

G

msh homeobox 1

decreases expression

ISO

dimethylarsinous acid results in decreased expression of MSX1 protein

NCBI chr14:77,185,802...77,189,735
Ensembl chr14:77,185,802...77,189,735

G

MX dynamin like GTPase 1

decreases expression

ISO

dimethylarsinous acid results in decreased expression of MX1 mRNA

NCBI chr11:36,799,659...36,825,209
Ensembl chr11:50,269,057...50,292,904

G

myosin light chain kinase

decreases expression

ISO

dimethylarsinous acid results in decreased expression of MYLK mRNA

NCBI chr11:65,783,008...66,030,239
Ensembl chr11:79,288,243...79,535,659

G

myosin Ib

increases expression

ISO

dimethylarsinous acid results in increased expression of MYO1B mRNA

NCBI chr 9:49,690,043...49,852,373
Ensembl chr 9:57,181,987...57,344,328

G

myogenic differentiation 1

affects localization
decreases expression

ISO

dimethylarsinous acid affects the localization of MYOD1 protein
dimethylarsinous acid results in decreased expression of MYOD1 protein

NCBI chr 1:96,884,864...96,887,574
Ensembl chr 1:106,021,161...106,023,871

G

myogenin

decreases expression

ISO

dimethylarsinous acid results in decreased expression of MYOG protein

NCBI chr13:48,297,476...48,300,065
Ensembl chr13:48,297,235...48,300,065

G

myocardial zonula adherens protein

increases expression

ISO

dimethylarsinous acid results in increased expression of MYZAP mRNA

NCBI chr 8:72,155,817...72,243,036
Ensembl chr 8:81,036,601...81,123,810

G

N-6 adenine-specific DNA methyltransferase 1

multiple interactions

ISO

[HEMK2 protein results in increased metabolism of monomethylarsonous acid] which results in increased chemical synthesis of dimethylarsinous acid

NCBI chr11:26,584,750...26,597,790
Ensembl chr11:40,070,993...40,083,680

G

nicotinamide phosphoribosyltransferase

increases expression

ISO

dimethylarsinous acid results in increased expression of NAMPT mRNA

NCBI chr 6:55,152,756...55,189,547
Ensembl chr 6:55,151,926...55,189,544

G

NSF attachment protein alpha

increases expression

ISO

dimethylarsinous acid results in increased expression of NAPA mRNA

NCBI chr 1:76,787,036...76,805,869
Ensembl chr 1:85,915,119...85,934,053

G

neuron navigator 2

increases expression

ISO

dimethylarsinous acid results in increased expression of NAV2 mRNA

NCBI chr 1:98,957,629...99,322,339
Ensembl chr 1:107,805,096...108,458,546

G

neuronal differentiation 1

affects localization
decreases expression

ISO

dimethylarsinous acid affects the localization of NEUROD1 protein
dimethylarsinous acid results in decreased expression of NEUROD1 protein

NCBI chr 3:84,766,483...84,770,454
Ensembl chr 3:84,764,725...84,770,810

G

nucleolar and coiled-body phosphoprotein 1

increases expression

ISO

dimethylarsinous acid results in increased expression of NOLC1 mRNA

NCBI chr 1:244,921,275...244,932,089
Ensembl chr 1:254,870,319...254,881,069

G

NAD(P)H quinone dehydrogenase 1

increases expression

ISO

dimethylarsinous acid results in increased expression of NQO1 mRNA

NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260

G

nuclear receptor subfamily 1, group I, member 2

increases expression

ISO

dimethylarsinous acid results in increased expression of NR1I2 mRNA

NCBI chr11:62,460,213...62,496,665
Ensembl chr11:75,965,632...76,002,380

G

neuregulin 1

decreases expression

ISO

dimethylarsinous acid results in decreased expression of NRG1 mRNA

NCBI chr16:65,954,084...67,007,484
Ensembl chr16:65,953,865...66,999,849

G

N-ethylmaleimide sensitive factor, vesicle fusing ATPase

decreases expression

ISO

dimethylarsinous acid results in decreased expression of NSF mRNA

NCBI chr10:89,227,937...89,357,383
Ensembl chr10:89,227,937...89,367,621

G

nucleoporin 88

decreases expression

ISO

dimethylarsinous acid results in decreased expression of NUP88 mRNA

NCBI chr10:55,667,903...55,692,249
Ensembl chr10:56,166,486...56,191,383

G

nuclear RNA export factor 1

increases expression

ISO

dimethylarsinous acid results in increased expression of NXF1 mRNA

NCBI chr 1:215,084,563...215,097,756
Ensembl chr 1:215,084,099...215,097,756

G

2'-5' oligoadenylate synthetase 1A

increases expression

ISO

dimethylarsinous acid results in increased expression of OAS1 mRNA

NCBI chr12:41,330,423...41,341,130
Ensembl chr12:41,285,211...41,341,128

G

ornithine decarboxylase 1

decreases expression

ISO

dimethylarsinous acid results in decreased expression of ODC1 mRNA

NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:46,058,463...46,065,146

G

oxysterol binding protein

increases expression

ISO

dimethylarsinous acid results in increased expression of OSBP mRNA

NCBI chr 1:218,313,455...218,343,263
Ensembl chr 1:218,313,148...218,343,258

G

poly (ADP-ribose) polymerase 1

decreases activity
multiple interactions

ISO

dimethylarsinous acid results in decreased activity of PARP1 protein
[monomethylarsonous acid co-treated with dimethylarsinous acid co-treated with Arsenic Trioxide] results in increased cleavage of PARP1 protein; Acetylcysteine inhibits the reaction [[monomethylarsonous acid co-treated with dimethylarsinous acid co-treated with Arsenic Trioxide] results in increased cleavage of PARP1 protein]; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[monomethylarsonous acid co-treated with dimethylarsinous acid co-treated with Arsenic Trioxide] results in increased cleavage of PARP1 protein]; dimethylarsinous acid inhibits the reaction [Hydrogen Peroxide results in increased activity of PARP1 protein]

PMID:17011244 PMID:29774349

NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567

G

polycomb group ring finger 2

decreases expression

ISO

dimethylarsinous acid results in decreased expression of PCGF2 mRNA

NCBI chr10:82,682,563...82,694,563
Ensembl chr10:83,179,916...83,183,999

G

programmed cell death 1 ligand 2

increases expression

ISO

dimethylarsinous acid results in increased expression of PDCD1LG2 mRNA

NCBI chr 1:227,158,941...227,223,938
Ensembl chr 1:236,565,526...236,637,490

G

pyruvate dehydrogenase kinase 3

decreases expression

ISO

dimethylarsinous acid results in decreased expression of PDK3 mRNA

NCBI chr X:58,486,699...58,553,533
Ensembl chr X:62,480,535...62,547,371

G

pleckstrin homology-like domain, family A, member 1

increases expression

ISO

dimethylarsinous acid results in increased expression of PHLDA1 mRNA

NCBI chr 7:48,853,690...48,855,894
Ensembl chr 7:48,853,260...48,857,542

G

plasminogen activator, urokinase receptor

increases expression

ISO

dimethylarsinous acid results in increased expression of PLAUR mRNA

NCBI chr 1:89,181,363...89,196,308
Ensembl chr 1:89,178,453...89,198,130

G

pleckstrin homology, MyTH4 and FERM domain containing H2

decreases expression

ISO

dimethylarsinous acid results in decreased expression of PLEKHH2 mRNA

NCBI chr 6:15,783,179...15,893,479
Ensembl chr 6:15,784,645...15,893,537

G

phospholipid phosphatase 4

decreases expression

ISO

dimethylarsinous acid results in decreased expression of PLPP4 mRNA

NCBI chr 1:183,829,794...183,959,319
Ensembl chr 1:193,260,434...193,389,675

G

prostate transmembrane protein, androgen induced 1

decreases expression

ISO

dimethylarsinous acid results in decreased expression of PMEPA1 mRNA

NCBI chr 3:182,430,193...182,478,649
Ensembl chr 3:182,430,193...182,478,649

G

PML nuclear body scaffold

multiple interactions

ISO

[monomethylarsonous acid co-treated with dimethylarsinous acid co-treated with Arsenic Trioxide] results in increased degradation of PML protein

NCBI chr 8:67,523,164...67,557,801
Ensembl chr 8:67,523,164...67,576,083

G

PNN interacting serine and arginine rich protein

decreases expression

ISO

dimethylarsinous acid results in decreased expression of PNISR mRNA

NCBI chr 5:35,395,965...35,422,852
Ensembl chr 5:40,192,735...40,219,611

G

DNA polymerase epsilon 2, accessory subunit

decreases expression

ISO

dimethylarsinous acid results in decreased expression of POLE2 mRNA

NCBI chr 6:93,410,713...93,448,782
Ensembl chr 6:93,410,758...93,435,361

G

periplakin

decreases expression

ISO

dimethylarsinous acid results in decreased expression of PPL mRNA

NCBI chr10:10,957,388...11,003,035
Ensembl chr10:10,957,341...11,003,658

G

protein phosphatase 2 regulatory subunit B', epsilon

decreases expression

ISO

dimethylarsinous acid results in decreased expression of PPP2R5E mRNA

NCBI chr 6:94,168,846...94,317,872
Ensembl chr 6:99,904,569...100,053,573

G

PML-RARA regulated adaptor molecule 1

multiple interactions

ISO

[monomethylarsonous acid co-treated with dimethylarsinous acid co-treated with Arsenic Trioxide] results in increased expression of PRAM1 protein

NCBI chr 7:14,428,548...14,438,081

G

protein kinase C, alpha

decreases expression

ISO

dimethylarsinous acid results in decreased expression of PRKCA mRNA

NCBI chr10:93,388,991...93,787,617
Ensembl chr10:93,388,991...93,787,572

G

serine protease 12

decreases expression

ISO

dimethylarsinous acid results in decreased expression of PRSS12 mRNA

NCBI chr 2:211,624,134...211,684,126
Ensembl chr 2:214,308,774...214,369,941

G

serine protease 23

decreases expression

ISO

dimethylarsinous acid results in decreased expression of PRSS23 mRNA

NCBI chr 1:143,402,725...143,422,182
Ensembl chr 1:152,813,670...152,947,871

G

proteasome 20S subunit alpha 3

decreases expression

ISO

dimethylarsinous acid results in decreased expression of PSMA3 mRNA

NCBI chr 6:89,483,741...89,503,775
Ensembl chr 6:95,219,629...95,241,032

G

proteasome 26S subunit, non-ATPase 11

decreases expression

ISO

dimethylarsinous acid results in decreased expression of PSMD11 mRNA

NCBI chr10:65,433,853...65,479,774
Ensembl chr10:65,931,279...65,976,234

G

prostaglandin-endoperoxide synthase 1

increases expression

ISO

dimethylarsinous acid results in increased expression of PTGS1 mRNA

NCBI chr 3:39,981,419...40,002,993
Ensembl chr 3:39,981,415...40,002,990

G

prostaglandin-endoperoxide synthase 2

increases expression

ISO

dimethylarsinous acid results in increased expression of PTGS2 mRNA

NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320

G

protein tyrosine phosphatase, non-receptor type 1

affects binding
decreases activity

ISO

dimethylarsinous acid binds to PTPN1 protein
dimethylarsinous acid results in decreased activity of PTPN1 protein

NCBI chr 3:177,056,588...177,106,424
Ensembl chr 3:177,057,659...177,106,416

G

protein tyrosine phosphatase, receptor type, C

decreases activity

ISO

dimethylarsinous acid results in decreased activity of PTPRC protein

NCBI chr13:52,147,717...52,259,810
Ensembl chr13:52,147,717...52,259,746

G

protein tyrosine phosphatase, receptor type Z1

decreases expression

ISO

dimethylarsinous acid results in decreased expression of PTPRZ1 mRNA

NCBI chr 4:52,363,006...52,560,905
Ensembl chr 4:52,363,295...52,560,903

G

quinolinate phosphoribosyltransferase

decreases expression

ISO

dimethylarsinous acid results in decreased expression of QPRT mRNA

NCBI chr 1:191,148,715...191,164,006
Ensembl chr 1:191,148,713...191,194,162

G

ras related dexamethasone induced 1

increases expression

ISO

dimethylarsinous acid results in increased expression of RASD1 mRNA

NCBI chr10:44,766,451...44,775,773
Ensembl chr10:45,265,979...45,267,710

G

regulator of calcineurin 1

increases expression

ISO

dimethylarsinous acid results in increased expression of RCAN1 mRNA

NCBI chr11:31,622,208...31,702,150
Ensembl chr11:45,108,124...45,118,236

G

reelin

increases expression

ISO

dimethylarsinous acid results in increased expression of RELN mRNA

NCBI chr 4:13,628,440...14,055,201
Ensembl chr 4:13,628,399...14,055,162

G

rhomboid domain containing 2

increases expression

ISO

dimethylarsinous acid results in increased expression of RHBDD2 mRNA

NCBI chr12:21,043,605...21,054,305
Ensembl chr12:26,680,969...26,691,080

G

ras homolog family member D

increases expression

ISO

dimethylarsinous acid results in increased expression of RHOD mRNA

NCBI chr 1:211,138,126...211,153,953
Ensembl chr 1:211,138,126...211,152,061

G

RIO kinase 3

increases expression

ISO

dimethylarsinous acid results in increased expression of RIOK3 mRNA

NCBI chr18:3,327,776...3,353,350
Ensembl chr18:3,602,535...3,628,108

G

Rho family GTPase 3

increases expression

ISO

dimethylarsinous acid results in increased expression of RND3 mRNA

NCBI chr 3:55,981,142...55,998,494
Ensembl chr 3:55,980,355...55,998,536

G

RNA pseudouridine synthase D4

decreases expression

ISO

dimethylarsinous acid results in decreased expression of RPUSD4 mRNA

NCBI chr 8:33,617,384...33,626,873
Ensembl chr 8:41,874,764...41,884,699

G

ribonucleotide reductase regulatory TP53 inducible subunit M2B

increases expression

ISO

dimethylarsinous acid results in increased expression of RRM2B mRNA

NCBI chr 7:69,077,024...69,108,742
Ensembl chr 7:70,965,590...70,993,670

G

retinoid X receptor alpha

increases expression

ISO

dimethylarsinous acid results in increased expression of RXRA mRNA

NCBI chr 3:31,387,892...31,474,415
Ensembl chr 3:31,388,223...31,474,417

G

S100 calcium binding protein A2

decreases expression

ISO

dimethylarsinous acid results in decreased expression of S100A2 mRNA

NCBI chr 2:178,374,659...178,375,903

G

S100 calcium binding protein A8

decreases expression

ISO

dimethylarsinous acid results in decreased expression of S100A8 mRNA

NCBI chr 2:178,464,095...178,465,223
Ensembl chr 2:178,464,702...178,465,221

G

sterile alpha motif domain containing 8

increases expression

ISO

dimethylarsinous acid results in increased expression of SAMD8 mRNA

NCBI chr15:2,512,104...2,562,368
Ensembl chr15:2,561,435...2,607,052

G

secretion associated, Ras related GTPase 1A

increases expression

ISO

dimethylarsinous acid results in increased expression of SAR1A mRNA

NCBI chr20:29,623,529...29,635,935
Ensembl chr20:30,166,334...30,178,710

G

stearoyl-CoA desaturase

decreases expression

ISO

dimethylarsinous acid results in decreased expression of SCD mRNA

NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:253,218,970...253,231,785

G

sodium channel epithelial 1 subunit alpha

decreases expression

ISO

dimethylarsinous acid results in decreased expression of SCNN1A mRNA

NCBI chr 4:159,809,187...159,832,409
Ensembl chr 4:159,809,170...159,832,405

G

SDE2 telomere maintenance homolog

increases expression

ISO

dimethylarsinous acid results in increased expression of SDE2 mRNA

NCBI chr13:92,578,843...92,595,142
Ensembl chr13:95,110,698...95,126,927

G

SEC14-like lipid binding 1

decreases expression

ISO

dimethylarsinous acid results in decreased expression of SEC14L1 mRNA

NCBI chr10:102,818,693...102,865,841
Ensembl chr10:102,818,693...102,865,839

G

serpin family B member 2

increases expression

ISO

dimethylarsinous acid results in increased expression of SERPINB2 mRNA

PMID:23487506 PMID:23876855

NCBI chr13:23,537,312...23,551,823
Ensembl chr13:24,056,021...24,065,031

G

serpin family B member 7

increases expression

ISO

dimethylarsinous acid results in increased expression of SERPINB7 mRNA

NCBI chr13:23,369,830...23,442,205
Ensembl chr13:23,910,306...23,956,834

G

sestrin 2

increases expression

ISO

dimethylarsinous acid results in increased expression of SESN2 mRNA

NCBI chr 5:144,702,287...144,721,241
Ensembl chr 5:149,986,317...150,005,255

G

S-phase kinase-associated protein 1

increases expression

ISO

dimethylarsinous acid results in increased expression of SKP1 mRNA

NCBI chr10:36,401,987...36,417,066
Ensembl chr10:36,903,078...36,918,308

G

S-phase kinase associated protein 2

increases expression

ISO

dimethylarsinous acid results in increased expression of SKP2 mRNA

NCBI chr 2:59,888,406...59,916,471
Ensembl chr 2:59,888,413...59,916,438

G

solute carrier family 12, member 6

increases expression

ISO

dimethylarsinous acid results in increased expression of SLC12A6 mRNA

NCBI chr 3:119,525,521...119,624,655
Ensembl chr 3:119,526,295...119,624,653

G

solute carrier family 26 member 2

decreases expression

ISO

dimethylarsinous acid results in decreased expression of SLC26A2 mRNA

NCBI chr18:54,648,276...54,666,627
Ensembl chr18:56,923,337...56,937,012

G

solute carrier family 3 member 2

increases expression

ISO

dimethylarsinous acid results in increased expression of SLC3A2 mRNA

NCBI chr 1:215,033,601...215,048,064
Ensembl chr 1:215,033,601...215,048,064

G

solute carrier family 41 member 2

increases expression

ISO

dimethylarsinous acid results in increased expression of SLC41A2 mRNA

NCBI chr 7:20,383,714...20,491,178
Ensembl chr 7:22,271,313...22,378,764

G

solute carrier family 7 member 11

increases expression

ISO

dimethylarsinous acid results in increased expression of SLC7A11 mRNA

NCBI chr 2:136,532,912...136,668,560
Ensembl chr 2:136,532,246...136,695,695

G

schlafen family member 5

increases expression

ISO

dimethylarsinous acid results in increased expression of SLFN5 mRNA

NCBI chr10:67,881,068...67,895,013
Ensembl chr10:68,378,449...68,392,544

G

slit guidance ligand 2

increases expression

ISO

dimethylarsinous acid results in increased expression of SLIT2 mRNA

NCBI chr14:66,829,661...67,168,517
Ensembl chr14:66,829,661...67,167,146

G

SLIT and NTRK-like family, member 6

decreases expression

ISO

dimethylarsinous acid results in decreased expression of SLITRK6 mRNA

NCBI chr15:87,563,506...87,570,125
Ensembl chr15:93,969,038...93,984,526

G

SMAD family member 7

decreases expression

ISO

dimethylarsinous acid results in decreased expression of SMAD7 mRNA

NCBI chr18:71,263,508...71,291,849
Ensembl chr18:71,263,508...71,291,849

G

superoxide dismutase 1

increases expression
increases response to substance

ISO

dimethylarsinous acid results in increased expression of SOD1 mRNA
SOD1 protein results in increased susceptibility to dimethylarsinous acid

PMID:20740636 PMID:20886546

NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399

G

superoxide dismutase 2

increases expression

ISO

dimethylarsinous acid results in increased expression of SOD2 mRNA

NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168

G

SRY-box transcription factor 10

decreases expression

ISO

dimethylarsinous acid results in decreased expression of SOX10 protein

NCBI chr 7:110,725,274...110,734,651
Ensembl chr 7:112,605,721...112,615,990

G

SRY-box transcription factor 9

decreases expression

ISO

dimethylarsinous acid results in decreased expression of SOX9 mRNA

NCBI chr10:98,305,744...98,311,250
Ensembl chr10:98,305,744...98,311,250

G

spermatogenesis associated 2

increases expression

ISO

dimethylarsinous acid results in increased expression of SPATA2 mRNA

NCBI chr 3:156,202,962...156,213,283
Ensembl chr 3:176,622,350...176,632,013

G

splA/ryanodine receptor domain and SOCS box containing 1

increases expression

ISO

dimethylarsinous acid results in increased expression of SPSB1 mRNA

NCBI chr 5:160,358,292...160,418,541
Ensembl chr 5:165,642,851...165,654,225

G

serine palmitoyltransferase, small subunit A

decreases expression

ISO

dimethylarsinous acid results in decreased expression of SPTSSA mRNA

NCBI chr 6:77,879,931...77,891,344
Ensembl chr 6:77,879,941...77,891,403

G

serine and arginine rich splicing factor 11

decreases expression

ISO

dimethylarsinous acid results in decreased expression of SRSF11 mRNA

NCBI chr 2:247,074,623...247,101,460
Ensembl chr 2:249,733,464...249,760,499

G

signal transducer and activator of transcription 1

increases expression

ISO

dimethylarsinous acid results in increased expression of STAT1 mRNA

NCBI chr 9:56,911,522...56,951,926
Ensembl chr 9:56,911,523...57,077,346

G

stanniocalcin 1

increases expression

ISO

dimethylarsinous acid results in increased expression of STC1 mRNA

NCBI chr15:50,709,439...50,720,093
Ensembl chr15:50,709,415...50,720,082

G

stanniocalcin 2

increases expression

ISO

dimethylarsinous acid results in increased expression of STC2 mRNA

NCBI chr10:16,251,046...16,260,815
Ensembl chr10:16,755,267...16,767,447

G

striatin 3

affects expression

ISO

dimethylarsinous acid affects the expression of STRN3 mRNA

NCBI chr 6:74,783,156...74,869,473
Ensembl chr 6:74,783,156...74,869,473

G

sulfotransferase family 1B member 1

decreases expression

ISO

dimethylarsinous acid results in decreased expression of SULT1B1 mRNA

NCBI chr14:20,492,763...20,505,491
Ensembl chr14:20,771,868...20,785,549

G

small ubiquitin-like modifier 1

multiple interactions

ISO

[monomethylarsonous acid co-treated with dimethylarsinous acid co-treated with Arsenic Trioxide] results in increased localization of SUMO1 protein

NCBI chr 9:61,078,790...61,108,697
Ensembl chr 9:68,572,911...68,602,890

G

tumor-associated calcium signal transducer 2

decreases expression

ISO

dimethylarsinous acid results in decreased expression of TACSTD2 mRNA

NCBI chr 4:98,037,620...98,039,320
Ensembl chr 4:98,033,251...98,039,323

G

transgelin

increases expression

ISO

dimethylarsinous acid results in increased expression of TAGLN mRNA

NCBI chr 8:46,224,939...46,230,413
Ensembl chr 8:55,121,301...55,127,563

G

transporter 1, ATP binding cassette subfamily B member

increases expression

ISO

dimethylarsinous acid results in increased expression of TAP1 mRNA

NCBI chr20:4,658,171...4,668,543
Ensembl chr20:4,658,172...4,668,810

G

transcription factor 12

decreases expression

ISO

dimethylarsinous acid results in decreased expression of TCF12 mRNA

NCBI chr 8:72,490,447...72,799,265
Ensembl chr 8:81,373,321...81,679,922

G

transcription factor CP2-like 1

decreases expression

ISO

dimethylarsinous acid results in decreased expression of TFCP2L1 mRNA

NCBI chr13:29,733,813...29,793,870
Ensembl chr13:32,286,643...32,346,671

G

transforming growth factor, beta 2

increases expression

ISO

dimethylarsinous acid results in increased expression of TGFB2 mRNA

PMID:19945496 PMID:20886546

NCBI chr13:100,691,540...100,793,227
Ensembl chr13:100,692,953...100,792,856

G

thrombomodulin

increases expression

ISO

dimethylarsinous acid results in increased expression of THBD mRNA

NCBI chr 3:156,316,526...156,320,178
Ensembl chr 3:156,306,632...156,320,582

G

thrombospondin 1

decreases expression

ISO

dimethylarsinous acid results in decreased expression of THBS1 mRNA

NCBI chr 3:125,510,250...125,525,402
Ensembl chr 3:125,510,250...125,525,402

G

thrombospondin 2

decreases expression

ISO

dimethylarsinous acid results in decreased expression of THBS2 mRNA

NCBI chr 1:64,343,523...64,372,918
Ensembl chr 1:64,343,523...64,372,918

G

TP53 induced glycolysis regulatory phosphatase

increases expression

ISO

dimethylarsinous acid results in increased expression of TIGAR mRNA

NCBI chr 4:159,927,136...159,946,077
Ensembl chr 4:161,613,306...161,632,229

G

toll-like receptor 4

increases expression

ISO

dimethylarsinous acid results in increased expression of TLR4 mRNA

NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007

G

transmembrane p24 trafficking protein 2

increases expression

ISO

dimethylarsinous acid results in increased expression of TMED2 mRNA

NCBI chr12:32,052,542...32,061,628
Ensembl chr12:37,713,529...37,722,606

G

transmembrane protein 158

increases expression

ISO

dimethylarsinous acid results in increased expression of TMEM158 mRNA

NCBI chr 8:122,913,675...122,914,673
Ensembl chr 8:131,787,277...131,796,882

G

transmembrane protein 44

decreases expression

ISO

dimethylarsinous acid results in decreased expression of TMEM44 mRNA

NCBI chr11:70,181,120...70,216,958
Ensembl chr11:83,686,015...83,721,859

G

transmembrane protein 50B

decreases expression

ISO

dimethylarsinous acid results in decreased expression of TMEM50B mRNA

NCBI chr11:30,804,835...30,837,675
Ensembl chr11:44,290,807...44,323,607

G

transmembrane protein 80

decreases expression

ISO

dimethylarsinous acid results in decreased expression of TMEM80 mRNA

NCBI chr 1:196,435,999...196,444,368
Ensembl chr 1:205,864,852...205,873,933

G

tumor necrosis factor

increases expression
increases secretion
multiple interactions

ISO

dimethylarsinous acid results in increased expression of TNF mRNA
dimethylarsinous acid results in increased secretion of TNF protein
Lipopolysaccharides inhibits the reaction [dimethylarsinous acid results in increased expression of TNF mRNA]; Lipopolysaccharides inhibits the reaction [dimethylarsinous acid results in increased secretion of TNF protein]

PMID:23487506 PMID:24140498

NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303

G

tumor protein p53 inducible nuclear protein 1

increases expression

ISO

dimethylarsinous acid results in increased expression of TP53INP1 mRNA

NCBI chr 5:24,253,986...24,272,250
Ensembl chr 5:29,051,264...29,069,484

G

trio Rho guanine nucleotide exchange factor

increases expression

ISO

dimethylarsinous acid results in increased expression of TRIO mRNA

NCBI chr 2:78,505,069...78,801,384
Ensembl chr 2:80,235,485...80,531,612

G

tubulin gamma complex component 3

increases expression

ISO

dimethylarsinous acid results in increased expression of TUBGCP3 mRNA

NCBI chr16:76,851,859...76,912,499
Ensembl chr16:83,553,959...83,614,623

G

thioredoxin domain containing 17

decreases expression

ISO

dimethylarsinous acid results in decreased expression of TXNDC17 mRNA

NCBI chr10:56,832,749...56,835,721
Ensembl chr10:57,331,312...57,334,284

G

uveal autoantigen with coiled-coil domains and ankyrin repeats

decreases expression

ISO

dimethylarsinous acid results in decreased expression of UACA mRNA

NCBI chr 8:61,259,415...61,347,789
Ensembl chr 8:70,155,047...70,243,415

G

UDP glucuronosyltransferase family 1 member A6

increases expression

ISO

dimethylarsinous acid results in increased expression of UGT1A6 mRNA

NCBI chr 9:88,747,213...88,808,465
Ensembl chr 9:96,144,786...96,256,264

G

ubiquitin specific peptidase 36

increases expression

ISO

dimethylarsinous acid results in increased expression of USP36 mRNA

NCBI chr10:103,995,970...104,027,492
Ensembl chr10:103,995,970...104,023,450

G

versican

decreases expression

ISO

dimethylarsinous acid results in decreased expression of VCAN mRNA

NCBI chr 2:20,761,718...20,860,637
Ensembl chr 2:22,497,035...22,595,955

G

vestigial-like family member 3

increases expression

ISO

dimethylarsinous acid results in increased expression of VGLL3 mRNA

NCBI chr11:3,642,993...3,692,590
Ensembl chr11:17,089,597...17,138,937

G

very low density lipoprotein receptor

increases expression

ISO

dimethylarsinous acid results in increased expression of VLDLR mRNA

NCBI chr 1:234,239,769...234,272,150
Ensembl chr 1:234,240,121...234,272,154

G

WASP like actin nucleation promoting factor

decreases expression

ISO

dimethylarsinous acid results in decreased expression of WASL mRNA

NCBI chr 4:53,083,536...53,132,061
Ensembl chr 4:54,049,082...54,097,570

G

WD repeat domain 72

decreases expression

ISO

dimethylarsinous acid results in decreased expression of WDR72 mRNA

NCBI chr 8:74,838,338...75,020,938
Ensembl chr 8:83,718,914...83,900,286

G

WAP four-disulfide core domain 17

increases expression

ISO

dimethylarsinous acid results in increased expression of ANOS1 mRNA

NCBI chr10:68,561,954...68,562,801

G

XIAP associated factor 1

affects expression

ISO

dimethylarsinous acid affects the expression of XAF1 mRNA

NCBI chr10:56,917,378...56,929,791
Ensembl chr10:57,415,658...57,428,349

G

zinc finger CCHC-type containing 2

increases expression

ISO

dimethylarsinous acid results in increased expression of ZCCHC2 mRNA

NCBI chr13:22,118,677...22,193,626
Ensembl chr13:22,634,171...22,708,464

G

zinc finger protein 827

increases expression

ISO

dimethylarsinous acid results in increased expression of ZNF827 mRNA

NCBI chr19:28,720,568...28,887,381
Ensembl chr19:45,614,604...45,844,430

methylarsonic acid

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

alpha-2-macroglobulin-like 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of A2ML1 mRNA

NCBI chr 4:161,815,111...161,857,286
Ensembl chr 4:163,501,585...163,543,506

G

acetoacetyl-CoA synthetase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of AACS mRNA

NCBI chr12:36,774,471...36,817,835
Ensembl chr12:36,774,471...36,822,543

G

alanine and arginine rich domain containing protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of AARD mRNA

NCBI chr 7:83,364,478...83,369,319
Ensembl chr 7:85,253,992...85,259,163

G

ATP binding cassette subfamily B member 1A

increases expression

EXP

monomethylarsonic acid results in increased expression of ABCB1A mRNA; monomethylarsonic acid results in increased expression of ABCB1A protein

NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135

G

ATP binding cassette subfamily C member 1

increases expression
affects expression

EXP
ISO

monomethylarsonic acid results in increased expression of ABCC1 mRNA; monomethylarsonic acid results in increased expression of ABCC1 protein
monomethylarsonic acid affects the expression of ABCC1 mRNA

PMID:16436460 PMID:24091636

NCBI chr10:1,022,041...1,162,431
Ensembl chr10:1,038,947...1,162,404

G

ATP binding cassette subfamily C member 2

increases expression

EXP
ISO

monomethylarsonic acid results in increased expression of ABCC2 mRNA; monomethylarsonic acid results in increased expression of ABCC2 protein

PMID:16436460 PMID:24091636

NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:252,614,017...252,673,471

G

ATP binding cassette subfamily C member 3

increases expression

EXP

monomethylarsonic acid results in increased expression of ABCC3 mRNA; monomethylarsonic acid results in increased expression of ABCC3 protein

NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,793,583...79,839,494

G

ArfGAP with coiled-coil, ankyrin repeat and PH domains 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ACAP1 mRNA

NCBI chr10:54,605,323...54,619,472
Ensembl chr10:55,104,040...55,118,185

G

acyl-CoA thioesterase 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ACOT1 mRNA

NCBI chr 6:103,636,173...103,644,167
Ensembl chr 6:109,367,268...109,380,749

G

acyl-CoA thioesterase 12

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ACOT12 mRNA

NCBI chr 2:22,986,867...23,027,538
Ensembl chr 2:24,721,910...24,765,298

G

acyl-CoA oxidase 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ACOX2 mRNA

NCBI chr15:16,660,584...16,692,160
Ensembl chr15:19,090,926...19,122,392

G

acrosin binding protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ACRBP mRNA

NCBI chr 4:157,851,149...157,864,211
Ensembl chr 4:159,537,391...159,550,454

G

ADAM metallopeptidase with thrombospondin type 1 motif, 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ADAMTS4 mRNA

NCBI chr13:83,670,556...83,680,045
Ensembl chr13:86,202,642...86,212,514

G

ADAM metallopeptidase with thrombospondin type 1 motif, 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ADAMTS6 mRNA

NCBI chr 2:35,421,483...35,633,305
Ensembl chr 2:37,155,288...37,367,070

G

adhesion G protein-coupled receptor G1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ADGRG1 mRNA

NCBI chr19:10,009,983...10,047,138
Ensembl chr19:10,010,031...10,047,124

G

adrenomedullin

multiple interactions
increases expression

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ADM mRNA
monomethylarsonic acid results in increased expression of ADM mRNA

PMID:34876320 PMID:38630284

NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:174,178,773...174,182,371

G

adrenoceptor alpha 2B

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ADRA2B mRNA

NCBI chr 3:114,585,174...114,589,220
Ensembl chr 3:135,038,474...135,042,525

G

adrenoceptor beta 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ADRB1 mRNA

NCBI chr 1:255,771,962...255,774,973
Ensembl chr 1:265,766,079...265,849,237

G

adrenoceptor beta 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ADRB2 mRNA

NCBI chr18:57,912,760...57,914,802
Ensembl chr18:57,911,348...57,914,803

G

ALF transcription elongation factor 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of AFF3 mRNA

NCBI chr 9:40,399,099...40,856,716
Ensembl chr 9:47,894,903...48,353,000

G

alpha-fetoprotein

increases expression

ISO

monomethylarsonic acid results in increased expression of AFP mRNA

NCBI chr14:17,857,584...17,875,645
Ensembl chr14:17,857,584...17,875,649

G

anterior gradient 3, protein disulphide isomerase family member

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of AGR3 mRNA

NCBI chr 6:52,643,391...52,666,638
Ensembl chr 6:58,370,701...58,399,859

G

AT hook, DNA binding motif, containing 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of AHDC1 mRNA

NCBI chr 5:145,228,228...145,294,170
Ensembl chr 5:150,512,037...150,583,144

G

aryl hydrocarbon receptor

multiple interactions

ISO

AHR mutant form inhibits the reaction [monomethylarsonic acid results in increased expression of CYP1A1 protein]; monomethylarsonic acid results in decreased expression of and affects the localization of AHR protein

NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901

G

adenylate kinase 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of AK4 mRNA

NCBI chr 5:116,039,222...116,099,064
Ensembl chr 5:121,154,572...121,214,401

G

aldo-keto reductase family 1, member C3

increases expression

ISO

monomethylarsonic acid results in increased expression of AKR1C3 mRNA

NCBI chr17:71,020,884...71,037,779
Ensembl chr17:70,970,900...71,048,438

G

aldo-keto reductase family 7, member A2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of AKR7A5 mRNA

NCBI chr 5:151,552,375...151,560,914
Ensembl chr 5:156,835,551...156,844,109

G

AKT serine/threonine kinase 1

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of AKT1 mRNA

NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610

G

aldolase, fructose-bisphosphate C

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ALDOC mRNA

NCBI chr10:63,217,477...63,221,066
Ensembl chr10:63,715,489...63,719,133

G

alpha-kinase 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ALPK1 mRNA

NCBI chr 2:216,126,939...216,247,180
Ensembl chr 2:218,780,189...218,921,646

G

alkaline phosphatase, placental

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of AKP3 mRNA

NCBI chr 9:87,765,846...87,768,606
Ensembl chr 9:95,213,374...95,219,451

G

angiopoietin like 7

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ANGPTL7 mRNA

NCBI chr 5:158,932,096...158,937,281
Ensembl chr 5:164,215,223...164,220,584

G

ankyrin repeat domain 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ANKRD1 mRNA

NCBI chr 1:233,815,851...233,834,891
Ensembl chr 1:243,228,448...243,263,751

G

ANKRD40 C-terminal like

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ANKRD40CL mRNA

NCBI chr10:79,227,791...79,236,365
Ensembl chr10:79,728,105...79,732,218

G

annexin A8

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ANXA8 mRNA

NCBI chr16:9,397,144...9,412,072
Ensembl chr16:9,403,353...9,418,310

G

apolipoprotein L7A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of APOL7A mRNA

Ensembl chr 7:111,011,645...111,017,084

G

apolipoprotein L9a

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of APOL9A mRNA

NCBI chr 7:109,140,871...109,149,799
Ensembl chr 7:111,021,453...111,028,213

G

aquaporin 3 (Gill blood group)

decreases expression

ISO

monomethylarsonic acid results in decreased expression of AQP3 mRNA

NCBI chr 5:61,035,165...61,040,683
Ensembl chr 5:61,035,166...61,040,685

G

amphiregulin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of AREG mRNA

NCBI chr14:17,256,384...17,265,641
Ensembl chr14:17,256,384...17,265,641

G

Rho GTPase activating protein 15

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ARHGAP15 mRNA

NCBI chr 3:27,989,368...28,592,722
Ensembl chr 3:48,382,904...49,011,378

G

Rho GTPase activating protein 25

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ARHGAP25 mRNA

NCBI chr 4:119,896,844...119,974,982
Ensembl chr 4:121,454,151...121,552,913

G

Rho GTPase activating protein 30

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ARHGAP30 mRNA

NCBI chr13:83,822,290...83,843,634
Ensembl chr13:86,354,547...86,376,888

G

Rho GTPase activating protein 45

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ARHGAP45 mRNA

NCBI chr 7:10,325,515...10,340,955
Ensembl chr 7:10,325,539...10,341,890

G

Rho GTPase activating protein 8

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ARHGAP8 mRNA

NCBI chr 7:115,842,223...115,902,094
Ensembl chr 7:117,730,578...117,782,030

G

Rho GDP dissociation inhibitor beta

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ARHGDIB mRNA

NCBI chr 4:169,822,951...169,841,884
Ensembl chr 4:171,554,140...171,573,068

G

Rho guanine nucleotide exchange factor 38

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ARHGEF38 mRNA

NCBI chr 2:221,610,212...221,739,841
Ensembl chr 2:224,284,238...224,413,974

G

ARF like GTPase 5C

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ARL5C mRNA

NCBI chr10:82,985,213...82,993,425
Ensembl chr10:83,481,540...83,488,406

G

ARF like GTPase 9

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ARL9 mRNA

NCBI chr14:31,157,573...31,166,803
Ensembl chr14:31,511,330...31,520,988

G

arsenite methyltransferase

increases metabolic processing
increases expression
multiple interactions
increases chemical synthesis

ISO

AS3MT protein polymorphism results in increased metabolism of monomethylarsonic acid; AS3MT protein results in increased metabolism of monomethylarsonic acid
monomethylarsonic acid results in increased expression of AS3MT protein
[AS3MT gene polymorphism affects the susceptibility to Arsenic] which results in increased abundance of monomethylarsonic acid; [AS3MT protein polymorphism results in increased metabolism of arsenite] which results in increased chemical synthesis of monomethylarsonic acid; [AS3MT protein polymorphism results in increased metabolism of monomethylarsonic acid] which results in increased chemical synthesis of Cacodylic Acid; [AS3MT protein polymorphism results in increased metabolism of monomethylarsonic acid] which results in increased chemical synthesis of dimethylarsinous acid; [AS3MT protein results in increased metabolism of arsenite] which results in increased chemical synthesis of monomethylarsonic acid; [AS3MT protein results in increased metabolism of monomethylarsonic acid] which results in increased chemical synthesis of Cacodylic Acid; [AS3MT protein results in increased metabolism of monomethylarsonic acid] which results in increased chemical synthesis of dimethylarsinous acid
AS3MT protein results in increased chemical synthesis of monomethylarsonic acid

PMID:22005461 PMID:22868225 PMID:24845704 PMID:36399430

NCBI chr 1:245,595,939...245,628,921
Ensembl chr 1:255,537,109...255,569,249

G

ankyrin repeat and SOCS box-containing 14

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ASB14 mRNA

NCBI chr16:2,095,567...2,123,259
Ensembl chr16:2,102,363...2,130,590

G

ankyrin repeat and SOCS box-containing 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ASB4 mRNA

NCBI chr 4:33,506,992...33,544,630
Ensembl chr 4:34,473,408...34,512,888

G

aspartic peptidase, retroviral-like 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ASPRV1 mRNA

NCBI chr 4:119,077,415...119,078,887
Ensembl chr 4:120,634,793...120,636,260

G

activating transcription factor 3

multiple interactions
increases expression

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ATF3 mRNA
monomethylarsonic acid results in increased expression of ATF3 mRNA; monomethylarsonic acid results in increased expression of ATF3 protein

PMID:34876320 PMID:38630284

NCBI chr13:102,751,278...102,800,520
Ensembl chr13:105,282,440...105,295,750

G

activating transcription factor 7 interacting protein 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ATF7IP2 mRNA

NCBI chr10:5,403,099...5,445,989
Ensembl chr10:5,909,658...5,952,995

G

ATPase phospholipid transporting 10D (putative)

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ATP10D mRNA

NCBI chr14:35,911,728...36,012,549
Ensembl chr14:36,265,696...36,366,460

G

ATPase copper transporting beta

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ATP7B mRNA

NCBI chr16:76,654,725...76,726,092
Ensembl chr16:76,653,660...76,728,801

G

Beta-1,3-galactosyltransferase 5

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of B3GALT5 mRNA

NCBI chr11:35,584,273...35,630,922
Ensembl chr11:49,006,560...49,101,283

G

UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of B3GNT5 mRNA

NCBI chr11:81,141,102...81,153,206
Ensembl chr11:94,645,480...94,660,514

G

B-cell scaffold protein with ankyrin repeats 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of BANK1 mRNA

NCBI chr 2:227,203,998...227,474,008
Ensembl chr 2:227,203,998...227,474,037

G

Btg3 associated nuclear protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of BANP mRNA

NCBI chr19:66,916,417...66,994,286
Ensembl chr19:66,916,267...66,991,317

G

BCL6 co-repressor-like 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of BCORL1 mRNA

NCBI chr X:132,394,703...132,462,414
Ensembl chr X:132,397,069...132,461,976

G

bifunctional apoptosis regulator

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of BFAR mRNA

NCBI chr10:1,552,019...1,585,040
Ensembl chr10:2,059,058...2,094,183

G

basic helix-loop-helix family, member e41

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of BHLHE41 mRNA

NCBI chr 4:178,834,264...178,838,618
Ensembl chr 4:180,565,003...180,569,355

G

BLK proto-oncogene, Src family tyrosine kinase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of BLK mRNA

NCBI chr15:41,802,701...41,841,004
Ensembl chr15:41,802,994...41,840,982

G

basic helix-loop-helix ARNT like 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of BMAL1 mRNA

NCBI chr 1:167,331,756...167,430,235
Ensembl chr 1:176,829,305...176,864,739

G

Bri3 binding protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of BRI3BP mRNA

NCBI chr12:31,176,742...31,188,563
Ensembl chr12:36,838,098...36,849,919

G

bromodomain and WD repeat domain containing 3

increases expression

ISO

monomethylarsonic acid results in increased expression of BRWD3 mRNA

NCBI chr X:73,768,343...73,861,643
Ensembl chr X:77,848,982...77,937,745

G

Bruton tyrosine kinase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of BTK mRNA

NCBI chr X:102,016,070...102,055,448
Ensembl chr X:102,016,074...102,055,143

G

B and T lymphocyte associated

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of BTLA mRNA

NCBI chr11:55,563,683...55,588,187
Ensembl chr11:69,052,644...69,093,224

G

C1q and TNF related 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of C1QTNF3 mRNA

NCBI chr 2:59,917,099...59,939,519
Ensembl chr 2:61,644,276...61,666,559

G

similar to human chromosome 19 open reading frame 38

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of AB124611 mRNA

NCBI chr 8:20,061,494...20,095,705
Ensembl chr 8:28,354,725...28,371,804

G

calcium voltage-gated channel subunit alpha1 I

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CACNA1I mRNA

NCBI chr 7:111,835,996...111,947,418
Ensembl chr 7:113,716,266...113,827,670

G

calcium/calmodulin-dependent protein kinase IG

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CAMK1G mRNA

NCBI chr13:104,877,909...104,901,658
Ensembl chr13:107,406,584...107,430,230

G

calpain 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CAPN3 mRNA

NCBI chr 3:107,407,518...107,457,858
Ensembl chr 3:127,861,589...127,911,638

G

caspase recruitment domain family, member 11

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CARD11 mRNA

NCBI chr12:18,735,088...18,872,045
Ensembl chr12:18,735,088...18,872,045

G

capping protein regulator and myosin 1 linker 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CARMIL2 mRNA

NCBI chr19:50,481,911...50,496,672
Ensembl chr19:50,484,324...50,496,669

G

caspase 3

affects response to substance
multiple interactions
increases expression

EXP
ISO

CASP3 protein affects the susceptibility to monomethylarsonic acid
[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of CASP3 mRNA
monomethylarsonic acid results in increased expression of CASP3 mRNA
[monomethylarsonic acid co-treated with Buthionine Sulfoximine] results in increased activity of CASP3 protein

PMID:15963344 PMID:17481689 PMID:23192986

NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732

G

catalase

multiple interactions

EXP

[CAT protein results in decreased oxidation of monomethylarsonous acid] which results in decreased chemical synthesis of monomethylarsonic acid

NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526

G

cation channel, sperm associated 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CATSPER4 mRNA

NCBI chr 5:146,427,682...146,447,346
Ensembl chr 5:151,711,194...151,730,750

G

coiled-coil domain containing 122

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CCDC122 mRNA

NCBI chr15:52,407,717...52,470,163
Ensembl chr15:58,816,873...58,879,592

G

coiled-coil domain containing 162

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CCDC162 mRNA

NCBI chr20:45,044,891...45,237,905
Ensembl chr20:46,627,277...46,818,249

G

coiled-coil domain containing 71-like

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CCDC71L mRNA

NCBI chr 6:48,960,020...48,964,112
Ensembl chr 6:54,617,540...55,014,344

G

coiled-coil domain containing 78

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CCDC78 mRNA

NCBI chr10:14,808,355...14,812,284
Ensembl chr10:15,311,868...15,319,425

G

coiled-coil domain containing 87

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CCDC87 mRNA

NCBI chr 1:202,135,021...202,137,717
Ensembl chr 1:211,475,789...211,568,008

G

coiled-coil domain containing 88C

decreases expression

ISO

monomethylarsonic acid results in decreased expression of CCDC88C mRNA

NCBI chr 6:125,899,337...126,019,162
Ensembl chr 6:125,899,526...126,018,865

G

coiled-coil domain containing 92B

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CCDC92B mRNA

NCBI chr10:59,479,798...59,501,486
Ensembl chr10:59,978,203...59,999,887

G

C-C motif chemokine ligand 22

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CCL22 mRNA

NCBI chr19:10,257,602...10,264,373
Ensembl chr19:10,263,589...10,270,359

G

cellular communication network factor 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CCN1 mRNA

NCBI chr 2:237,222,730...237,225,689
Ensembl chr 2:237,222,432...237,225,883

G

cyclin D1

increases expression

EXP

monomethylarsonic acid results in increased expression of CCND1 mRNA

NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810

G

cyclin E1

increases expression

EXP

monomethylarsonic acid results in increased expression of CCNE1 mRNA

NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:99,918,674...99,927,822

G

C-C motif chemokine receptor 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CCR6 mRNA

NCBI chr 1:52,474,477...52,508,301
Ensembl chr 1:55,021,833...55,046,059

G

C-C motif chemokine receptor 7

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CCR7 mRNA

NCBI chr10:84,594,399...84,604,514
Ensembl chr10:84,593,594...84,604,501

G

CD180 molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD180 mRNA

NCBI chr 2:33,855,940...33,870,046
Ensembl chr 2:35,589,451...35,603,982

G

Cd2 molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD2 mRNA

NCBI chr 2:191,399,510...191,412,659
Ensembl chr 2:191,399,510...191,413,665

G

CD22 molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD22 mRNA

NCBI chr 1:95,243,785...95,270,430
Ensembl chr 1:95,244,868...95,259,730

G

Cd28 molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD28 mRNA

NCBI chr 9:69,660,316...69,689,192
Ensembl chr 9:69,545,326...69,689,192

G

CD37 molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD37 mRNA

NCBI chr 1:95,719,171...95,724,662
Ensembl chr 1:104,849,166...104,861,276

G

CD40 molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD40 mRNA

NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:174,209,719...174,224,847

G

CD46 molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD46 mRNA

NCBI chr13:109,104,122...109,134,903

G

Cd5 molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD5 mRNA

NCBI chr 1:216,790,245...216,811,209
Ensembl chr 1:216,790,245...216,811,209

G

CD52 molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD52 mRNA

NCBI chr 5:146,319,789...146,321,348
Ensembl chr 5:151,603,524...151,605,086

G

Cd53 molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD53 mRNA

NCBI chr 2:194,352,139...194,399,668
Ensembl chr 2:197,040,369...197,218,593

G

Cd6 molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD6 mRNA

NCBI chr 1:216,867,767...216,906,642
Ensembl chr 1:216,867,771...216,879,432

G

Cd69 molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD69 mRNA

NCBI chr 4:162,725,446...162,733,364
Ensembl chr 4:164,411,485...164,419,509

G

CD79a molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD79A mRNA

NCBI chr 1:89,621,460...89,625,813
Ensembl chr 1:89,621,460...89,625,812

G

CD79b molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD79B mRNA

NCBI chr10:91,739,134...91,742,312
Ensembl chr10:91,739,137...91,742,405

G

CD83 molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD83 mRNA

NCBI chr17:20,887,309...20,907,009
Ensembl chr17:21,093,281...21,113,047

G

CD84 molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD84 mRNA

NCBI chr13:86,859,979...86,899,984
Ensembl chr13:86,859,990...86,894,318

G

CD86 molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD86 mRNA

NCBI chr11:77,647,565...77,706,178
Ensembl chr11:77,647,600...77,725,361

G

cell division cycle 25B

decreases activity

ISO

monomethylarsonic acid results in decreased activity of CDC25B protein

NCBI chr 3:138,860,148...138,870,287
Ensembl chr 3:138,860,130...138,870,492

G

CDC42 effector protein 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CDC42EP2 mRNA

NCBI chr 1:212,631,317...212,640,231
Ensembl chr 1:212,629,881...212,640,234

G

cadherin 1

increases expression

EXP

monomethylarsonic acid results in increased expression of CDH1 mRNA

NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565

G

cadherin 2

increases expression

EXP

monomethylarsonic acid results in increased expression of CDH2 mRNA

NCBI chr18:8,051,097...8,265,288
Ensembl chr18:8,051,097...8,265,288

G

cyclin dependent kinase like 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CDKL1 mRNA

NCBI chr 6:93,960,157...94,005,207
Ensembl chr 6:93,959,911...94,006,115

G

cyclin-dependent kinase inhibitor 1A

decreases expression
multiple interactions

EXP
ISO

monomethylarsonic acid results in decreased expression of CDKN1A mRNA
[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of CDKN1A mRNA

PMID:17481689 PMID:23192986

NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969

G

CECR2, histone acetyl-lysine reader

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CECR2 mRNA

NCBI chr 4:153,890,310...153,998,078
Ensembl chr 4:155,562,727...155,666,741

G

carboxylesterase 2F

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CES2F mRNA

NCBI chr19:7,527...14,898
Ensembl chr19:13,987...21,358

G

cilia and flagella associated protein 47

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CFAP47 mRNA

NCBI chr X:43,264,687...43,616,607
Ensembl chr X:47,149,334...47,504,257

G

ChaC glutathione-specific gamma-glutamylcyclotransferase 1

increases expression

ISO

monomethylarsonic acid results in increased expression of CHAC1 mRNA

NCBI chr 3:126,796,131...126,799,352
Ensembl chr 3:126,796,024...126,799,361

G

chondroadherin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CHAD mRNA

NCBI chr10:79,512,170...79,515,941
Ensembl chr10:80,008,767...80,012,816

G

cysteine and histidine rich domain containing 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CHORDC1 mRNA

NCBI chr 8:15,374,356...15,398,436
Ensembl chr 8:23,650,865...23,677,696

G

cholinergic receptor nicotinic alpha 9 subunit

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CHRNA9 mRNA

NCBI chr14:42,235,218...42,241,939
Ensembl chr14:42,588,948...42,595,669

G

carbohydrate sulfotransferase 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CHST3 mRNA

NCBI chr20:28,114,386...28,152,046
Ensembl chr20:28,657,308...28,694,526

G

circadian associated repressor of transcription

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CIART mRNA

NCBI chr 2:186,108,744...186,113,778
Ensembl chr 2:186,108,752...186,112,246

G

class II, major histocompatibility complex, transactivator

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CIITA mRNA

NCBI chr10:5,139,947...5,187,493
Ensembl chr10:5,647,085...5,694,342

G

cartilage intermediate layer protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CILP mRNA

NCBI chr 8:65,777,281...65,792,251
Ensembl chr 8:74,671,534...74,687,409

G

cold inducible RNA binding protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CIRBP mRNA

NCBI chr 7:10,184,515...10,189,623

G

Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2

increases expression

ISO

monomethylarsonic acid results in increased expression of CITED2 mRNA

NCBI chr 1:14,132,303...14,134,746
Ensembl chr 1:14,103,457...14,134,782

G

chloride channel accessory 4

decreases expression

ISO

monomethylarsonic acid results in decreased expression of CLCA4 mRNA

NCBI chr 2:233,883,625...233,904,993
Ensembl chr 2:236,544,201...236,563,435

G

cardiotrophin-like cytokine factor 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CLCF1 mRNA

NCBI chr 1:201,507,763...201,517,607
Ensembl chr 1:210,937,255...210,947,064

G

C-type lectin domain containing 7A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CLEC7A mRNA

NCBI chr 4:162,902,731...162,913,931
Ensembl chr 4:164,588,754...164,599,919

G

clusterin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CLU mRNA

NCBI chr15:44,336,619...44,375,861
Ensembl chr15:44,359,914...44,375,860

G

cannabinoid receptor 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CNR2 mRNA

NCBI chr 5:153,408,968...153,435,092
Ensembl chr 5:153,409,147...153,435,961

G

cochlin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of COCH mRNA

NCBI chr 6:74,766,485...74,780,504
Ensembl chr 6:74,766,419...74,780,502

G

collagen type XI alpha 2 chain

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of COL11A2 mRNA

NCBI chr20:4,788,829...4,818,492
Ensembl chr20:4,788,829...4,817,648

G

collagen type VII alpha 1 chain

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of COL7A1 mRNA

NCBI chr 8:109,604,877...109,637,249
Ensembl chr 8:118,483,364...118,517,439

G

collagen like tail subunit of asymmetric acetylcholinesterase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of COLQ mRNA

NCBI chr16:6,731,850...6,824,973
Ensembl chr16:6,738,251...6,793,501

G

coronin 1A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CORO1A mRNA

NCBI chr 1:190,726,129...190,731,133
Ensembl chr 1:190,726,130...190,731,102

G

coactosin-like F-actin binding protein 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of COTL1 mRNA

NCBI chr19:64,780,309...64,814,629
Ensembl chr19:64,780,322...64,814,840

G

cleavage and polyadenylation specific factor 4-like

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CPSF4L mRNA

NCBI chr10:98,741,816...98,756,069
Ensembl chr10:99,242,794...99,257,172

G

carboxypeptidase X (M14 family), member 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CPXM1 mRNA

NCBI chr 3:117,588,532...117,595,330
Ensembl chr 3:138,041,645...138,048,857

G

complement C3d receptor 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CR2 mRNA

NCBI chr13:106,678,579...106,716,595
Ensembl chr13:109,213,867...109,244,552

G

CDP-L-ribitol pyrophosphorylase A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CRPPA mRNA

NCBI chr 6:53,120,264...53,397,030
Ensembl chr 6:58,848,621...59,181,406

G

cytotoxic and regulatory T cell molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CRTAM mRNA

NCBI chr 8:50,237,210...50,274,472
Ensembl chr 8:50,237,210...50,274,472

G

cryptochrome circadian regulator 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CRY1 mRNA

NCBI chr 7:18,529,823...18,594,092
Ensembl chr 7:20,417,107...20,481,822

G

cysteine and serine rich nuclear protein 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CSRNP2 mRNA

NCBI chr 7:131,594,232...131,610,075
Ensembl chr 7:133,473,027...133,488,868

G

catenin alpha 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CTNNA3 mRNA

NCBI chr20:23,614,469...25,200,026
Ensembl chr20:23,613,016...25,198,805

G

C-X-C motif chemokine ligand 10

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CXCL10 mRNA

NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261

G

C-X-C motif chemokine ligand 9

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CXCL9 mRNA

NCBI chr14:16,007,166...16,012,077
Ensembl chr14:16,007,204...16,014,299

G

cytochrome b-245 beta chain

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CYBB mRNA

NCBI chr X:16,030,596...16,065,065
Ensembl chr X:16,030,596...16,065,065

G

cytochrome P450, family 1, subfamily a, polypeptide 1

multiple interactions
increases expression

ISO

AHR mutant form inhibits the reaction [monomethylarsonic acid results in increased expression of CYP1A1 protein]; monomethylarsonic acid promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A1 protein]; monomethylarsonic acid promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; monomethylarsonic acid results in increased expression of and results in increased activity of CYP1A1 protein
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CYP1A1 mRNA
monomethylarsonic acid results in increased expression of CYP1A1 mRNA

PMID:24161444 PMID:34876320

NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012

G

cytochrome P450, family 1, subfamily a, polypeptide 2

increases expression

EXP

monomethylarsonic acid results in increased expression of CYP1A2 mRNA

NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149

G

cytochrome P450, family 2, subfamily b, polypeptide 1

multiple interactions
increases expression

EXP

[monomethylarsonic acid co-treated with Diethylnitrosamine] results in increased expression of CYP2B1 mRNA; [monomethylarsonic acid co-treated with Diethylnitrosamine] results in increased expression of CYP2B1 protein
monomethylarsonic acid results in increased expression of CYP2B1 mRNA

PMID:12115560 PMID:17481689

NCBI chr 1:81,518,387...81,544,999

G

cytochrome P450, family 2, subfamily b, polypeptide 2

multiple interactions

EXP

[monomethylarsonic acid co-treated with Diethylnitrosamine] results in increased expression of CYP2B2 mRNA

NCBI chr 1:90,722,243...90,736,272

G

cytochrome P450, subfamily 2, polypeptide 11

increases expression

EXP

monomethylarsonic acid results in increased expression of CYP2C11 mRNA

NCBI chr 1:246,175,216...246,211,445
Ensembl chr 1:246,174,711...246,211,853

G

cytochrome P450, family 4, subfamily f, polypeptide 18

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CYP4F18 mRNA

NCBI chr16:17,763,543...17,804,944
Ensembl chr16:17,740,001...17,838,958

G

DAB adaptor protein 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DAB1 mRNA

NCBI chr 5:123,621,510...124,742,585
Ensembl chr 5:124,369,415...124,742,584

G

D-box binding PAR bZIP transcription factor

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DBP mRNA

NCBI chr 1:96,175,796...96,180,745
Ensembl chr 1:105,312,108...105,317,205

G

doublecortin-like kinase 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DCLK3 mRNA

NCBI chr 8:111,401,544...111,453,999
Ensembl chr 8:120,279,757...120,332,432

G

damage specific DNA binding protein 2

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of DDB2 mRNA

NCBI chr 3:77,185,114...77,207,650
Ensembl chr 3:97,640,579...97,664,066

G

DNA-damage inducible transcript 3

increases expression

ISO

monomethylarsonic acid results in increased expression of DDIT3 protein

NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509

G

DEF6 guanine nucleotide exchange factor

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DEF6 mRNA

NCBI chr20:6,268,579...6,290,030
Ensembl chr20:6,269,357...6,291,771

G

defensin alpha 5

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DEFA21 mRNA

NCBI chr16:77,044,994...77,047,318
Ensembl chr16:77,044,994...77,047,318

G

7-dehydrocholesterol reductase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DHCR7 mRNA

NCBI chr 1:208,444,434...208,460,408
Ensembl chr 1:208,444,434...208,461,382

G

dehydrogenase/reductase 11

decreases expression

ISO

monomethylarsonic acid results in decreased expression of DHRS11 mRNA

NCBI chr10:69,698,214...69,708,294
Ensembl chr10:70,195,637...70,205,893

G

dehydrogenase/reductase 9

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DHRS9 mRNA

NCBI chr 3:54,147,834...54,170,052
Ensembl chr 3:74,555,606...74,581,376

G

DIRAS family GTPase 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DIRAS2 mRNA

NCBI chr17:12,730,040...12,761,511
Ensembl chr17:12,880,385...12,914,291

G

dynein, axonemal, heavy chain 10

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DNAH10 mRNA

NCBI chr12:31,823,451...31,946,857
Ensembl chr12:37,472,813...37,640,860

G

dynein axonemal intermediate chain 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DNAI4 mRNA

NCBI chr 5:117,787,398...117,876,216
Ensembl chr 5:123,016,480...123,105,283

G

DnaJ heat shock protein family (Hsp40) member B13

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DNAJB13 mRNA

NCBI chr 1:164,260,716...164,275,172
Ensembl chr 1:164,260,724...164,275,093

G

DnaJ heat shock protein family (Hsp40) member B3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DNAJB3 mRNA

NCBI chr 9:88,795,542...88,796,555
Ensembl chr 9:96,243,071...96,244,408

G

deoxyribonuclease 1 like 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DNASE1L2 mRNA

NCBI chr10:13,471,850...13,473,447
Ensembl chr10:13,976,012...13,978,366

G

deoxyribonuclease 1L3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DNASE1L3 mRNA

NCBI chr15:19,351,683...19,378,536
Ensembl chr15:19,352,493...19,378,531

G

DNA methyltransferase 1

decreases expression

EXP

monomethylarsonic acid results in decreased expression of DNMT1 mRNA

NCBI chr 8:27,716,797...27,763,405
Ensembl chr 8:27,716,797...27,763,119

G

dedicator of cytokinesis 10

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DOCK10 mRNA

NCBI chr 9:81,843,599...82,101,540
Ensembl chr 9:89,291,800...89,549,973

G

dedicator of cytokinesis 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DOCK2 mRNA

NCBI chr10:19,331,412...19,748,987
Ensembl chr10:19,331,412...19,748,969

G

docking protein 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DOK3 mRNA

NCBI chr17:9,109,633...9,115,188
Ensembl chr17:9,114,762...9,120,335

G

dopamine receptor D3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DRD3 mRNA

NCBI chr11:70,385,586...70,437,793
Ensembl chr11:70,385,586...70,446,760

G

dual oxidase 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DUOX2 mRNA

NCBI chr 3:129,680,543...129,698,886
Ensembl chr 3:129,680,546...129,699,203

G

dual oxidase maturation factor 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DUOXA1 mRNA

NCBI chr 3:129,703,416...129,714,110
Ensembl chr 3:129,703,416...129,706,829

G

dual oxidase maturation factor 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DUOXA2 mRNA

NCBI chr 3:129,698,938...129,702,656
Ensembl chr 3:129,698,092...129,702,656

G

dual specificity phosphatase 1

multiple interactions
increases expression

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DUSP1 mRNA
monomethylarsonic acid results in increased expression of DUSP1 mRNA

PMID:34876320 PMID:38630284

NCBI chr10:17,184,853...17,187,646
Ensembl chr10:17,184,823...17,187,644

G

dual specificity phosphatase 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DUSP2 mRNA

NCBI chr 3:114,556,325...114,558,510
Ensembl chr 3:135,009,590...135,011,809

G

dual specificity phosphatase 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DUSP6 mRNA

NCBI chr 7:35,979,502...35,983,834
Ensembl chr 7:35,977,921...35,983,833

G

ELL associated factor 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of EAF2 mRNA

NCBI chr11:77,465,585...77,509,993
Ensembl chr11:77,406,020...77,509,993

G

endothelin 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of EDN1 mRNA

NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687

G

ephrin A3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of EFNA3 mRNA

NCBI chr 2:177,026,928...177,035,838
Ensembl chr 2:177,026,933...177,044,843

G

early growth response 1

increases expression
multiple interactions

ISO

monomethylarsonic acid results in increased expression of EGR1 mRNA
[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of EGR1 mRNA

PMID:15345372 PMID:23192986

NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843

G

early growth response 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of EGR3 mRNA

NCBI chr15:45,150,335...45,156,052
Ensembl chr15:51,560,344...51,565,712

G

extracellular leucine-rich repeat and fibronectin type III domain containing 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ELFN2 mRNA

NCBI chr 7:110,220,293...110,272,770
Ensembl chr 7:112,074,331...112,153,451

G

endonuclease, poly(U)-specific

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ENDOU mRNA

NCBI chr 7:128,844,872...128,866,572
Ensembl chr 7:130,723,972...130,745,672

G

eomesodermin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of EOMES mRNA

NCBI chr 8:127,059,215...127,067,070
Ensembl chr 8:127,059,215...127,067,070

G

EPM2A glucan phosphatase, laforin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of EPM2A mRNA

NCBI chr 1:5,727,111...5,845,338
Ensembl chr 1:7,547,342...7,669,604

G

epiregulin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of EREG mRNA

NCBI chr14:17,311,485...17,325,260
Ensembl chr14:17,311,485...17,325,260

G

endogenous retrovirus group FRD member 1, envelope

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SYNA mRNA

NCBI chr12:22,151,211...22,158,264
Ensembl chr12:27,787,680...27,794,732

G

estrogen receptor 1

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of ESR1 mRNA

NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354

G

ethanolamine kinase 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ETNK2 mRNA

NCBI chr13:44,811,012...44,829,052
Ensembl chr13:47,363,060...47,381,100

G

ETS proto-oncogene 1, transcription factor

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ETS1 mRNA

NCBI chr 8:39,303,936...39,426,022
Ensembl chr 8:39,303,925...39,426,021

G

exophilin 5

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of EXPH5 mRNA

NCBI chr 8:53,698,825...53,775,371
Ensembl chr 8:62,595,116...62,671,575

G

fatty acid binding protein 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FABP1 mRNA

NCBI chr 4:104,744,302...104,753,119
Ensembl chr 4:104,744,309...104,753,113

G

fatty acid binding protein 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FABP3 mRNA

NCBI chr 5:142,651,962...142,658,707
Ensembl chr 5:147,936,119...147,942,881

G

fatty acid desaturase 3

increases expression

ISO

monomethylarsonic acid results in increased expression of FADS3 mRNA

NCBI chr 1:216,110,547...216,127,431
Ensembl chr 1:216,110,201...216,141,758

G

family with sequence similarity 151, member A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of FAM151A mRNA

NCBI chr 5:121,514,804...121,527,555
Ensembl chr 5:126,743,555...126,756,373

G

FAM161 centrosomal protein B

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of FAM161B mRNA

NCBI chr 6:103,990,603...104,007,754
Ensembl chr 6:109,722,569...109,750,036

G

family with sequence similarity 169, member B

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FAM169B mRNA

NCBI chr 1:121,878,670...121,968,272
Ensembl chr 1:131,288,799...131,370,145

G

family with sequence similarity 89, member A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FAM89A mRNA

NCBI chr19:52,710,002...52,722,630
Ensembl chr19:69,607,391...69,620,019

G

FA complementation group D2

multiple interactions

ISO

[monomethylarsonic acid results in decreased activity of FANCD2 protein] which results in increased susceptibility to diepoxybutane; [monomethylarsonic acid results in decreased activity of FANCD2 protein] which results in increased susceptibility to Hydroxyurea; [monomethylarsonic acid results in decreased activity of FANCD2 protein] which results in increased susceptibility to Mitomycin

NCBI chr 4:148,234,633...148,299,035
Ensembl chr 4:148,234,708...148,299,035

G

Fas cell surface death receptor

decreases expression

ISO

monomethylarsonic acid results in decreased expression of FAS mRNA

NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104

G

Fas ligand

increases expression

EXP

monomethylarsonic acid results in increased expression of FASLG mRNA

NCBI chr13:76,680,885...76,706,042
Ensembl chr13:76,688,243...76,695,503

G

fructose-bisphosphatase 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FBP1 mRNA

NCBI chr17:2,207,271...2,230,076
Ensembl chr17:2,213,492...2,235,746

G

F-box and leucine-rich repeat protein 22

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of FBXL22 mRNA

NCBI chr 8:67,069,998...67,076,685
Ensembl chr 8:75,965,027...75,971,714

G

F-box protein 24

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of FBXO24 mRNA

NCBI chr12:19,072,668...19,083,067
Ensembl chr12:24,709,468...24,719,848

G

Fc epsilon receptor II

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FCER2A mRNA

NCBI chr12:1,742,809...1,754,476
Ensembl chr12:6,540,703...6,549,374

G

Fc receptor-like A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FCRLA mRNA

NCBI chr13:83,160,453...83,170,170
Ensembl chr13:85,693,122...85,703,176

G

farnesyl diphosphate farnesyl transferase 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FDFT1 mRNA

NCBI chr15:37,412,143...37,440,198
Ensembl chr15:41,588,117...41,616,168

G

farnesyl diphosphate synthase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FDPS mRNA

NCBI chr 2:176,795,192...176,804,816
Ensembl chr 2:176,795,192...176,807,136

G

fer-1-like family member 5

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of FER1L5 mRNA

NCBI chr 9:38,605,835...38,661,869
Ensembl chr 9:46,103,760...46,156,479

G

free fatty acid receptor 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FFAR1 mRNA

NCBI chr 1:95,238,785...95,239,689
Ensembl chr 1:95,238,785...95,239,691

G

fibroblast growth factor 11

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of FGF11 mRNA

NCBI chr10:54,516,508...54,522,067
Ensembl chr10:55,016,411...55,020,454

G

fibroblast growth factor 2

increases expression

ISO

monomethylarsonic acid results in increased expression of FGF2 mRNA

NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:122,164,454...122,224,493

G

fibroblast growth factor binding protein 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FGFBP3 mRNA

NCBI chr 1:234,644,023...234,646,028
Ensembl chr 1:244,056,307...244,065,654

G

FGR proto-oncogene, Src family tyrosine kinase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FGR mRNA

NCBI chr 5:145,189,814...145,219,571
Ensembl chr 5:150,473,792...150,503,169

G

FKBP prolyl isomerase 5

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of FKBP5 mRNA

NCBI chr20:6,458,931...6,577,227
Ensembl chr20:6,458,940...6,543,118

G

flagellum associated containing coiled-coil domains 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FLACC1 mRNA

NCBI chr 9:60,315,581...60,343,692
Ensembl chr 9:67,809,739...67,837,793

G

Fli-1 proto-oncogene, ETS transcription factor

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FLI1 mRNA

NCBI chr 8:30,831,422...30,950,468
Ensembl chr 8:39,089,533...39,208,557

G

filamin C

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FLNC mRNA

NCBI chr 4:58,034,088...58,061,882
Ensembl chr 4:58,999,547...59,027,240

G

Fms related receptor tyrosine kinase 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FLT3 mRNA

NCBI chr12:12,660,035...12,735,584
Ensembl chr12:12,659,946...12,735,581

G

fibronectin type III domain containing 10

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FNDC10 mRNA

NCBI chr 5:166,299,587...166,311,477
Ensembl chr 5:171,580,033...171,595,399

G

Fos proto-oncogene, AP-1 transcription factor subunit

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of FOS mRNA
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of FOS mRNA

PMID:23192986 PMID:34876320

NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598

G

formyl peptide receptor 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of FPR1 mRNA

NCBI chr 1:58,745,019...58,756,776
Ensembl chr 1:67,421,313...67,422,520

G

fascin actin-bundling protein 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FSCN1 mRNA

NCBI chr12:16,710,601...16,723,734
Ensembl chr12:16,710,601...16,723,734

G

ferritin light chain 1

increases expression

ISO

monomethylarsonic acid results in increased expression of FTL mRNA

NCBI chr 1:95,936,387...95,938,234
Ensembl chr X:45,399,355...45,399,915
Ensembl chr 2:45,399,355...45,399,915
Ensembl chr 1:45,399,355...45,399,915

G

fucosyltransferase 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of FUT1 mRNA

NCBI chr 1:105,223,399...105,226,817
Ensembl chr 1:105,223,390...105,227,513

G

growth arrest and DNA-damage-inducible, alpha

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of GADD45A mRNA

NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:97,484,502...97,486,807

G

guanylate binding protein 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GBP4 mRNA

NCBI chr 2:233,978,163...233,992,124
Ensembl chr 2:233,978,486...233,992,120

G

guanylate binding protein family member 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GBP9 mRNA

NCBI chr14:4,730,286...4,756,508
Ensembl chr14:4,968,325...4,983,692
Ensembl chr14:4,968,325...4,983,692

G

GTP cyclohydrolase 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of GCH1 mRNA

NCBI chr15:22,884,006...22,917,412
Ensembl chr15:22,884,006...22,917,412

G

germinal center-associated, signaling and motility

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GCSAM mRNA

NCBI chr11:55,195,757...55,207,011
Ensembl chr11:68,660,438...68,669,584

G

growth differentiation factor 15

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GDF15 mRNA

NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,838,436...18,842,022

G

GTPase, IMAP family member 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GIMAP6 mRNA

NCBI chr 4:77,653,703...77,659,112
Ensembl chr 4:78,983,504...78,990,010

G

GTPase, IMAP family member 8

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GIMAP8 mRNA

NCBI chr 4:77,600,104...77,611,593
Ensembl chr 4:78,931,029...78,942,488

G

gap junction protein, beta 1

increases expression

EXP

monomethylarsonic acid results in increased expression of GJB1 mRNA

NCBI chr X:70,541,845...70,549,776
Ensembl chr X:70,541,862...70,549,843

G

GLI family zinc finger 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GLI1 mRNA

NCBI chr 7:65,042,237...65,054,888
Ensembl chr 7:65,042,237...65,054,540

G

glycine receptor, beta

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of GLRB mRNA

NCBI chr 2:166,134,616...166,207,498
Ensembl chr 2:168,432,736...168,505,614

G

G protein subunit alpha 15

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GNA15 mRNA

NCBI chr 7:8,184,632...8,205,508
Ensembl chr 7:8,835,357...8,856,268

G

G protein subunit alpha transducin 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GNAT1 mRNA

NCBI chr 8:108,350,935...108,355,671
Ensembl chr 8:117,229,575...117,234,311

G

G protein-coupled receptor 132

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GPR132 mRNA

NCBI chr 6:131,924,061...131,943,327
Ensembl chr 6:137,745,241...137,763,157

G

G protein-coupled receptor 141

decreases expression

ISO

monomethylarsonic acid results in decreased expression of GPR141 mRNA

NCBI chr17:45,117,818...45,180,053
Ensembl chr17:49,733,713...49,875,719

G

G protein-coupled receptor 157

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GPR157 mRNA

NCBI chr 5:160,550,703...160,566,432
Ensembl chr 5:165,833,673...165,851,280

G

G protein-coupled receptor 17

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of GPR17 mRNA

NCBI chr18:23,576,232...23,583,153
Ensembl chr18:23,850,107...23,857,702

G

G protein-coupled receptor 174

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GPR174 mRNA

NCBI chr X:72,355,452...72,396,146
Ensembl chr X:76,377,973...76,468,985

G

G protein-coupled receptor 179

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GPR179 mRNA

NCBI chr10:82,324,568...82,340,448
Ensembl chr10:82,821,113...82,836,833

G

G protein-coupled receptor 18

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GPR18 mRNA

NCBI chr15:98,997,427...99,001,177
Ensembl chr15:105,404,077...105,408,836

G

G protein-coupled receptor 183

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GPR183 mRNA

NCBI chr15:99,037,764...99,050,550
Ensembl chr15:105,437,561...105,466,977

G

G protein-coupled receptor 34

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GPR34 mRNA

NCBI chr X:9,104,829...9,113,796
Ensembl chr X:11,776,371...11,843,240

G

glutathione peroxidase 7

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of GPX7 mRNA

NCBI chr 5:123,145,151...123,153,141
Ensembl chr 5:128,372,875...128,381,725

G

GRAM domain containing 2A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GRAMD2A mRNA

NCBI chr 8:60,079,744...60,117,788
Ensembl chr 8:69,003,807...69,013,573

G

GRB2-related adaptor protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GRAP mRNA

NCBI chr10:46,298,965...46,352,057
Ensembl chr10:46,832,390...46,851,523

G

glutathione S-transferase alpha 2

increases expression
decreases expression

EXP
ISO

monomethylarsonic acid results in increased expression of GSTA2 mRNA
monomethylarsonic acid results in decreased expression of GSTA2 mRNA; monomethylarsonic acid results in decreased expression of GSTA2 protein

PMID:15345372 PMID:16436460 PMID:17481689

NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:88,064,616...88,077,092

G

glutathione S-transferase mu 1

increases expression

EXP

monomethylarsonic acid results in increased expression of GSTM1 mRNA; monomethylarsonic acid results in increased expression of GSTM1 protein

NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:198,338,008...198,343,569

G

glutathione S-transferase omega 1

multiple interactions
increases reduction

ISO

[GSTO1 protein results in increased metabolism of monomethylarsonic acid] which results in increased chemical synthesis of monomethylarsonous acid
GSTO1 protein results in increased reduction of monomethylarsonic acid

PMID:12928150 PMID:15929903

NCBI chr 1:246,721,089...246,731,228
Ensembl chr 1:256,662,531...256,676,167

G

glutathione S-transferase pi 1

increases expression

EXP

monomethylarsonic acid results in increased expression of GSTP1 mRNA; monomethylarsonic acid results in increased expression of GSTP2 mRNA; monomethylarsonic acid results in increased expression of GSTP2 protein

PMID:16436460 PMID:17481689

NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:210,767,237...210,769,705

G

glutathione S-transferase theta 1

affects methylation
multiple interactions

ISO

GSTT1 protein affects the methylation of monomethylarsonic acid
[GSTT1 gene polymorphism affects the metabolism of Arsenic] which affects the abundance of monomethylarsonic acid

PMID:17431481 PMID:32650499

NCBI chr20:12,856,068...12,873,020
Ensembl chr20:12,856,083...12,873,019

G

guanylate cyclase activator 1B

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of GUCA1B mRNA

NCBI chr 9:13,599,619...13,607,455
Ensembl chr 9:21,097,274...21,105,107

G

granzyme A

decreases expression

ISO

monomethylarsonic acid results in decreased expression of GZMA mRNA

NCBI chr 2:44,740,569...44,752,502
Ensembl chr 2:46,473,763...46,485,696

G

granzyme K

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GZMK mRNA

NCBI chr 2:46,573,997...46,582,015
Ensembl chr 2:46,573,997...46,582,015

G

3-hydroxyanthranilate 3,4-dioxygenase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HAAO mRNA

NCBI chr 6:16,598,325...16,617,590
Ensembl chr 6:16,598,087...16,617,356

G

hematopoietic cell specific Lyn substrate 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HCLS1 mRNA

NCBI chr11:77,322,873...77,346,333
Ensembl chr11:77,322,873...77,346,387

G

hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HCN2 mRNA

NCBI chr 7:10,620,422...10,639,457
Ensembl chr 7:10,620,422...10,639,457

G

histidine decarboxylase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HDC mRNA

NCBI chr 3:113,847,256...113,865,334
Ensembl chr 3:134,300,632...134,318,711

G

hedgehog acyltransferase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HHAT mRNA

NCBI chr13:104,024,507...104,283,580
Ensembl chr13:106,541,866...106,811,563

G

hematopoietically expressed homeobox

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HHEX mRNA

NCBI chr 1:244,602,945...244,608,532
Ensembl chr 1:244,602,825...244,608,604

G

hexokinase 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of HK2 mRNA

NCBI chr 4:115,234,509...115,283,530
Ensembl chr 4:116,792,258...116,841,275

G

3-hydroxy-3-methylglutaryl-CoA synthase 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HMGCS1 mRNA

NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:53,382,643...53,399,802

G

3-hydroxy-3-methylglutaryl-CoA synthase 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HMGCS2 mRNA

NCBI chr 2:185,875,609...185,903,505
Ensembl chr 2:188,547,767...188,592,242

G

heme oxygenase 1

increases expression
multiple interactions
decreases expression

ISO
EXP

monomethylarsonic acid results in increased expression of HMOX1 mRNA
[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of HMOX1 mRNA
monomethylarsonic acid results in decreased expression of HMOX1 mRNA

PMID:15345372 PMID:23192986 PMID:24091636

NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818

G

4-hydroxy-2-oxoglutarate aldolase 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HOGA1 mRNA

NCBI chr 1:240,856,991...240,884,243
Ensembl chr 1:250,806,255...250,833,869

G

hippocalcin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of HPCA mRNA

NCBI chr 5:146,739,978...146,750,961
Ensembl chr 5:146,739,978...146,749,983

G

heparan sulfate-glucosamine 3-sulfotransferase 3B1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of HS3ST3B1 mRNA

NCBI chr10:48,561,473...48,593,970
Ensembl chr10:49,060,693...49,093,185

G

heat shock transcription factor 2 binding protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HSF2BP mRNA

NCBI chr20:10,035,562...10,123,059
Ensembl chr20:10,035,263...10,121,826

G

heat shock protein family A (Hsp70) member 1A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of HSPA1A mRNA

NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,855,780...3,877,979

G

heat shock protein family A (Hsp70) member 1B

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of HSPA1B mRNA

NCBI chr20:3,859,756...3,863,800
Ensembl chr20:3,855,780...3,877,979

G

heat shock protein family A (Hsp70) member 8

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of HSPA8 mRNA

NCBI chr 8:50,080,514...50,084,376
Ensembl chr 8:50,080,199...50,084,372

G

heat shock protein family B (small) member 7

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HSPB7 mRNA

NCBI chr 5:153,727,782...153,731,268
Ensembl chr 5:159,010,629...159,014,243

G

heat shock protein family H (Hsp110) member 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of HSPH1 mRNA

NCBI chr12:5,390,916...5,410,224
Ensembl chr12:10,427,297...10,446,891

G

hydrogen voltage-gated channel 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HVCN1 mRNA

NCBI chr12:34,341,673...34,370,010
Ensembl chr12:40,001,498...40,042,020

G

intercellular adhesion molecule 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ICAM1 mRNA

NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617

G

inducible T-cell co-stimulator

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ICOS mRNA

NCBI chr 9:62,368,075...62,406,900
Ensembl chr 9:69,877,785...69,900,960

G

insulin-like growth factor 1 receptor

increases expression

EXP

monomethylarsonic acid results in increased expression of IGF1R mRNA

NCBI chr 1:130,959,787...131,248,664
Ensembl chr 1:130,959,997...131,248,664

G

insulin-like growth factor binding protein 1

increases expression

ISO

monomethylarsonic acid results in increased expression of IGFBP1 mRNA

NCBI chr14:86,261,277...86,266,344
Ensembl chr14:86,261,277...86,266,344

G

immunoglobulin heavy chain like 16

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of IGHV4-1 mRNA

NCBI chr 6:134,212,480...134,234,464

G

immunoglobulin kappa variable like, pseudogene 13

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IGKV1-133 mRNA

NCBI chr 4:96,968,574...96,969,477

G

IKAROS family zinc finger 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IKZF1 mRNA

NCBI chr14:90,468,696...90,556,522
Ensembl chr14:90,469,172...90,557,574

G

interleukin 10 receptor subunit alpha

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL10RA mRNA

NCBI chr 8:45,563,009...45,578,041
Ensembl chr 8:54,459,882...54,475,028

G

interleukin 13 receptor subunit alpha 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL13RA2 mRNA

NCBI chr X:115,814,620...115,886,080
Ensembl chr X:115,814,622...115,841,455

G

interleukin 20 receptor subunit beta

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL20RB mRNA

NCBI chr 8:100,979,085...101,010,829
Ensembl chr 8:109,854,012...109,889,363

G

interleukin 21 receptor

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL21R mRNA

NCBI chr 1:189,598,682...189,626,340
Ensembl chr 1:189,598,558...189,626,342

G

interleukin 22 receptor subunit alpha 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL22RA2 mRNA

NCBI chr 1:14,353,736...14,377,844
Ensembl chr 1:16,184,113...16,197,950

G

interleukin 27 receptor subunit alpha

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL27RA mRNA

NCBI chr19:24,109,963...24,121,977
Ensembl chr19:41,014,730...41,026,760

G

interleukin 36, beta

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL36B mRNA

NCBI chr 3:7,024,881...7,030,388
Ensembl chr 3:27,423,171...27,428,678

G

interleukin 5 receptor subunit alpha

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL5RA mRNA

NCBI chr 4:141,186,749...141,221,348
Ensembl chr 4:141,171,158...141,220,943

G

interleukin 7 receptor

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL7R mRNA

NCBI chr 2:60,179,561...60,204,937
Ensembl chr 2:60,181,382...60,211,027

G

interleukin 9 receptor

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL9R mRNA

NCBI chr10:15,431,706...15,444,144
Ensembl chr10:15,936,156...15,947,613

G

insulin 1

multiple interactions

ISO

monomethylarsonic acid inhibits the reaction [INS1 protein results in increased uptake of Glucose]

NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:261,186,119...261,186,682

G

insulin induced gene 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of INSIG1 mRNA

NCBI chr 4:8,049,339...8,057,812
Ensembl chr 4:8,049,556...8,057,778

G

interferon regulatory factor 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IRF4 mRNA

NCBI chr17:33,930,460...33,948,842
Ensembl chr17:33,930,471...33,948,730

G

integrin subunit alpha 10

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ITGA10 mRNA

NCBI chr 2:184,182,869...184,202,172
Ensembl chr 2:186,871,711...186,891,012

G

integrin subunit alpha 8

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ITGA8 mRNA

NCBI chr17:75,304,004...75,501,510
Ensembl chr17:80,213,143...80,410,633

G

integrin subunit alpha L

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ITGAL mRNA

NCBI chr 1:191,348,424...191,386,228
Ensembl chr 1:191,348,542...191,386,225

G

integrin subunit beta 8

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ITGB8 mRNA

NCBI chr 6:140,125,002...140,208,261
Ensembl chr 6:146,165,484...146,351,245

G

inter-alpha trypsin inhibitor, heavy chain 3

increases expression

EXP

monomethylarsonic acid results in increased expression of ITIH3 mRNA

NCBI chr16:6,101,922...6,117,154
Ensembl chr16:6,108,382...6,123,374

G

ITPRIP like 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ITPRIPL2 mRNA

NCBI chr 1:172,801,152...172,803,047
Ensembl chr 1:182,231,093...182,245,858

G

IZUMO1 receptor, JUNO

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IZUMO1R mRNA

NCBI chr 8:11,744,384...11,748,131
Ensembl chr 8:20,025,831...20,029,578

G

junction mediating and regulatory protein, p53 cofactor

increases expression

ISO

monomethylarsonic acid results in increased expression of JMY mRNA

NCBI chr 2:24,662,104...24,730,955
Ensembl chr 2:26,409,969...26,465,649

G

Jun proto-oncogene, AP-1 transcription factor subunit

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of JUN mRNA

NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285

G

potassium voltage-gated channel modifier subfamily G member 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KCNG1 mRNA

NCBI chr 3:156,960,717...156,992,877
Ensembl chr 3:177,392,031...177,411,507

G

potassium voltage-gated channel interacting protein 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KCNIP4 mRNA

NCBI chr14:61,380,699...62,531,399
Ensembl chr14:65,593,366...66,743,993

G

potassium inwardly-rectifying channel, subfamily J, member 13

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of KCNJ13 mRNA

NCBI chr 9:88,063,003...88,071,112
Ensembl chr 9:95,510,877...95,520,817

G

potassium two pore domain channel subfamily K member 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of KCNK6 mRNA

NCBI chr 1:84,525,613...84,533,948

G

kelch-like family member 30

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KLHL30 mRNA

NCBI chr 9:91,942,475...91,952,756
Ensembl chr 9:99,390,014...99,400,295

G

kelch-like family member 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KLHL6 mRNA

NCBI chr11:94,475,262...94,514,653
Ensembl chr11:94,475,262...94,514,623

G

killer cell lectin like receptor B1A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KLRB1 mRNA

NCBI chr 4:163,576,672...163,590,201
Ensembl chr 4:163,576,672...163,619,374

G

kynurenine 3-monooxygenase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KMO mRNA

NCBI chr13:90,089,340...90,121,108
Ensembl chr13:90,089,463...90,125,151

G

keratin 12

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KRT12 mRNA

NCBI chr10:84,370,803...84,378,103
Ensembl chr10:84,866,965...84,874,265

G

keratin 17

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KRT17 mRNA

NCBI chr10:85,178,673...85,183,392
Ensembl chr10:85,679,070...85,683,787

G

keratin 18

decreases expression

EXP

monomethylarsonic acid results in decreased expression of KRT18 mRNA

NCBI chr 7:135,036,168...135,039,844
Ensembl chr 7:135,035,982...135,039,848
Ensembl chr10:135,035,982...135,039,848

G

keratin 27

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KRT27 mRNA

NCBI chr10:84,298,684...84,303,967
Ensembl chr10:84,794,684...84,800,131

G

L3MBTL histone methyl-lysine binding protein 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of L3MBTL3 mRNA

NCBI chr 1:18,988,763...19,089,247
Ensembl chr 1:20,808,973...20,908,608

G

ladinin 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LAD1 mRNA

NCBI chr13:47,249,605...47,263,967
Ensembl chr13:49,800,472...49,815,709

G

leucyl-tRNA synthetase 2, mitochondrial

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LARS2 mRNA

NCBI chr 8:123,010,271...123,106,395
Ensembl chr 8:131,887,753...131,983,866

G

lymphocyte transmembrane adaptor 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LAX1 mRNA

NCBI chr13:45,134,825...45,145,381
Ensembl chr13:47,686,849...47,697,460

G

lymphocyte cytosolic protein 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LCP1 mRNA

NCBI chr15:56,846,375...56,954,090
Ensembl chr15:56,847,433...56,954,092

G

low density lipoprotein receptor

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LDLR mRNA

NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:28,546,146...28,570,675

G

lymphoid enhancer binding factor 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LEF1 mRNA

NCBI chr 2:222,340,541...222,453,931
Ensembl chr 2:222,340,704...222,453,929

G

galectin 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LGALS2 mRNA

NCBI chr 7:110,403,171...110,410,046
Ensembl chr 7:112,282,822...112,285,392

G

galectin 8

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of LGALS8 mRNA

NCBI chr17:62,716,368...62,744,272
Ensembl chr17:62,719,828...62,744,482

G

LHFPL tetraspan subfamily member 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of LHFPL2 mRNA

NCBI chr 2:25,281,771...25,428,128
Ensembl chr 2:27,016,700...27,162,859

G

lipase C, hepatic type

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LIPC mRNA

NCBI chr 8:80,390,470...80,516,463
Ensembl chr 8:80,390,471...80,516,285

G

lysophosphatidylcholine acyltransferase 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of LPCAT4 mRNA

NCBI chr 3:99,044,729...99,052,963
Ensembl chr 3:119,499,128...119,507,362

G

leupaxin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LPXN mRNA

NCBI chr 1:209,928,297...209,963,085
Ensembl chr 1:219,353,708...219,387,742

G

leucine rich repeat containing 31

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LRRC31 mRNA

NCBI chr 2:112,702,844...112,725,431
Ensembl chr 2:114,631,136...114,652,269

G

leucine-rich repeat kinase 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LRRK2 mRNA

NCBI chr 7:124,706,246...124,867,234
Ensembl chr 7:124,706,080...124,867,239

G

lanosterol synthase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LSS mRNA

NCBI chr20:12,091,138...12,118,858
Ensembl chr20:12,073,543...12,118,253

G

lymphotoxin alpha

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LTA mRNA

NCBI chr20:3,622,291...3,625,852
Ensembl chr20:3,623,527...3,625,533

G

lymphotoxin beta

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LTB mRNA

NCBI chr20:3,627,536...3,629,381
Ensembl chr20:3,632,210...3,634,054

G

leukotriene B4 receptor 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LTB4R2 mRNA

NCBI chr15:33,228,634...33,230,453
Ensembl chr15:33,228,634...33,230,453

G

lymphocyte antigen 6 family member D

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LY6D mRNA

NCBI chr 7:108,532,207...108,533,943
Ensembl chr 7:108,532,215...108,533,716

G

lymphocyte antigen 6 family member G6C

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of LY6G6C mRNA

NCBI chr20:3,753,632...3,757,205
Ensembl chr20:3,758,290...3,762,927

G

lymphocyte antigen 9

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LY9 mRNA

NCBI chr13:84,079,345...84,100,783
Ensembl chr13:86,611,784...86,657,293

G

LYL1, basic helix-loop-helix family member

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LYL1 mRNA

NCBI chr19:23,452,140...23,455,007
Ensembl chr19:40,354,819...40,359,834

G

mitogen-activated protein kinase kinase kinase 19

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MAP3K19 mRNA

NCBI chr13:41,852,633...41,896,078
Ensembl chr13:41,852,531...41,895,565

G

mitogen-activated protein kinase kinase kinase 9

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MAP3K9 mRNA

NCBI chr 6:101,423,754...101,488,822
Ensembl chr 6:107,161,534...107,220,061

G

mitogen activated protein kinase kinase kinase kinase 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MAP4K1 mRNA

NCBI chr 1:84,270,951...84,292,496
Ensembl chr 1:93,398,454...93,419,993

G

mitogen activated protein kinase 1

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of MAPK1 mRNA

NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825

G

mitogen-activated protein kinase 15

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MAPK15 mRNA

NCBI chr 7:109,575,619...109,595,339
Ensembl chr 7:109,575,561...109,595,346

G

melanin-concentrating hormone receptor 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MCHR1 mRNA

NCBI chr 7:112,761,554...112,764,746
Ensembl chr 7:114,641,580...114,644,919

G

MDM2 proto-oncogene

increases expression
multiple interactions

EXP
ISO

monomethylarsonic acid results in increased expression of MDM2 mRNA
[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of MDM2 mRNA

PMID:17481689 PMID:23192986

NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:55,176,560...55,200,791

G

myocyte enhancer factor 2C

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MEF2C mRNA

NCBI chr 2:15,708,732...15,871,639
Ensembl chr 2:15,708,924...15,871,640

G

meiosis specific with coiled-coil domain

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MEIOC mRNA

NCBI chr10:87,628,807...87,646,485
Ensembl chr10:88,128,990...88,147,829

G

milk fat globule EGF and factor V/VIII domain containing

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MFGE8 mRNA

NCBI chr 1:133,064,665...133,080,069
Ensembl chr 1:142,474,028...142,489,431

G

major facilitator superfamily domain containing 12

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MFSD12 mRNA

NCBI chr 7:8,345,171...8,354,050
Ensembl chr 7:8,998,050...9,004,724

G

MFSD2 lysolipid transporter B, sphingolipid

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MFSD2B mRNA

NCBI chr 6:27,870,182...27,883,768
Ensembl chr 6:33,589,852...33,601,626

G

microRNA 145

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MIR145A mRNA

NCBI chr18:57,369,983...57,370,070

G

Mir155 host gene

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MIR155HG mRNA

NCBI chr11:23,773,468...23,775,697

G

microRNA 192

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MIR192 mRNA

NCBI chr 1:212,994,209...212,994,318
Ensembl chr 1:212,994,209...212,994,318

G

mohawk homeobox

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MKX mRNA

NCBI chr17:55,077,073...55,156,877
Ensembl chr17:59,773,570...59,850,345

G

mixed lineage kinase domain like pseudokinase

increases phosphorylation

ISO

monomethylarsonic acid results in increased phosphorylation of MLKL protein

NCBI chr19:39,277,526...39,304,555
Ensembl chr19:56,186,860...56,213,858

G

maestro heat-like repeat family member 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MROH6 mRNA

NCBI chr 7:107,566,212...107,576,469
Ensembl chr 7:109,449,268...109,455,087

G

maestro heat-like repeat family member 7

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MROH7 mRNA

NCBI chr 5:121,463,826...121,509,233
Ensembl chr 5:126,692,649...126,731,161

G

membrane spanning 4-domains A1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MS4A1 mRNA

NCBI chr 1:217,331,274...217,351,934
Ensembl chr 1:217,331,274...217,343,447

G

membrane spanning 4-domains A18

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MS4A18 mRNA

NCBI chr 1:217,069,752...217,090,869
Ensembl chr 1:217,069,884...217,090,754

G

mutS homolog 2

decreases expression

EXP

monomethylarsonic acid results in decreased expression of MSH2 mRNA

NCBI chr 6:12,567,368...12,626,534
Ensembl chr 6:12,567,368...12,626,503

G

misato mitochondrial distribution and morphology regulator 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MSTO1 mRNA

NCBI chr 2:176,603,755...176,608,037
Ensembl chr 2:176,599,671...176,608,026

G

metallothionein 1, pseudogene 3

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of MT1E mRNA

NCBI chr17:74,786,652...74,787,040
Ensembl chr17:79,695,809...79,696,200

G

metallothionein 1A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MT1 mRNA

NCBI chr19:10,831,959...10,832,975
Ensembl chr17:79,695,809...79,696,200
Ensembl chr X:79,695,809...79,696,200
Ensembl chr19:79,695,809...79,696,200

G

metallothionein 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MT4 mRNA

NCBI chr19:10,863,813...10,865,909
Ensembl chr19:10,869,735...10,871,831

G

mevalonate diphosphate decarboxylase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MVD mRNA

NCBI chr19:67,404,911...67,414,974
Ensembl chr19:67,404,911...67,422,366

G

mevalonate kinase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MVK mRNA

NCBI chr12:47,802,002...47,819,503
Ensembl chr12:47,802,002...47,819,503

G

MX dynamin like GTPase 1

multiple interactions

ISO

[Arsenic results in increased abundance of monomethylarsonic acid] which affects the expression of MX1 mRNA
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MX1 mRNA

PMID:28793237 PMID:34876320

NCBI chr11:36,799,659...36,825,209
Ensembl chr11:50,269,057...50,292,904

G

Max dimerization protein 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MXD3 mRNA

NCBI chr17:9,301,430...9,305,156
Ensembl chr17:9,302,321...9,310,278

G

MYB proto-oncogene, transcription factor

decreases expression

ISO

monomethylarsonic acid results in decreased expression of MYB mRNA

NCBI chr 1:17,759,309...17,793,306
Ensembl chr 1:17,759,309...17,792,547

G

MYB proto-oncogene like 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MYBL1 mRNA

NCBI chr 5:9,582,905...9,618,179
Ensembl chr 5:14,365,768...14,399,588

G

MYC proto-oncogene, bHLH transcription factor

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of MYC mRNA

NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028

G

myosin IG

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MYO1G mRNA

NCBI chr14:81,386,701...81,401,843
Ensembl chr14:85,600,619...85,615,760

G

myotilin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MYOT mRNA

NCBI chr18:36,705,244...36,724,849
Ensembl chr18:36,956,191...36,976,265

G

marginal zone B and B1 cell-specific protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MZB1 mRNA

NCBI chr18:27,513,087...27,515,148
Ensembl chr18:27,513,089...27,515,182

G

N-6 adenine-specific DNA methyltransferase 1

increases abundance

ISO

HEMK2 gene polymorphism results in increased abundance of monomethylarsonic acid

NCBI chr11:26,584,750...26,597,790
Ensembl chr11:40,070,993...40,083,680

G

N(alpha)-acetyltransferase 80, NatH catalytic subunit

decreases expression

ISO

monomethylarsonic acid results in decreased expression of NAA80 mRNA

NCBI chr 8:117,132,957...117,136,207
Ensembl chr 8:117,133,494...117,136,207

G

N-acetylated alpha-linked acidic dipeptidase-like 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NAALADL1 mRNA

NCBI chr 1:212,829,917...212,843,474
Ensembl chr 1:212,829,916...212,843,474

G

napsin A aspartic peptidase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NAPSA mRNA

NCBI chr 1:95,064,726...95,077,101
Ensembl chr 1:104,200,960...104,213,608

G

neutrophil cytosolic factor 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NCF1 mRNA

NCBI chr12:28,121,816...28,131,080
Ensembl chr12:28,121,366...28,131,079

G

neutrophil cytosolic factor 2

increases expression

ISO

monomethylarsonic acid results in increased expression of NCF2 mRNA

NCBI chr13:67,505,492...67,536,015
Ensembl chr13:67,505,375...67,536,149

G

noncompact myelin associated protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NCMAP mRNA

NCBI chr 5:147,608,042...147,623,266
Ensembl chr 5:152,894,316...152,902,414

G

N-myc downstream regulated 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NDRG1 mRNA

NCBI chr 7:100,573,526...100,614,902
Ensembl chr 7:100,573,523...100,614,913

G

N-deacetylase and N-sulfotransferase 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NDST3 mRNA

NCBI chr 2:211,702,728...211,868,159
Ensembl chr 2:214,389,447...214,539,164

G

nuclear paraspeckle assembly transcript 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of NEAT1 mRNA

NCBI chr 1:203,129,229...203,140,014

G

nebulin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NEB mRNA

NCBI chr 3:36,613,677...36,811,618
Ensembl chr 3:57,022,822...57,220,709

G

nectin cell adhesion molecule 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NECTIN1 mRNA

NCBI chr 8:44,101,776...44,164,863
Ensembl chr 8:52,998,662...53,086,664

G

NFE2 like bZIP transcription factor 1

multiple interactions

ISO

[NFE2L1 protein alternative form results in decreased methylation of arsenite] which results in decreased abundance of monomethylarsonic acid

NCBI chr10:82,296,824...82,309,472
Ensembl chr10:82,292,508...82,309,375

G

NFE2 like bZIP transcription factor 2

decreases expression
decreases phosphorylation
multiple interactions

ISO

monomethylarsonic acid results in decreased expression of NFE2L2 mRNA
monomethylarsonic acid results in decreased phosphorylation of NFE2L2 protein
monomethylarsonic acid results in increased expression of and affects the localization of NFE2L2 protein; NFE2L2 mutant form inhibits the reaction [monomethylarsonic acid results in increased expression of NQO1 protein]

PMID:24091636 PMID:24161444 PMID:38630284

NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090

G

nuclear factor, interleukin 3 regulated

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of NFIL3 mRNA

NCBI chr17:12,280,499...12,295,728
Ensembl chr17:12,432,198...12,450,826

G

nuclear factor kappa B subunit 1

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of NFKB1 mRNA

NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:226,689,745...226,783,088

G

niban apoptosis regulator 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of NIBAN3 mRNA

NCBI chr16:18,307,122...18,318,589
Ensembl chr16:18,341,141...18,352,575

G

NIPA-like domain containing 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NIPAL4 mRNA

NCBI chr10:30,583,926...30,600,640
Ensembl chr10:31,085,267...31,101,979

G

NLR family, pyrin domain containing 9

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of NLRP9B mRNA

NCBI chr 1:68,291,180...68,341,512
Ensembl chr 1:77,319,218...77,378,658

G

neuromedin U

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NMU mRNA

NCBI chr14:32,198,789...32,226,397
Ensembl chr14:32,198,943...32,226,632

G

nocturnin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of NOCT mRNA

NCBI chr 2:135,271,189...135,291,407
Ensembl chr 2:137,422,074...137,442,282

G

Nodal modulator 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NOMO1 mRNA

NCBI chr 1:96,505,460...96,556,280
Ensembl chr 1:105,641,879...105,692,707

G

neuronal PAS domain protein 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of NPAS4 mRNA

NCBI chr 1:202,281,260...202,298,681
Ensembl chr 1:211,711,338...211,716,102

G

neuropeptide FF receptor 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NPFFR1 mRNA

NCBI chr20:29,539,795...29,573,951
Ensembl chr20:30,082,604...30,114,998

G

NAD(P)H quinone dehydrogenase 1

multiple interactions
increases expression

ISO

monomethylarsonic acid promotes the reaction [sulforaphane results in increased expression of and results in increased activity of NQO1 protein]; monomethylarsonic acid promotes the reaction [sulforaphane results in increased expression of NQO1 mRNA]; monomethylarsonic acid promotes the reaction [Tetrachlorodibenzodioxin results in increased activity of NQO1 protein]; monomethylarsonic acid promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA]; monomethylarsonic acid results in increased expression of and results in increased activity of NQO1 protein; NFE2L2 mutant form inhibits the reaction [monomethylarsonic acid results in increased expression of NQO1 protein]
monomethylarsonic acid results in increased expression of NQO1 mRNA

NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260

G

nuclear receptor subfamily 0, group B, member 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of NR0B2 mRNA

NCBI chr 5:151,063,160...151,066,475
Ensembl chr 5:151,063,160...151,066,475

G

5' nucleotidase, ecto

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of NT5E mRNA

NCBI chr 8:89,271,046...89,314,918
Ensembl chr 8:98,150,900...98,195,645

G

nuclear GTPase, germinal center associated

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NUGGC mRNA

NCBI chr15:39,821,851...39,866,122
Ensembl chr15:43,997,438...44,041,643

G

neurexophilin and PC-esterase domain family, member 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NXPE3 mRNA

NCBI chr11:44,726,905...44,777,694
Ensembl chr11:58,195,976...58,248,644

G

neurexophilin and PC-esterase domain family member 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NXPE4 mRNA

NCBI chr 8:48,502,697...48,744,101
Ensembl chr 8:57,631,895...57,644,186

G

nyctalopin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of NYX mRNA

NCBI chr X:9,280,864...9,301,900
Ensembl chr X:11,953,018...11,974,810

G

2'-5' oligoadenylate synthetase 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of OAS2 mRNA

NCBI chr12:35,802,824...35,830,778
Ensembl chr12:41,467,315...41,495,881

G

8-oxoguanine DNA glycosylase

increases expression

EXP

monomethylarsonic acid results in increased expression of OGG1 mRNA

NCBI chr 4:146,474,701...146,481,959
Ensembl chr 4:148,030,349...148,037,604

G

olfactory receptor family 10 subfamily J member 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of OR10J2 mRNA

NCBI chr13:88,255,644...88,256,634
Ensembl chr13:88,255,644...88,256,634

G

odd-skipped related transcription factor 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of OSR2 mRNA

NCBI chr 7:66,487,841...66,495,003
Ensembl chr 7:68,373,049...68,380,805

G

3-oxoacid CoA transferase 2A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of OXCT2A mRNA

NCBI chr 5:135,600,812...135,602,570
Ensembl chr 5:140,874,503...140,902,881

G

P2Y receptor family member 10

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of P2RY10 mRNA

NCBI chr X:72,121,558...72,207,174
Ensembl chr X:76,184,001...76,280,953

G

purinergic receptor P2Y2

decreases expression

ISO

monomethylarsonic acid results in decreased expression of P2RY2 mRNA

NCBI chr 1:164,764,119...164,779,578
Ensembl chr 1:164,759,213...164,781,852

G

prolyl 4-hydroxylase subunit alpha 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of P4HA1 mRNA

NCBI chr20:27,302,046...27,352,098
Ensembl chr20:27,845,141...27,895,404

G

parvin, gamma

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PARVG mRNA

NCBI chr 7:115,456,183...115,475,707
Ensembl chr 7:117,336,187...117,362,155

G

paired box 5

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PAX5 mRNA

NCBI chr 5:63,554,784...63,741,380
Ensembl chr 5:63,560,722...63,739,987

G

paired box 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PAX6 mRNA

NCBI chr 3:112,590,034...112,611,771
Ensembl chr 3:112,590,391...112,611,763

G

phosphatidylethanolamine binding protein 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PBP2 mRNA

NCBI chr 4:168,155,827...168,157,121
Ensembl chr 4:169,856,292...169,889,596

G

protocadherin related 15

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PCDH15 mRNA

NCBI chr20:13,997,094...15,496,446
Ensembl chr20:13,999,116...15,493,958

G

protocadherin gamma subfamily B, 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PCDHGB1 mRNA

NCBI chr18:29,501,739...29,508,024

G

PC-esterase domain containing 1B

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PCED1B mRNA

NCBI chr 7:128,394,388...128,528,231
Ensembl chr 7:130,270,554...130,410,365

G

proliferating cell nuclear antigen

increases expression

EXP

monomethylarsonic acid results in increased expression of PCNA mRNA

NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901

G

proprotein convertase subtilisin/kexin type 9

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PCSK9 mRNA

NCBI chr 5:126,440,102...126,462,507
Ensembl chr 5:126,440,102...126,462,507

G

pleckstrin homology-like domain, family A, member 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PHLDA1 mRNA

NCBI chr 7:48,853,690...48,855,894
Ensembl chr 7:48,853,260...48,857,542

G

polymeric immunoglobulin receptor

decreases expression

ISO

monomethylarsonic acid results in decreased expression of PIGR mRNA

NCBI chr13:42,298,905...42,326,877
Ensembl chr13:44,851,182...44,879,141

G

paired-like homeodomain 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PITX1 mRNA

NCBI chr17:8,794,051...8,805,477
Ensembl chr17:8,799,319...8,805,476

G

phospholipase A2 group IIA

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PLA2G2A mRNA

NCBI chr 5:156,359,725...156,362,302
Ensembl chr 5:156,359,725...156,362,297

G

phospholipase A2, group IID

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PLA2G2D mRNA

NCBI chr 5:156,299,374...156,305,816
Ensembl chr 5:156,297,777...156,305,812

G

phospholipase A2, group IVF

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PLA2G4F mRNA

NCBI chr 3:107,249,053...107,266,201
Ensembl chr 3:127,703,841...127,718,348

G

plasminogen activator, urokinase receptor

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PLAUR mRNA

NCBI chr 1:89,181,363...89,196,308
Ensembl chr 1:89,178,453...89,198,130

G

phospholipase B1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PLB1 mRNA

NCBI chr 6:29,807,127...29,945,607
Ensembl chr 6:29,809,290...29,930,183

G

phospholipase D family, member 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PLD4 mRNA

NCBI chr 6:131,818,860...131,827,457
Ensembl chr 6:137,639,945...137,649,024

G

pleckstrin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PLEK mRNA

NCBI chr14:95,598,650...95,631,326
Ensembl chr14:95,598,654...95,655,721

G

pleckstrin homology and RhoGEF domain containing G4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PLEKHG4 mRNA

NCBI chr19:33,251,788...33,266,490
Ensembl chr19:50,159,754...50,182,133

G

placenta expressed transcript 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PLET1 mRNA

NCBI chr 8:50,842,242...50,853,666
Ensembl chr 8:59,738,529...59,750,406

G

polo-like kinase 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PLK3 mRNA

NCBI chr 5:135,843,725...135,848,900
Ensembl chr 5:135,843,725...135,848,900

G

plexin C1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PLXNC1 mRNA

NCBI chr 7:29,390,038...29,543,985
Ensembl chr 7:31,276,978...31,431,092

G

phorbol-12-myristate-13-acetate-induced protein 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PMAIP1 mRNA

NCBI chr18:62,255,970...62,262,384
Ensembl chr18:62,255,598...62,262,382

G

patatin-like phospholipase domain containing 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PNPLA1 mRNA

NCBI chr20:6,917,993...6,952,157
Ensembl chr20:6,919,115...6,955,143

G

patatin-like phospholipase domain containing 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PNPLA3 mRNA

NCBI chr 7:117,173,485...117,194,065
Ensembl chr 7:117,173,516...117,194,594

G

POU class 2 homeobox associating factor 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of POU2AF1 mRNA

NCBI chr 8:51,521,813...51,548,819
Ensembl chr 8:60,436,844...60,445,176

G

POU class 2 homeobox 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of POU2F2 mRNA

NCBI chr 1:80,682,330...80,769,756
Ensembl chr 1:89,812,093...89,897,564

G

protein phosphatase 1, regulatory subunit 12B

decreases expression

ISO

monomethylarsonic acid results in decreased expression of PPP1R12B mRNA

NCBI chr13:46,199,418...46,397,108
Ensembl chr13:48,751,477...48,948,922

G

protein phosphatase 1, regulatory subunit 16B

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PPP1R16B mRNA

NCBI chr 3:147,323,652...147,419,658
Ensembl chr 3:167,743,952...167,839,242

G

PRAME like 34

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PRAMEL34 mRNA

NCBI chr14:13,850,057...13,852,806
Ensembl chr14:14,153,477...14,156,758

G

protein kinase C, alpha

increases expression

EXP

monomethylarsonic acid results in increased expression of PRKCA mRNA

NCBI chr10:93,388,991...93,787,617
Ensembl chr10:93,388,991...93,787,572

G

proline rich 5 like

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PRR5L mRNA

NCBI chr 3:88,001,951...88,173,532
Ensembl chr 3:108,458,633...108,537,763

G

serine protease 16

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PRSS16 mRNA

NCBI chr17:42,514,306...42,521,885
Ensembl chr17:47,210,081...47,217,658

G

phosphatase and tensin homolog

decreases expression

ISO
EXP

monomethylarsonic acid results in decreased expression of PTEN mRNA

NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:240,043,707...240,110,330

G

prostaglandin F receptor

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PTGFR mRNA

NCBI chr 2:240,731,185...240,766,674
Ensembl chr 2:243,393,350...243,425,623

G

protein tyrosine phosphatase, non-receptor type 7

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PTPN7 mRNA

NCBI chr13:46,570,904...46,584,048
Ensembl chr13:49,122,609...49,136,094

G

protein tyrosine phosphatase, receptor type, C

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PTPRC mRNA

NCBI chr13:52,147,717...52,259,810
Ensembl chr13:52,147,717...52,259,746

G

protein tyrosine phosphatase, receptor type, C-associated protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PTPRCAP mRNA

NCBI chr 1:201,449,133...201,451,293
Ensembl chr 1:210,878,573...210,881,753

G

pyroglutamylated RFamide peptide receptor

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of QRFPR mRNA

NCBI chr 2:119,053,083...119,096,864
Ensembl chr 2:120,981,235...121,025,020

G

RAB33A, member RAS oncogene family

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RAB33A mRNA

NCBI chr X:127,694,219...127,706,378
Ensembl chr X:132,572,148...132,584,254

G

RAD51 paralog C

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RAD51C mRNA

NCBI chr10:72,205,032...72,231,643
Ensembl chr10:72,702,299...72,729,143

G

RPA1 related single stranded DNA binding protein, X-linked

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RADX mRNA

NCBI chr X:103,089,284...103,176,840
Ensembl chr X:107,877,920...107,965,476

G

Raf-1 proto-oncogene, serine/threonine kinase

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of RAF1 mRNA

NCBI chr 4:150,352,158...150,412,813
Ensembl chr 4:150,352,160...150,412,813

G

ral guanine nucleotide dissociation stimulator like 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RGL3 mRNA

NCBI chr 8:20,500,846...20,520,471
Ensembl chr 8:28,776,909...28,796,771

G

Rap guanine nucleotide exchange factor like 1

decreases expression

ISO

monomethylarsonic acid results in decreased expression of RAPGEFL1 mRNA

NCBI chr10:83,793,711...83,810,373
Ensembl chr10:84,289,980...84,306,614

G

RAS protein activator like 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RASAL3 mRNA

NCBI chr 7:11,396,554...11,411,347
Ensembl chr 7:12,047,090...12,061,883

G

ras related dexamethasone induced 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RASD1 mRNA

NCBI chr10:44,766,451...44,775,773
Ensembl chr10:45,265,979...45,267,710

G

RAS guanyl releasing protein 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RASGRP3 mRNA

NCBI chr 6:19,895,361...19,993,945
Ensembl chr 6:25,647,386...25,710,591

G

RAS-like family 11 member A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RASL11A mRNA

NCBI chr12:8,258,148...8,260,909
Ensembl chr12:13,372,023...13,376,451

G

REC114 meiotic recombination protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of REC114 mRNA

NCBI chr 8:59,063,352...59,221,439
Ensembl chr 8:67,958,421...68,119,234

G

REC8 meiotic recombination protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of REC8 mRNA

NCBI chr15:33,079,818...33,087,283
Ensembl chr15:33,079,801...33,087,282

G

receptor accessory protein 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of REEP6 mRNA

NCBI chr 7:10,024,601...10,031,507
Ensembl chr 7:10,024,602...10,031,740

G

regenerating family member 3 beta

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of REG3B mRNA

NCBI chr 4:110,861,775...110,865,015
Ensembl chr 4:112,419,776...112,423,014

G

regenerating family member 3 gamma

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of REG3G mRNA

NCBI chr 4:110,922,805...110,927,803
Ensembl chr 4:112,482,183...112,484,738

G

RELA proto-oncogene, NF-kB subunit

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of RELA mRNA

NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817

G

RELT-like 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RELL2 mRNA

NCBI chr18:29,789,996...29,793,986
Ensembl chr18:30,041,563...30,045,187

G

regulatory factor X-associated protein

decreases expression

ISO

monomethylarsonic acid results in decreased expression of RFXAP mRNA

NCBI chr 2:139,008,052...139,012,235
Ensembl chr 2:141,158,215...141,162,397

G

regulator of G-protein signaling 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RGS1 mRNA

NCBI chr13:56,018,546...56,022,889
Ensembl chr13:58,568,844...58,573,187

G

ras homolog family member H

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RHOH mRNA

NCBI chr14:42,341,135...42,371,971
Ensembl chr14:42,693,413...42,749,967

G

receptor-interacting serine-threonine kinase 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RIPK3 mRNA

NCBI chr15:33,253,071...33,262,025
Ensembl chr15:33,253,071...33,262,025

G

RHO family interacting cell polarization regulator 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RIPOR2 mRNA

NCBI chr17:40,751,771...40,975,611
Ensembl chr17:40,751,771...40,975,337

G

ribonuclease A family member 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RNASE6 mRNA

NCBI chr15:26,827,896...26,830,807
Ensembl chr15:26,827,009...26,830,825

G

ring finger protein 225

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RNF225 mRNA

NCBI chr 1:73,543,598...73,546,269
Ensembl chr 1:82,615,787...82,618,456

G

ring finger protein 24

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RNF24 mRNA

NCBI chr 3:118,520,459...118,575,213
Ensembl chr 3:138,973,492...139,028,177

G

ROS proto-oncogene 1 , receptor tyrosine kinase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ROS1 mRNA

NCBI chr20:31,432,636...31,583,998
Ensembl chr20:31,975,329...32,126,547

G

ribonuclease P RNA component H1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of RPPH1 mRNA

NCBI chr15:24,033,679...24,033,935
Ensembl chr15:26,507,215...26,507,512

G

ribosomal protein S6 kinase related

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RSKR mRNA

NCBI chr10:63,185,286...63,191,963
Ensembl chr10:63,683,479...63,687,889

G

RT1 class II, locus DOa

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of H2-OA mRNA

NCBI chr20:4,753,587...4,756,590
Ensembl chr20:4,755,499...4,758,478

G

RT1 class II, locus DOb

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of H2-OB mRNA

NCBI chr20:4,619,418...4,625,627
Ensembl chr20:4,619,694...4,627,523

G

rubicon like autophagy enhancer

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RUBCNL mRNA

NCBI chr15:50,332,458...50,377,494
Ensembl chr15:56,741,869...56,779,649

G

ryanodine receptor 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RYR1 mRNA

NCBI chr 1:84,292,578...84,423,824
Ensembl chr 1:93,420,078...93,551,305

G

ryanodine receptor 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RYR3 mRNA

NCBI chr 3:99,431,755...99,979,125
Ensembl chr 3:119,885,878...120,433,677

G

S100 calcium binding protein G

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of S100G mRNA

NCBI chr X:35,337,636...35,340,205
Ensembl chr X:35,337,675...35,340,205

G

sphingosine-1-phosphate receptor 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of S1PR4 mRNA

NCBI chr 7:8,207,767...8,210,043
Ensembl chr 7:8,858,904...8,860,800

G

sacsin molecular chaperone

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SACS mRNA

NCBI chr15:35,285,783...35,370,335
Ensembl chr15:39,472,905...39,546,419

G

sterile alpha motif domain containing 4A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SAMD4 mRNA

NCBI chr15:20,135,994...20,352,131
Ensembl chr15:22,614,287...22,831,872

G

SAM domain, SH3 domain and nuclear localization signals, 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SAMSN1 mRNA

NCBI chr11:14,484,523...14,534,900
Ensembl chr11:27,970,564...28,021,944

G

SAM and SH3 domain containing 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SASH3 mRNA

NCBI chr X:127,326,815...127,341,521
Ensembl chr X:132,204,543...132,219,419

G

sciellin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SCEL mRNA

NCBI chr15:80,339,661...80,456,546
Ensembl chr15:86,754,373...86,871,195

G

sodium voltage-gated channel alpha subunit 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SCN4A mRNA

NCBI chr10:91,246,936...91,296,670
Ensembl chr10:91,746,715...91,796,324

G

secreted and transmembrane 1B

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SECTM1A mRNA

NCBI chr10:106,324,070...106,333,779
Ensembl chr10:106,822,397...106,832,104

G

selectin L

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SELL mRNA

NCBI chr13:78,950,100...78,969,604
Ensembl chr13:78,950,015...78,969,600

G

semaphorin 7A (John Milton Hagen blood group)

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SEMA7A mRNA

NCBI chr 8:67,244,318...67,267,060
Ensembl chr 8:67,243,824...67,267,058

G

serpin family C member 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SERPINC1 mRNA

NCBI chr13:73,257,208...73,271,476
Ensembl chr13:75,790,546...75,817,643

G

serpin family F member 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SERPINF2 mRNA

NCBI chr10:60,770,698...60,778,782
Ensembl chr10:60,770,698...60,778,996

G

secreted frizzled-related protein 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SFRP4 mRNA

NCBI chr17:49,974,532...50,026,448
Ensembl chr17:50,015,812...50,026,395

G

serum/glucocorticoid regulated kinase 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SGK1 mRNA

NCBI chr 1:24,799,391...24,916,886
Ensembl chr 1:24,799,396...24,807,231

G

SH3 domain containing 21

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SH3D21 mRNA

NCBI chr 5:138,429,180...138,444,540
Ensembl chr 5:143,713,718...143,729,257

G

shroom family member 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SHROOM4 mRNA

NCBI chr X:18,537,371...18,748,665
Ensembl chr X:18,540,913...18,748,700

G

signaling lymphocytic activation molecule family member 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLAMF1 mRNA

NCBI chr13:86,802,708...86,837,890
Ensembl chr13:86,802,708...86,837,890

G

SLAM family member 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLAMF6 mRNA

NCBI chr13:86,916,956...86,937,697
Ensembl chr13:86,916,122...86,938,354

G

SLAM family member 7

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLAMF7 mRNA

NCBI chr13:84,135,656...84,154,528
Ensembl chr13:86,668,060...86,686,341

G

solute carrier family 10 member 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC10A1 mRNA

NCBI chr 6:106,344,319...106,357,944
Ensembl chr 6:106,344,319...106,357,944

G

solute carrier family 10 member 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC10A6 mRNA

NCBI chr14:6,080,716...6,102,902
Ensembl chr14:6,385,537...6,408,894

G

solute carrier family 13 member 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC13A1 mRNA

NCBI chr 4:52,569,179...52,647,126
Ensembl chr 4:53,534,768...53,612,704

G

solute carrier family 14 member 1 (Kidd blood group)

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC14A1 mRNA

NCBI chr18:73,840,568...73,883,925
Ensembl chr18:73,840,569...73,870,489

G

solute carrier family 15, member 5

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC15A5 mRNA

NCBI chr 4:170,878,021...170,971,620
Ensembl chr 4:172,608,999...172,702,893

G

solute carrier family 16 member 8

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC16A8 mRNA

NCBI chr 7:112,698,701...112,702,496
Ensembl chr 7:112,698,701...112,702,496

G

solute carrier family 26 member 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC26A2 mRNA

NCBI chr18:54,648,276...54,666,627
Ensembl chr18:56,923,337...56,937,012

G

solute carrier family 27 member 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC27A3 mRNA

NCBI chr 2:178,150,835...178,155,503
Ensembl chr 2:178,150,835...178,155,503

G

solute carrier family 28 member 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC28A2 mRNA

NCBI chr 3:109,324,815...109,387,702
Ensembl chr 3:129,807,537...129,841,291

G

solute carrier family 28 member 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC28A3 mRNA

NCBI chr17:6,062,563...6,112,965
Ensembl chr17:6,068,060...6,120,417

G

solute carrier family 29 member 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC29A4 mRNA

NCBI chr12:16,967,047...16,998,276
Ensembl chr12:16,967,047...16,988,338

G

solute carrier family 2 member 1

increases import
decreases expression

ISO
EXP

SLC2A1 protein results in increased import of monomethylarsonic acid
monomethylarsonic acid results in decreased expression of SLC2A1 mRNA

PMID:17064664 PMID:38630284

NCBI chr 5:138,002,522...138,030,742
Ensembl chr 5:138,002,522...138,030,742

G

solute carrier family 2 member 5

multiple interactions
decreases expression

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC2A5 mRNA
monomethylarsonic acid results in decreased expression of SLC2A5 mRNA

PMID:34876320 PMID:38630284

NCBI chr 5:165,857,412...165,892,928
Ensembl chr 5:165,866,172...165,894,038

G

solute carrier family 34 member 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC34A2 mRNA

NCBI chr14:57,910,931...57,930,236
Ensembl chr14:62,123,316...62,143,360

G

solute carrier family 38, member 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC38A3 mRNA

NCBI chr 8:117,202,534...117,220,310
Ensembl chr 8:117,202,536...117,218,630

G

solute carrier family 38, member 8

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC38A8 mRNA

NCBI chr19:47,522,781...47,561,443
Ensembl chr19:64,437,013...64,463,960

G

solute carrier family 39 member 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC39A2 mRNA

NCBI chr15:27,063,699...27,066,349
Ensembl chr15:27,064,237...27,066,349

G

solute carrier family 41, member 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC41A3 mRNA

NCBI chr 4:123,109,555...123,154,766
Ensembl chr 4:124,666,808...124,711,967

G

solute carrier family 5 member 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC5A3 mRNA

NCBI chr11:44,799,787...44,802,233
Ensembl chr11:44,790,297...44,818,157

G

solute carrier family 5 member 9

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC5A9 mRNA

NCBI chr 5:126,709,762...126,733,468
Ensembl chr 5:131,938,216...131,961,922

G

solute carrier family 6 member 18

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC6A18 mRNA

NCBI chr 1:29,607,288...29,621,925
Ensembl chr 1:31,436,630...31,450,478

G

solute carrier family 7 member 9

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC7A9 mRNA

NCBI chr 1:88,109,517...88,132,653
Ensembl chr 1:97,247,547...97,269,543

G

solute carrier family 8 member A3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC8A3 mRNA

NCBI chr 6:106,605,611...106,739,208
Ensembl chr 6:106,605,621...106,721,412

G

solute carrier family 9 member A3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC9A3 mRNA

NCBI chr 1:29,124,633...29,167,912
Ensembl chr 1:30,953,216...30,996,002

G

solute carrier organic anion transporter family, member 5A1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLCO5A1 mRNA

NCBI chr 5:11,012,001...11,141,180
Ensembl chr 5:11,012,075...11,141,177

G

stannin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SNN mRNA

NCBI chr10:4,572,933...4,581,606
Ensembl chr 1:82,440,586...82,441,390
Ensembl chr10:82,440,586...82,441,390

G

sterol O-acyltransferase 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SOAT2 mRNA

NCBI chr 7:133,281,818...133,294,915
Ensembl chr 7:135,160,402...135,173,513

G

superoxide dismutase 1

increases expression

ISO
EXP

monomethylarsonic acid results in increased expression of SOD1 mRNA

NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399

G

superoxide dismutase 2

increases expression

EXP
ISO

monomethylarsonic acid results in increased expression of SOD2 mRNA

NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168

G

SP100 nuclear antigen

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SP140 mRNA

NCBI chr 9:86,310,990...86,377,036
Ensembl chr 9:93,759,075...93,825,068

G

sperm associated antigen 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SPAG1 mRNA

NCBI chr 7:67,361,474...67,421,369
Ensembl chr 7:69,246,582...69,306,482

G

spermatogenesis associated 6-like

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SPATA6L mRNA

NCBI chr 1:226,630,470...226,682,979
Ensembl chr 1:236,033,147...236,096,730

G

spermatogenesis associated, serine-rich 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SPATS1 mRNA

NCBI chr 9:15,527,179...15,562,286
Ensembl chr 9:23,024,609...23,059,730

G

small proline-rich protein 1A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SPRR1A mRNA

NCBI chr 2:180,750,709...180,752,625
Ensembl chr 2:180,750,709...180,752,991

G

small proline rich protein 2A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SPRR2H mRNA

NCBI chr 2:180,511,568...180,511,840

G

sprouty RTK signaling antagonist 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SPRY4 mRNA

NCBI chr18:30,436,513...30,451,426
Ensembl chr18:30,687,039...30,704,173

G

serine palmitoyltransferase, small subunit B

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SPTSSB mRNA

NCBI chr 2:154,133,728...154,162,127
Ensembl chr 2:156,432,512...156,460,909

G

squalene epoxidase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SQLE mRNA

NCBI chr 7:92,758,175...92,773,049
Ensembl chr 7:92,757,409...92,773,050

G

SRC proto-oncogene, non-receptor tyrosine kinase

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of SRC mRNA

NCBI chr 3:166,511,616...166,559,463
Ensembl chr 3:166,511,985...166,559,462

G

sterol regulatory element binding transcription factor 1

decreases expression

ISO

monomethylarsonic acid results in decreased expression of SREBF1 mRNA

NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,507,152...45,529,164

G

sterol regulatory element binding transcription factor 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SREBF2 mRNA

NCBI chr 7:115,542,774...115,600,945
Ensembl chr 7:115,543,290...115,600,943

G

SRSF protein kinase 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SRPK3 mRNA

NCBI chr X:151,510,452...151,515,208
Ensembl chr X:156,661,875...156,666,531

G

ST3 beta-galactoside alpha-2,3-sialyltransferase 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ST3GAL4 mRNA

NCBI chr 8:33,415,666...33,465,319
Ensembl chr 8:41,673,510...41,712,551

G

ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ST6GALNAC3 mRNA

NCBI chr 2:242,129,755...242,645,120
Ensembl chr 2:244,789,627...245,304,977

G

ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ST8SIA4 mRNA

NCBI chr 9:95,990,131...96,084,661
Ensembl chr 9:103,437,479...103,532,008

G

ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ST8SIA6 mRNA

NCBI chr17:76,740,755...76,884,178
Ensembl chr17:81,653,687...81,792,732

G

signal transducing adaptor family member 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of STAP1 mRNA

NCBI chr14:22,301,278...22,336,218
Ensembl chr14:22,236,616...22,342,652

G

signal transducer and activator of transcription 3

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of STAT3 mRNA

NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359

G

sushi domain containing 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SUSD3 mRNA

NCBI chr17:15,400,845...15,417,851
Ensembl chr17:15,606,906...15,624,262

G

synaptonemal complex protein 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SYCP2 mRNA

NCBI chr 3:165,431,715...165,502,134
Ensembl chr 3:185,814,035...185,876,492

G

synaptotagmin 5

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SYT5 mRNA

NCBI chr 1:78,320,034...78,327,750
Ensembl chr 1:78,320,034...78,327,746

G

synaptotagmin 8

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SYT8 mRNA

NCBI chr 1:207,017,602...207,023,076
Ensembl chr 1:207,017,461...207,023,076

G

TBC1 domain family, member 10C

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TBC1D10C mRNA

NCBI chr 1:210,906,621...210,913,649
Ensembl chr 1:210,906,616...210,994,356

G

transcription factor 23

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TCF23 mRNA

NCBI chr 6:31,117,839...31,126,575
Ensembl chr 6:31,120,127...31,125,878

G

transcription factor 24

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TCF24 mRNA

NCBI chr 5:9,274,659...9,282,876
Ensembl chr 5:14,058,039...14,063,345

G

t-complex protein 10b

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TCP10A mRNA

NCBI chr 1:52,937,823...52,961,307
Ensembl chr 1:55,485,411...55,508,836

G

terminal nucleotidyltransferase 5B

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TENT5B mRNA

NCBI chr 5:145,695,358...145,702,668
Ensembl chr11:27,212,316...27,214,238
Ensembl chr 5:27,212,316...27,214,238

G

transforming growth factor, beta 1

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of TGFB1 mRNA

NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899

G

transforming growth factor, beta receptor 2

increases expression

EXP

monomethylarsonic acid results in increased expression of TGFBR2 mRNA

NCBI chr 8:124,672,677...124,761,741
Ensembl chr 8:124,674,986...124,761,469

G

transglutaminase 7

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TGM7 mRNA

NCBI chr 3:108,051,890...108,068,116
Ensembl chr 3:128,505,650...128,529,939

G

thrombomodulin

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of THBD mRNA

NCBI chr 3:156,316,526...156,320,178
Ensembl chr 3:156,306,632...156,320,582

G

thrombospondin 2

decreases expression

ISO

monomethylarsonic acid results in decreased expression of THBS2 mRNA

NCBI chr 1:64,343,523...64,372,918
Ensembl chr 1:64,343,523...64,372,918

G

thymocyte selection associated

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of THEMIS mRNA

NCBI chr 1:18,251,136...18,483,851
Ensembl chr 1:18,272,056...18,483,502

G

TRAF-interacting protein with forkhead-associated domain

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TIFA mRNA

NCBI chr 2:216,257,926...216,267,635
Ensembl chr 2:218,909,915...218,956,224

G

toll-like receptor 8

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TLR8 mRNA

NCBI chr X:27,091,780...27,116,092
Ensembl chr X:30,708,033...30,737,079

G

toll-like receptor 9

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TLR9 mRNA

NCBI chr 8:115,743,407...115,747,523
Ensembl chr 8:115,742,889...115,750,148

G

transmembrane 4 L six family member 20

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TM4SF20 mRNA

NCBI chr 9:84,038,715...84,052,615
Ensembl chr 9:91,486,847...91,500,745

G

transmembrane p24 trafficking protein 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TMED6 mRNA

NCBI chr19:34,966,813...34,972,900
Ensembl chr19:51,876,561...51,882,648

G

transmembrane protein 140

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TMEM140 mRNA

NCBI chr 4:64,503,621...64,514,620
Ensembl chr 4:64,500,439...64,521,990

G

transmembrane protein 156

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TMEM156 mRNA

NCBI chr14:43,221,464...43,252,453
Ensembl chr14:43,577,023...43,606,109

G

transmembrane protein 17

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TMEM17 mRNA

NCBI chr14:96,483,648...96,524,238
Ensembl chr14:100,685,093...100,725,470

G

transmembrane protein 266

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TMEM266 mRNA

NCBI chr 8:55,707,122...55,820,692
Ensembl chr 8:64,603,186...64,716,769

G

transmembrane protein 71

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TMEM71 mRNA

NCBI chr 7:98,276,975...98,323,161
Ensembl chr 7:100,166,516...100,204,969

G

TNF receptor superfamily member 13B

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TNFRSF13B mRNA

NCBI chr10:46,301,336...46,322,460
Ensembl chr10:46,301,316...46,324,408

G

TNF receptor superfamily member 13C

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TNFRSF13C mRNA

NCBI chr 7:113,736,046...113,738,523
Ensembl chr 7:115,616,303...115,618,620

G

TNF receptor superfamily member 1A

decreases expression

EXP

monomethylarsonic acid results in decreased expression of TNFRSF1A mRNA

NCBI chr 4:159,837,119...159,849,817
Ensembl chr 4:159,837,032...159,849,816

G

TNF receptor superfamily member 25

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TNFRSF25 mRNA

NCBI chr 5:162,621,669...162,626,341
Ensembl chr 5:167,904,786...167,909,052

G

TNF superfamily member 11

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TNFSF11 mRNA

NCBI chr15:60,083,008...60,114,479
Ensembl chr15:60,083,008...60,114,479

G

TNF superfamily member 8

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TNFSF8 mRNA

NCBI chr 5:82,266,436...82,292,858
Ensembl chr 5:82,266,436...82,292,858

G

troponin I2, fast skeletal type

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TNNI2 mRNA

NCBI chr 1:197,595,012...197,597,554
Ensembl chr 1:207,024,416...207,027,038

G

troponin T3, fast skeletal type

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TNNT3 mRNA

NCBI chr 1:197,652,535...197,669,736
Ensembl chr 1:207,081,812...207,099,423

G

tumor protein p53

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of TP53 mRNA

NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299

G

tubulin polymerization promoting protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TPPP mRNA

NCBI chr 1:31,085,680...31,109,703
Ensembl chr 1:31,089,824...31,109,654

G

transformer 2 alpha

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TRA2A mRNA

NCBI chr 4:78,220,838...78,239,737
Ensembl chr 4:79,551,542...79,570,619

G

TNF receptor-associated factor 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TRAF1 mRNA

NCBI chr 3:18,222,024...18,242,163
Ensembl chr 3:38,619,506...38,636,264

G

Tnf receptor-associated factor 3

decreases expression

ISO

monomethylarsonic acid results in decreased expression of TRAF3 mRNA

NCBI chr 6:130,199,696...130,307,168
Ensembl chr 6:136,027,157...136,128,363

G

TRAF3 interacting protein 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TRAF3IP3 mRNA

NCBI chr13:104,694,802...104,719,655
Ensembl chr13:107,223,502...107,248,155

G

tetratricopeptide repeat and ankyrin repeat containing 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TRANK1 mRNA

NCBI chr 8:111,275,973...111,355,491
Ensembl chr 8:120,154,362...120,234,087

G

T cell receptor associated transmembrane adaptor 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TRAT1 mRNA

NCBI chr11:52,035,750...52,077,805
Ensembl chr11:65,498,742...65,542,381

G

tripartite motif containing 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TRIM6 mRNA

NCBI chr 1:158,683,746...158,696,936
Ensembl chr 1:168,095,564...168,109,719

G

transient receptor potential cation channel, subfamily C, member 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TRPC3 mRNA

NCBI chr 2:119,481,313...119,619,333
Ensembl chr 2:121,409,436...121,475,823

G

transient receptor potential cation channel, subfamily V, member 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TRPV3 mRNA

NCBI chr10:57,883,546...57,915,865
Ensembl chr10:58,382,054...58,411,800

G

transient receptor potential cation channel, subfamily V, member 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TRPV6 mRNA

NCBI chr 4:70,507,347...70,523,013
Ensembl chr 4:71,474,007...71,489,671

G

tetraspanin 32

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TSPAN32 mRNA

NCBI chr 1:198,190,128...198,204,447
Ensembl chr 1:207,619,567...207,656,946

G

tubulin tyrosine ligase like 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TTLL2 mRNA

NCBI chr 1:52,967,183...52,976,690
Ensembl chr 1:55,515,397...55,524,071

G

tubulin tyrosine ligase like 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TTLL3 mRNA

NCBI chr 4:146,532,958...146,558,425
Ensembl chr 4:148,089,575...148,113,499

G

tubulin tyrosine ligase like 9

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TTLL9 mRNA

NCBI chr 3:141,429,351...141,475,965
Ensembl chr 3:161,876,685...161,936,215

G

tweety family member 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TTYH3 mRNA

NCBI chr12:13,996,831...14,025,457
Ensembl chr12:19,110,824...19,139,371

G

TXK tyrosine kinase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TXK mRNA

NCBI chr14:35,463,369...35,519,448
Ensembl chr14:35,817,893...35,873,460

G

thioredoxin 1

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of TXN mRNA

NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:77,507,321...77,520,307

G

thioredoxin reductase 1

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of TXNRD1 mRNA

NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:22,719,317...22,739,817

G

uncoupling protein 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of UCP2 mRNA

NCBI chr 1:164,251,373...164,257,742
Ensembl chr 1:164,251,373...164,257,743

G

UDP glucuronosyltransferase 1 family, polypeptide A2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of UGT1A2 mRNA

NCBI chr 9:88,791,216...88,808,465
Ensembl chr 9:96,144,786...96,256,264

G

UDP glucuronosyltransferase family 1 member A5

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of UGT1A5 mRNA

NCBI chr 9:96,210,053...96,256,264
Ensembl chr 9:96,144,786...96,256,264

G

UL16 binding protein 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ULBP1 mRNA

NCBI chr 1:3,506,106...3,527,982

G

vascular cell adhesion molecule 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of VCAM1 mRNA

NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:206,723,044...206,742,801

G

vascular endothelial growth factor A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of VEGFA mRNA

NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194

G

vanin 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of VNN1 mRNA

NCBI chr 1:23,356,324...23,366,629
Ensembl chr 1:23,356,330...23,366,629

G

V-set pre-B cell surrogate light chain 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of VPREB3 mRNA

NCBI chr20:12,717,421...12,718,785

G

vacuolar protein sorting 25 homolog

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of VPS25 mRNA

NCBI chr10:86,196,062...86,201,606
Ensembl chr10:86,696,157...86,701,871

G

WASP actin nucleation promoting factor

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of WAS mRNA

NCBI chr X:17,077,057...17,085,802
Ensembl chr X:17,073,314...17,085,802

G

WDFY family member 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of WDFY4 mRNA

NCBI chr16:8,221,853...8,450,494
Ensembl chr16:8,228,147...8,456,761

G

WD repeat domain 31

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of WDR31 mRNA

NCBI chr 5:75,897,074...75,917,461
Ensembl chr 5:80,908,726...80,933,046

G

WD repeat domain 54

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of WDR54 mRNA

NCBI chr 4:115,654,968...115,677,979
Ensembl chr 4:117,212,677...117,219,270

G

Wnt family member 1

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of WNT1 mRNA

NCBI chr 7:131,817,558...131,821,605
Ensembl chr 7:131,817,558...131,821,605

G

XK related 8

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of XKR8 mRNA

NCBI chr 5:144,938,061...144,945,195
Ensembl chr 5:150,222,061...150,228,564

G

X-prolyl aminopeptidase 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of XPNPEP2 mRNA

NCBI chr X:132,165,696...132,194,937
Ensembl chr X:132,165,701...132,195,126

G

zeta chain of T cell receptor associated protein kinase 70

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ZAP70 mRNA

NCBI chr 9:46,485,605...46,507,552
Ensembl chr 9:46,485,598...46,509,062

G

zinc finger and BTB domain containing 16

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ZBTB16 mRNA

NCBI chr 8:57,885,886...58,073,507
Ensembl chr 8:57,891,081...58,073,507

G

zinc finger and BTB domain containing 40

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ZBTB40 mRNA

NCBI chr 5:149,216,496...149,283,746
Ensembl chr 5:154,503,128...154,537,863

G

zinc finger CCCH type containing 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ZC3H6 mRNA

NCBI chr 3:116,203,466...116,254,186
Ensembl chr 3:136,657,414...136,706,504

G

zinc finger DHHC-type palmitoyltransferase 19

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ZDHHC19 mRNA

NCBI chr11:68,277,847...68,289,110
Ensembl chr11:81,782,903...81,794,008

G

zinc finger homeobox 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ZFHX2 mRNA

NCBI chr15:32,501,755...32,541,720
Ensembl chr15:32,503,115...32,535,085

G

zinc finger protein 503

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ZFP503 mRNA

NCBI chr15:2,313,060...2,316,848
Ensembl chr15:2,362,427...2,366,238

G

zinc finger protein 831

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ZFP831 mRNA

NCBI chr 3:163,393,787...163,510,654
Ensembl chr 3:183,811,648...183,927,253

G

ZFP92 zinc finger protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ZFP92 mRNA

NCBI chr X:151,116,794...151,142,451
Ensembl chr X:156,268,234...156,294,516

G

zinc finger protein 950

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ZFP950 mRNA

NCBI chr 1:260,248,231...260,265,211

G

zinc finger, matrin type 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ZMAT4 mRNA

NCBI chr16:74,671,975...75,063,805
Ensembl chr16:74,671,979...75,063,750

G

zinc finger MYM-type containing 3

decreases expression

ISO

monomethylarsonic acid results in decreased expression of ZMYM3 mRNA

NCBI chr X:66,528,585...66,544,234
Ensembl chr X:70,568,573...70,584,768

phenylarsonic acid

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

glutaminase

decreases expression
decreases activity

ISO

benzenearsonic acid results in decreased expression of GLS protein
benzenearsonic acid results in decreased activity of GLS protein

NCBI chr 9:56,836,584...56,908,861
Ensembl chr 9:56,836,584...56,908,861

G

heme oxygenase 1

increases expression

EXP

benzenearsonic acid results in increased expression of HMOX1 mRNA

NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

angiopoietin 1

decreases expression

ISO

Roxarsone results in decreased expression of ANGPT1 mRNA

NCBI chr 7:73,528,345...73,783,953
Ensembl chr 7:75,418,218...75,668,696

G

chondromodulin

decreases expression

ISO

Roxarsone results in decreased expression of CNMD mRNA

NCBI chr15:55,041,548...55,066,297
Ensembl chr15:61,450,450...61,475,350

G

C-X-C motif chemokine ligand 9

decreases expression

ISO

Roxarsone results in decreased expression of CXCL9 mRNA

NCBI chr14:16,007,166...16,012,077
Ensembl chr14:16,007,204...16,014,299

G

ectonucleotide pyrophosphatase/phosphodiesterase 2

increases secretion

ISO

Roxarsone results in increased secretion of ENPP2 protein

NCBI chr 7:88,092,140...88,214,758
Ensembl chr 7:88,092,140...88,214,957

G

FH2 domain containing 1

decreases expression

ISO

Roxarsone results in decreased expression of INF1 mRNA

NCBI chr 2:169,790,917...169,829,580
Ensembl chr 2:172,089,010...172,125,956

G

hepatocyte growth factor

increases expression

ISO

Roxarsone results in increased expression of HGF mRNA

NCBI chr 4:19,628,902...19,700,467
Ensembl chr 4:19,632,267...19,700,851

G

leptin

decreases expression

ISO

Roxarsone results in decreased expression of LEP mRNA

NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:58,626,523...58,640,661

G

matrix metallopeptidase 9

increases expression

ISO

Roxarsone results in increased expression of MMP9 mRNA; Roxarsone results in increased expression of MMP9 protein

NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442

G

mechanistic target of rapamycin kinase

increases expression
multiple interactions

EXP

Roxarsone results in increased expression of MTOR mRNA
Roxarsone results in increased expression of and results in increased phosphorylation of MTOR protein; Sirolimus inhibits the reaction [Roxarsone results in increased expression of and results in increased phosphorylation of MTOR protein]

NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:164,167,928...164,277,435

G

nitric oxide synthase 3

multiple interactions

ISO

Roxarsone results in increased phosphorylation of and results in increased activity of NOS3 protein

NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664

G

platelet and endothelial cell adhesion molecule 1

increases expression
multiple interactions

ISO

Roxarsone results in increased expression of PECAM1 protein
Semaxinib inhibits the reaction [Roxarsone results in increased expression of PECAM1 protein]

NCBI chr10:92,090,263...92,152,002
Ensembl chr10:92,090,235...92,151,839

G

plasminogen

decreases expression

ISO

Roxarsone results in decreased expression of PLG mRNA

NCBI chr 1:50,872,927...50,915,406
Ensembl chr 1:50,872,926...50,917,320

G

ribosomal protein S6 kinase B1

multiple interactions
increases expression

EXP

Roxarsone results in increased expression of and results in increased phosphorylation of RPS6KB1 protein; Sirolimus inhibits the reaction [Roxarsone results in increased expression of and results in increased phosphorylation of RPS6KB1 protein]
Roxarsone results in increased expression of RPS6KB1 mRNA

NCBI chr10:71,817,794...71,865,211
Ensembl chr10:71,815,614...71,865,238

G

vascular endothelial growth factor A

multiple interactions

EXP

Roxarsone results in increased expression of and results in increased secretion of VEGFA protein

NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194

Term paths to the root

Path 1
Term	Annotations
CHEBI ontology	20862
chemical entity	20860
atom	20860
metalloid atom	15683
arsenic atom	15041
arsenic molecular entity	15041
organoarsenic compound	1281
1,2-phenylenebis(dimethylarsane)	0
1-dimethylarsinoyl-(2Z,5Z, 8Z,11Z,14Z,17Z)-heneicosahexaene	0
1-dimethylarsinoyl-(3Z,6Z,9Z,12Z,15Z,18Z)-docosahexaene	0
1-dimethylarsinoyl-decane	0
1-dimethylarsinoyl-heptadecane	0
1-dimethylarsinoyl-tricosane	0
2-Aminoethylarsonate	0
3-[(4-arsonophenyl)diazenyl]-AcTyrGlyGly	0
3-[(4-arsonophenyl)diazenyl]-AcTyrGlyGlyNHNHBoc	0
ABA diazonium	0
arsenoacetic acid	0
arsenocholine	0
arsolanes +	0
arsoles +	0
arsphenamine	0
arsphenamine pentamer	0
arsphenamine trimer	0
dimethylarsinic acid	1031
methylarsinous acid +	280
organoarsonic acid +	664
organoarsonic acid anion +	0
organoarsonic acid salt +	0
Path 2
Term	Annotations
CHEBI ontology	20862
subatomic particle	20860
composite particle	20860
hadron	20860
baryon	20860
nucleon	20860
atomic nucleus	20860
atom	20860
main group element atom	20781
main group molecular entity	20781
p-block molecular entity	20781
carbon group molecular entity	20715
organic molecular entity	20710
organometalloidal compound	1281
organoarsenic compound	1281
1,2-phenylenebis(dimethylarsane)	0
1-dimethylarsinoyl-(2Z,5Z, 8Z,11Z,14Z,17Z)-heneicosahexaene	0
1-dimethylarsinoyl-(3Z,6Z,9Z,12Z,15Z,18Z)-docosahexaene	0
1-dimethylarsinoyl-decane	0
1-dimethylarsinoyl-heptadecane	0
1-dimethylarsinoyl-tricosane	0
2-Aminoethylarsonate	0
3-[(4-arsonophenyl)diazenyl]-AcTyrGlyGly	0
3-[(4-arsonophenyl)diazenyl]-AcTyrGlyGlyNHNHBoc	0
ABA diazonium	0
arsenoacetic acid	0
arsenocholine	0
arsolanes +	0
arsoles +	0
arsphenamine	0
arsphenamine pentamer	0
arsphenamine trimer	0
dimethylarsinic acid	1031
methylarsinous acid +	280
organoarsonic acid +	664
organoarsonic acid anion +	0
organoarsonic acid salt +	0

paths to the root